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“Parents of autistic children know that there is some constitutional infirmity within their 
children’s minds that eventually must be addressed in neurophysiological and neurochemical 
terms. To what extent I have woven a tapestry of logic or fantasy is to be seen.”  
- Jaak Panksepp, 1979, pg. 177  
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Abstract 
Autism Spectrum Disorder (ASD) is a diverse disorder, and the heterogenous range of 
possible presentations hinders our understanding of its aetiology. Recently there has been a surge 
of genome wide association studies for ASD, while historically psychological theories were 
relied on to explain the emergence of ASD. These fields continue to provide insights into ASD, 
but they tend to operate in parallel – genetic studies often lack comprehensive psychological 
phenotyping and theoretical backing, and psychological studies tend to lack genetic explanations. 
I propose that moving forward, genotype-phenotype studies should have a strong foundation in 
both fields and should focus on genes and theories with real-world implications for ASD 
diagnostics and/or interventions. This approach can be supported by focusing on established, 
well supported psychological theories, and selected ASD candidate genes that could be 
implicated in these theories, and ideally the genetic mechanism implicated should be one that can 
be targeted by existing medications.  
I therefore selected two prominent psychological theories, the Social Motivation Theory 
for ASD (Panksepp, 1979) and the ToM Theory for ASD (Baron-Cohen et al., 1985), and 
selected an ASD candidate gene that was likely implicated in each of these theories, namely the 
mu-opioid receptor gene (OPRM1) and the serotonin transporter promoter length polymorphism 
(5-HTTLPR) respectively. For the first study of this protocol, I assessed the possible 
relationships between social motivation, OPRM1, and the ASD phenotype. For the second study, 
I assessed possible relationships between ToM deficits, 5-HTTLPR, and the ASD phenotype. 
These two studies shared a sample of 153 male children 4-16 years old; 51 boys per group (i.e. 
non-verbal ASD; verbal ASD; neurotypical). All ASD children completed ADOS2 assessment 
for ASD phenotyping.  
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For the Social Motivation Study, attachment was used as a proxy to assess level of social 
motivation in all participants, and 76 of the 102 children with ASD provided DNA for OPRM1 
genotyping. Comparisons across all three groups showed that the ASD samples had significantly 
lower social motivation than the neurotypical sample, with the non-verbal ASD group displaying 
the most severely reduced level of social motivation. Reduced social motivation was associated 
with ASD-related deficits in the non-verbal ASD sample but not the verbal ASD sample. Finally, 
I was unable to statistically assess the role of OPRM1 as hypothesized, due to an 
unprecedentedly high rate of the OPRM1 G allele, which indicated atypical mu-opioid processes. 
This clearly implicated OPRM1 in ASD and is the first study to show this so convincingly. 
Overall, this study’s findings led me to suggest that Panksepp’s (1979) theory could be updated 
to include a threshold effect such that more severely reduced social motivation in ASD is 
associated with little-to-no language acquisition, while those with less severely reduced social 
motivation are able to develop language and this protects against associations between social 
motivation and ASD-related deficits in childhood.  
For the Theory of Mind Study, the verbal ASD sample and neurotypical sample 
completed a developmental ToM Battery (i.e. University of Cape Town Theory of Mind Battery) 
and WASI assessment to establish verbal intelligence quotient (VIQ) scores, and 70 of the 
children with ASD were successfully genotyped for 5-HTTLPR. This study found that verbal 
male children with ASD tended to be one developmental stage behind age-matched neurotypical 
peers on ToM tasks. ToM deficits were associated with greater impairment in overall ASD 
severity and in symptoms from the social communication and interaction domain. For the non-
verbal ASD sample, the 5-HTTLPR short allele, which is implicated in atypical serotonergic 
transmission, was associated with greater impairment overall and in the restricted and repetitive 
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behaviours and interests symptom domain. No associations between 5-HTTLPR and ToM, or 
with ASD-related symptoms, was found for the verbal ASD group. This again suggested that 
language acquisition is an important consideration in genotype-phenotype studies in male 
children with ASD.  
This protocol illustrated the importance of including a range of ASD presentations in 
research studies. This is especially true in the case of non-verbal participants with ASD, as the 
possibility of different genotype-phenotype relationships in verbal versus non-verbal children 
with ASD has not been a major research focus to date, with little research being available. This 
finding may have implications for diagnostic and intervention practices in ASD, as current 
knowledge is generally based on research with verbal children with ASD and may therefore have 
some limitations being generalised to non-verbal children with ASD. Specifically, the genotype-
phenotype relationships for these two theories and genes were only found for the non-verbal 
ASD group, suggesting they may benefit from medications which target these pathways, such as 
naltrexone and SSRIs, although further research is needed to confirm this. Overall, 
contextualising these genotype-phenotype studies within prominent psychological theories has 
provided greater insight into these theories, at least in the context of male children with ASD. 
This has provided more nuanced knowledge on the roles of these two ASD candidate genes in 
the male ASD-phenotype, and identified possible treatment roles for targeting these genes in 
specific children with ASD.  
 
Keywords: Autism Spectrum Disorder; social motivation; SEPARATION-DISTRESS; OPRM1; 
Theory of Mind; 5-HTTLPR. 
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Chapter 1: General Introduction to Protocol 
This research protocol was compiled and submitted as my dissertation for the degree of 
Doctor of Philosophy at the University of Cape Town (UCT). This research was conducted under 
the primary supervision of Associate Professor Susan Malcolm-Smith, with co-supervision by 
Prof. Kirsty Donald, as part of our Autism Research Team in the ACSENT Laboratory, UCT. 
Under said supervision, I was able to design this project, collect all data, and finally conduct the 
analyses and compile this write up. I was involved in all aspects of data collection, and 
personally conducted all ADOS2 assessments and the bulk of the Autism Spectrum Disorder 
(ASD) data collection. I co-supervised honours and masters students in our team who assisted 
with data collection, particularly the parent interviews and data collection for the neurotypical 
group. All DNA was personally collected and was then processed at the Department of Human 
Genetics, UCT. 
The overarching focus of this dissertation is on genotype-phenotype studies in the field of 
ASD. There is a large body of research in this field, but I found that psychological research often 
lacked sufficient biological backing, and conversely, genetic studies lacked sufficient 
psychological input when compiling ASD phenotypic data. I hope to contribute to the field by 
showing how the roles of ASD candidate genes can be better understood when investigated in a 
hypothesis-driven manner, alongside prominent psychological theories underlying our current 
understanding of ASD.  
Currently, we know that ASD affects individuals from the start of development and 
throughout the lifespan. Yet despite the high prevalence and sometimes devastating effects of 
this disorder, we do not have a definitive understanding of the causes of ASD; without a full 
understanding of the causes and contributing factors, our prevention and treatment efforts will 
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always be limited. This thesis did not aim to find a central or single cause for ASD, but rather 
sought to assess two prominent psychological theories for ASD alongside appropriate ASD 
candidate genes. Numerous psychological theories exist to explain the emergence of ASD, and 
hundreds of ASD candidate genes have been identified. Together these fields should contribute 
to elucidating the underlying causes of ASD, of core deficits, and how this disorder unfolds 
across development in this way we can understand the biological and developmental pathways 
underling ASD and see beyond the confusion that exists due to the heterogenous presentations 
evident in this disorder.  
Due to the sheer volume of research in both fields, I believe that a useful way forward 
would be to explore the role of selected ASD candidate genes in prominent psychological 
theories using a hypothesis-driven approach. Psychological theories should be selected based on 
the level of support from existing research, as well as their ability to meaningfully explain the 
emergence and development of ASD. Candidate genes should be selected based on their 
likelihood of being implicated directly in critical elements of said psychological theories, and on 
outcomes that could result from identifying their role in ASD – that is, we should aim for 
knowledge that can lead to improvements in diagnostics, interventions, and medical treatments. 
My thesis therefore reviews our current knowledge of ASD, explores two selected psychological 
theories with associated candidate genes, and discusses my findings and the validity of this 
approach to genotype-phenotype research in ASD.  
This protocol was therefore written up across five chapters. This first chapter gives an 
overview of the approach I’ve taken toward this research. Chapter Two then provides a literature 
review on our current knowledge of ASD. ASD is complex disorder, with a history of changing 
psychological theories explaining it, and newer medical research attempting to do the same. 
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Understanding this developing knowledge sets the foundation for the way forward; taking our 
existing knowledge and bringing it together cohesively across fields, as I hoped to do, presents 
the opportunity to understand the biological and psychological aspects of this disorder. In turn, 
this may open further avenues to improve diagnostics and treatment options.  
Chapter Three focuses on the first psychological theory of interest, the Social Motivation 
Theory for ASD (Panksepp, 1979). This theory proposed that ASD arises when mu-opioid 
systems are disrupted, either by increased baseline opioid levels or increased activation, and that 
the effects of these disruptions undermine social interest in the individual such that infants do not 
find social interaction pleasurable or social separations unpleasant. This psychological theory 
directly implicated the mu-opioid receptor gene (OPRM1) in biological pathways to ASD, but 
the exact role of this gene in the ASD phenotypes has yet to be adequately explored within an 
ASD sample. I selected the Social Motivation Theory for ASD as it has long been researched in 
animal models and is very well supported at this level but lacked sufficient research in human 
studies. I also selected this theory because the effects of the implicated gene (i.e. OPRM1) can 
easily be targeted by existing medications. I therefore explored the level of social motivation 
deficits in ASD when compared to neurotypical children, how these deficits related to the ASD 
phenotype, and what role OPRM1 played in reduced social motivation and/or ASD-related 
deficits.  
Chapter Four focused on the ToM Theory for ASD, as Theory of Mind (ToM) has long 
been an area of interest in ASD research (Baron-Cohen et al., 1985). ToM deficits are common 
in ASD samples, and their role in the overall phenotype and in specific ASD-related deficits has 
not been fully elucidated. I therefore aimed to quantify the degree of ToM deficit compared to 
neurotypical samples, and to explore the role of ToM deficits in the ASD phenotype. Although 
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the ToM Theory for ASD does not implicate a specific ASD candidate gene, the serotonin 
transporter promoter length polymorphism (5-HTTLPR) is of interest as it regulates the 
neurotransmission of serotonin, which is implicated in ToM processing (Bosia et al., 2011; 
Murphy et al., 2006). Further, 5-HTTLPR has shown atypical allelic distribution patterns in ASD 
samples (Arieff et al., 2010). To my knowledge, two phenotype-genotype studies for 5-HTTLPR 
in ASD have been reported (Brune et al., 2006; Tordjman et al., 2001). These studies did not 
agree on the role of 5-HTTLPR in overall ASD severity, or in whether it was associated with 
specific aspects of the ASD phenotype. 5-HTTLPR is easily targeted by serotonin-specific re-
uptake inhibitors (SSRIs) which are already in use in some ASD treatment regimens (Sugie et 
al., 2005). However, treatment outcomes are mixed and it is unclear why some children show an 
alleviation of ASD-related symptoms with this treatment approach, while others do not, and the 
symptoms which do appear to benefit from treatment are not consistent across cases. I therefore 
aimed to further explore the role of ToM in the ASD-phenotype, and to explore the role of 5-
HTTLPR in the ASD phenotype and in ToM deficits in ASD.  
Finally, Chapter Five provides an overview of the results from the above two studies, as 
well as a general discussion on pertinent findings. This chapter explores the value of this 
approach to phenotype-phenotype research in ASD. The strengths and weaknesses of the current 
protocol are also discussed, with suggestions for future research.  
While this protocol aimed to clarify associations between selected ASD candidate genes 
and core aspects of ASD with a male sample, it is noted that this study was conducted in a South 
African context - that is, in the context of a resource limited developing country. While organic 
findings could be universal, at least for male children with ASD, their phenotypic outcomes are 
likely to be influenced by cultural and environmental factors. The context of this protocol should 
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be seen as a strength, however, as globally we need to increase our focus on ASD in various 
contexts and move away from our current over-reliance on research and knowledge from first 
world countries (de Vries, 2016). ASD constantly evades full understanding due to the 
complexity and variability of its presentations, so exploring a range of ASD presentations across 
a range of contexts is necessary. I hope the current protocol and its approach to merging 
psychological and genetic research will aid in moving forward toward a better understanding of 
this disorder.  
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Chapter 2: Current Understanding of ASD 
 ASD is a neurodevelopmental disorder characterised by deficits in social communication 
and social interaction, alongside restricted and repetitive behaviours and interests (American 
Psychiatric Association, 2013). ASD is a pervasive disorder with lifelong deficits. Although it is 
prevalent worldwide, its full aetiology remains poorly understood, and this places limitations on 
prevention and intervention efforts. As a neurodevelopmental disorder, these deficits present in 
early development. However, deficits may only become clinically recognised when the child is 
older and the demands on social communication and interactions skills increase to the point 
where they exceed the child’s capabilities. 
Although ASD is a social disorder, it is not a homogenous disorder and the core social 
difficulties can present in a number of ways, resulting in an unusually diverse range of symptom 
presentations (American Psychiatric Association, 2013). Several social areas are assessed during 
the ASD diagnostic process, from the ability to socially modulate eye-contact, to the ability to 
identify emotions and to understand one’s role in social relationships (Lord et al., 2003; Rutter, 
Le Couteur, et al., 2003). ASD initially had subtypes due to the diverse range of presentations 
(American Psychiatric Association, 2000), although the new diagnostic criteria have moved 
away from subtyping and instead focus on severity in each symptom domain and additional 
descriptors that specify whether common signs, such as language impairment, are present 
(Appendix A; American Psychiatric Association, 2013). Ongoing research has revealed that 
some children previously thought to have ASD actually presented with unique genetic disorders 
(e.g. Rett’s syndrome; Caballero & Hendrich, 2005). Although currently all ASD cases are 
considered to represent one disorder, it is possible that further research may reveal that some 
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cases represent different genetic disorders It is therefore important to understand the genetic 
similarities and differences across what are currently the considered ASD phenotype spectrum.  
The variance in the ASD phenotype is seen in how the diagnosis of ASD can be given to 
one child who has significant difficulties with socially modulating their eye-contact, directing 
facial expression, and with initiation of social overtures on one hand, as well as to another child 
who presents very differently with numerous but inappropriate social overtures, stereotyped 
speech, and difficulty reading social cues (Caballero & Hendrich, 2005). There is little clarity on 
how deficits in different social skills relate to overall level of ASD severity, or how initial social 
deficits underlie the development of later social deficits. 
In addition to varying qualitative presentations, ASD also presents on a spectrum of 
severity (American Psychiatric Association, 2013). Some children will present with no 
expressive language and with self-harming behaviours and an inability to conduct self-care, 
while others may be able to function in mainstream schooling and some even complete tertiary 
education despite some restricted interests, compulsions, and difficulties relating to others 
(American Psychiatric Association, 2013). The diversity of possible symptom presentations for 
ASD and the range of possible outcomes further complicates our understanding of this disorder. 
Prevalence 
ASD is one of the most prevalent developmental disorders globally with prevalence rates 
ranging from 13.1 to 27.5 per 1000 (Baio et al., 2018; Taylor & Seltzer, 2011). Worldwide 
prevalence rates are heavily dependent on reports from Europe and the USA, while the 
prevalence of ASD in many developing countries remains unknown. A community survey of 
1169 children in Uganda identified 8 children with ASD (i.e. 6.8/1000 of the sample) (Kakooza-
Mwesige et al., 2014), while a study in a paediatric neurology clinic in Nigeria identified 54 
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cases of ASD among 2320 patients (i.e. 23.3/1000 in a paediatric neurological sample) (Lagunja 
et al., 2014). While these samples are small, and the second sample is not from the general 
community, they show that ASD is prevalent in Africa. There is no official reported prevalence 
rate for ASD in South Africa, but an estimated average of ten children per week are diagnosed 
with ASD between three tertiary level state hospitals in the Western Cape (Bateman, 2013). As 
the Western Cape is only one of nine provinces, this indicates a high prevalence of ASD in South 
Africa. 
ASD is predominantly diagnosed in males, with the ratio of male to female diagnoses 
being 4:1 (American Psychiatric Association, 2013), although a metanalysis of 54 studies found 
that the ratio was closer to 3:1 (Loomes et al., 2017). There is some evidence that females with 
ASD have a different phenotype to males with the same diagnosis, although the nature of these 
differences requires further investigations (Rivet & Matson, 2011). The prevalence of ASD does 
not appear to be affected by race or ethnicity, but research indicates that communities of low 
socio-economic status (SES) are likely to under-identify cases of ASD, and that diagnoses from 
these areas tend to be made at a later age (Bertrand et al., 2001; Bakare & Munir, 2011b; 
Fombonne et al., 1994). 
The high prevalence of ASD is concerning and there is an increasing global awareness of 
the burden of this disorder (Baird et al., 2006; Bertrand et al., 2001; Kogan et al., 2009; 
Malcolm-Smith et al., 2013). The heterogeneous nature of the disorder results in needs for 
support across various domains, but many of these children will never develop into 
independently functioning adults. ASD therefore places substantial strain on families and the 
state. There is generally very little information available locally on ASD and its social and 
monetary cost (Kogan et al., 2009) and South Africa also lacks sufficient diagnostic and 
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intervention services, meaning that even when a formal diagnosis is made, very limited services 
are available to the child and their family.  
ASD in South Africa 
de Vries (2016, p. 130) commented that “almost everything we know about ASD comes 
from high-income countries, mainly the USA, UK, and other European countries”, and continues 
to point out that this is despite the reality that 90% of people with ASD live in contexts that are 
low and middle-income, such as Africa. The paucity of research in South Africa, and Africa in 
general, means very little is known about ASD diagnostics, prevalence, and phenotypes in South 
Africa. To date, even prevalence rates are unclear in the African region, as there have yet to be 
any comprehensive prevalence studies in sub-Saharan Africa at all (Harrison et al., 2014).  
However, there is a rising interest in ASD locally, and the last decade has shown an 
increase in African research, particularly in South Africa and Nigeria (Abubakar et al., 2016). 
Local studies have focused on issues such as the appropriate use of the ADOS2 in Cape Town, 
South Africa (Smith et al., 2017), on the role of genetics in ASD (Arieff et al., 2010; Sharma et 
al., 2013), and on symptom presentations in terms of empathic responses such as cradling bias 
(Pileggi et al., 2015) and ToM development (Hoogenhout & Malcolm-Smith, 2014, 2016). 
ASD Resources in South Africa  
Despite this increase in research, South Africa is critically under-resourced to deal with 
the high incidence of ASD. In the Western Cape, the Red Cross War Memorial Children’s 
Hospital, Lentegeur Hospital, and Tygerberg Hospital report collectively diagnosing 10 children 
a week with ASD (Bateman, 2013), but there are only 9 schools in the entire country that are 
specifically tailored to provide the specialised education required for children with ASD. In 
general, medical and clinical professionals have limited access to diagnostic and intervention 
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services through the public health sector (Malcolm-Smith et al., 2013). In South Africa there are 
no standard policies or good practice guidelines for the diagnosis, treatment, support, or 
education of people with ASD (de Vries, 2016). 
South Africa further struggles due to poor access to appropriate ASD assessment 
measures. When resources can be accessed, many practitioners are not adequately educated 
about ASD to know to use them (Mitchell & Holdt, 2014). Further, there are concerns about the 
use of Western tests in South Africa, which is a culturally and linguistically diverse country. 
Globally, the ADOS2 is the gold standard for ASD diagnosis assessment (Chambers et al., 2017), 
but at the time of the current research there was no standardised and validated translation of the 
ADOS2 into a non-English South African language (Smith et al., 2017).  
Chambers et al. (2017) conducted a study in urban and peri-urban areas in 
Pietermaritzburg, South Africa, where they translated several ASD diagnostic measures, 
including the ADOS2, into isiZulu. Assessment with 26 isiZulu-speaking toddlers (n = 10 ASD 
participants; n = 16 non-ASD participants) found that the ADOS2 was still able to reliably, and 
validly, identify ASD “red flags”, although a comprehensive validation study was not conducted 
due to the small sample size. Similarly, Smith et al. (2017) assessed the cultural appropriateness 
of an Afrikaans translation of the ADOS2 in a Western Cape sample. A pre-pilot study of this 
translation was conducted with 7 children from a clinical sample with their caregivers in the 
room for the assessment; caregivers were then given the opportunity to report back on how 
appropriate they found the measure. The researchers noted some of the subtests were not 
culturally appropriate for their low-to-middle socioeconomic sample, such as the Description of 
a Picture task, Demonstration task, and the Birthday Party task. Overall, however, the study 
found that most of the ADOS2 materials were familiar and appropriate for use with this sample, 
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and the ADO2 translation was able to identify the participant with ASD, and that the other six 
children did not meet the criteria for an ASD diagnosis.  
The shortage of appropriate tests and access to resources also results in a later age of 
diagnosis locally compared to the USA and UK. Mitchell and Holdt (2014) conducted a 
qualitative study with seven families in KwaZulu-Natal, South Africa, where they explored the 
process of ASD diagnosis. The families reported that the diagnostic process was time-consuming 
and laborious, and time between initial concern and final diagnosis took over three years on 
average, with one family reporting a diagnosis time of seven years. Part of this difficulty was the 
number of clinicians and professionals required to make the diagnosis, with the families 
reporting an average of seven practitioners being seen before reaching a diagnosis. It is noted 
that these families had the means to pursue some private services, but the majority of the South 
African population has limited socioeconomic means, and their dependence on the limited state 
facilities could result in an even poorer outlook, with many children never receiving a formal 
diagnosis.  
Non-Verbal ASD in South Africa 
A further characteristic of ASD locally that needs to be noted is the high reported 
prevalence of non-verbal children with this disorder. Bakare and Munir (2011 a, b) conducted 
two literature reviews on the presentation of ASD in Africa, and they found that there was a 
much higher rate of non-verbal ASD presentations compared to Western presentations, and 
further, that these children often failed to develop meaningful expressive language as they aged. 
In their literature search they found that over 50% of cases reported lacked expressive language. 
They observed that this could be due to poor access to diagnostics and then to intervention 
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resources. Limited access to resources, however, could also result in a bias such that children 
with more severe ASD are more likely to be seen and diagnosed.  
Springer et al. (2013) conducted a retrospective review of the medical files available at 
Tygerberg’s Children Hospital, South Africa, and found 58 children who met the criteria for an 
ASD diagnosis. Using the classification of “non-verbal” for children who used fewer than 10 
non-echoed words, they found their sample was predominantly non-verbal (72.4%, n = 42). One 
possible reason for the higher rate of non-verbal diagnoses in South Africa is that these children 
are frequently referred for hearing tests when they fail to develop language, and may therefore be 
given priority at the clinics compared to verbal children with possible ASD, resulting in children 
with milder forms of ASD either not presenting to health care facilities or not being referred to 
the appropriate institutes.  
Research findings from the USA and UK cannot be assumed to be appropriate in South 
Africa without considering our context. In order to understand the occurrence of ASD locally and 
work toward revealing its aetiology, research needs to be conducted within a local context. While 
international research has laid the foundation for understanding ASD, the unique local context 
emphasises the need to conduct further research in South Africa. 
ASD Diagnostic Criteria 
An ASD diagnosis, as per the DSM-5 (American Psychiatric Association, 2013), requires 
a child to have deficits in two main symptom dimensions (Appendix A). The first dimension 
encapsulates deficits in social communication and interaction, and the second dimension refers to 
deficits related to restricted and / or repetitive behaviours, interests or activities. Deficits in both 
dimensions must be present in multiple contexts. Current and historical symptoms are assessed 
during diagnostic processes as symptoms must be present in early development to indicate a 
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neurodevelopmental disorder. Consideration of historical symptoms is especially important when 
assessing language development, as delayed language development is often a key symptom of 
ASD, but a child may have overcome this delay by the time they see a clinician for diagnostic 
purposes. When assessing symptoms in early development one must be mindful that symptoms 
may not yet be fully manifest but will become more apparent as the child ages and demands 
exceed their capabilities in a more apparent manner (Lauritsen, 2013). A child must have 
symptoms in both core symptom domains to meet the diagnostic criteria, the deficits must cause 
impairment to their functioning, and their symptoms must be best explained by an ASD 
diagnosis and not by any other learning or developmental disorders (American Psychiatric 
Association, 2013). An ASD diagnosis under the DSM-5 can also include specifiers noting 
whether the ASD diagnosis is with or without comorbid intellectual impairment, language 
impairment, and / or catatonia, or is associated with a known medical or genetic disorder, an 
environmental factor, or with another neurodevelopmental, mental, or behavioural disorder.  
ASD is generally diagnosed at the age of 3 or 4 years old, or later in developing 
countries, but atypical development is often noted prior to this age (Chakrabarti & Fombonne, 
2005; Chawarska et al., 2007; Mitchell & Holdt, 2014). Some early signs of ASD may be present 
at 6 months of age if the child fails to make eye-contact or to show anticipatory gestures, or if 
they show a general disregard for social interaction. Later, at 1 year and older, a failure to 
respond to their name, or to orient themselves toward someone interacting with them, may be 
seen. At two years and older, expressive language may fail to develop, may be delayed, or may 
be atypical. Atypical expressive language may include pronoun reversals, echolalia, or 
stereotyped speech, and speech is often unusual in rhythm or tone. This can be accompanied by 
poor joint attention, limited facial expressions and gestures, low social interest in others and poor 
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empathy (Chawarska et al., 2007; Cox et al., 1999). As the child continues to age, those who do 
develop language often fail to also develop the gestures and facial expressions that accompany 
typical speech, and those that do may fail to integrate these with their speech. 
ASD is a pervasive disorder that continues to impact the individual throughout their life. 
Adults with ASD tend to find the transition from the structured school environment into the adult 
world challenging (Taylor & Seltzer, 2011). Adults with ASD tend to have limited independence, 
struggle to form adult friendships and relationships, and battle with unemployment and low 
economic status (Eaves & Ho, 2008; Howlin & Moss, 2012; Taylor & Seltzer, 2011). Adults with 
ASD who do find employment are often limited to part-time work, and this work tends to be 
menial in nature. Some studies have found that individuals who were able to find some form of 
employment or develop relationships tended to be those with better language capabilities by age 
five, as well as the absence of comorbid intellectual difficulties (Eaves & Ho, 2008). However, it 
was also found that adults with ASD without comorbid intellectual difficulties had far less 
support options than those with intellectual difficulties. Overall, adults with ASD continue to 
struggle with ASD-related symptoms and difficulties, and only a portion manage full 
independence as adults.  
Other Common ASD Characteristics 
In addition to the core areas of deficits required for an ASD diagnosis, ASD has many 
associated features that are common in this disorder, although these are not unique to it 
(American Psychiatric Association, 2013). 
Children with ASD may experience sensory difficulties. As with many aspects of ASD, 
the heterogenous nature of this disorder is evident: some children may present with 
hypersensitivity to sensory input, while others can present with hyposensitivity (American 
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Psychiatric Association, 2013). Hypersensitivity to sound is common and results in great 
difficulties integrating an otherwise high functioning child into mainstream schooling or daily 
activities. By contrast, children with hyposensitivity have been reported to injure themselves and 
show limited pain response, placing them at a higher risk for self-injury. These children also tend 
to show an unusual interest in sensation, often seeking higher stimulation in firmer touch from 
caregivers, and showing a fascination with the sounds and smells of objects. 
Children with ASD may present with mildly delayed motor milestones or motor 
symptoms (American Psychiatric Association, 2013; Lam & Yeung, 2012; Manjiviona & Prior, 
1995; Noterdaeme et al., 2010; Szatmari et al., 2006; Thede & Coolidge, 2007). Some motor 
symptoms are included under the motor component of restricted and repetitive behaviours, such 
as arm flapping, while others are included under the self-injurious behaviour component, such as 
head-banging. Generally motor symptoms can be present in the form of clumsiness or odd gait, 
and toe-walking is especially common. Individuals may present with catatonic-like symptoms, 
but this is rare. 
Sleep difficulties are also commonly associated with ASD, including slow sleep onset, 
irregular sleep-waking patterns, many night awakenings, and early waking (Gabriels et al., 2005; 
Krakowiak et al., 2008; Richdale, 1999; Springer et al., 2013). Poor sleep can aggravate existing 
symptoms, and can lead to further difficulties in concentration, in school performance, in 
behaviour, and additional stress for the child and caregivers.  
Gastrointestinal symptoms, dietary sensitivities, and difficulty with food intake are 
commonly noted in children with ASD (Cermak et al., 2010; Chandler et al., 2013; Knivsberg et 
al., 2002; Kral et al., 2013; Talay-Ongan & Wood, 2000; White, 2003), although gastrointestinal 
symptoms are not always more common in ASD samples compared to neurotypical samples 
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(Black, Kaye, & Jick, 2002). These children can be highly selective with food and are often 
unwilling to try new or unfamiliar foods (Cermak et al., 2010; Kral et al., 2013; Talay-Ongan & 
Wood, 2000). Children may display odd behaviours with food, such as touching and smelling 
without eating the food, and ingesting non-food substances is also reported. Some researchers 
have ascribed these difficulties with food to sensory sensitivity in reaction to the textures, smells 
and tastes of the foods; this may be why some children are resistant to some foods and, 
conversely, could also explain intense fascination with certain foods shown by some other 
children with ASD (Cermak et al., 2010; Talay-Ongan & Wood, 2000). Gastrointestinal 
symptoms such as vomiting, diarrhoea, abdominal pain, bloating, and constipation are also more 
common in children with ASD when compared to neurotypical children (Cermak et al., 2010; 
Chandler et al., 2013; Kral et al., 2013; White, 2003). The above challenges with food and 
gastrointestinal symptoms combine to create daily challenges in eating routines, and limited food 
intake can result in inadequate nutrition, stunted development, and may exacerbate other ASD 
symptoms (Cermak et al., 2010; Knivsberg et al., 2002; Kral et al., 2013; White, 2003). 
Children with ASD may also receive comorbid diagnoses (American Psychiatric 
Association, 2013). Intellectual impairment is one of the most common comorbid diagnoses 
(American Psychiatric Association, 2013; Baio et al., 2018; Chakrabarti & Fombonne, 2005; 
Happe & Frith, 2006; Thede & Coolidge, 2007). Intellectual ability can range from severely 
impaired to above average. However, even individuals with high intellectual functioning can 
present with a substantial difficulty with adaptive functional skills in social contexts. 
Anxiety is very common in ASD, and as these individuals reach adulthood they may be 
diagnosed with comorbid depression or anxiety disorders (American Psychiatric Association, 
2013; Simonoff et al., 2008). Attention Deficit/Hyperactivity Disorder (ADHD) (American 
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Psychiatric Association, 2013; Peacock et al., 2012; Simonoff et al., 2008) and seizures or 
Epilepsy (American Psychiatric Association, 2013; Bolton et al., 2011; Peacock et al., 2012; 
Simonoff et al., 2008) are also frequently diagnosed in children with ASD.  
The heterogeneous nature of ASD, as well as the possible associated characteristics and 
comorbidities, can make it a challenging disorder to characterise and diagnose. The high 
prevalence of ASD globally underscores the need to further improve our understanding of the 
disorder, as well as our current diagnostic procedures and interventions. 
Social Deficits 
At its core, ASD is a disorder of social ability, with striking impairment in 
communication and interaction (American Psychiatric Association, 2013). From the origin of its 
conceptualisation, ASD was characterised as a disorder where a child was unable to socially 
connect with others, including their caregivers, and that even those who developed language 
struggled to use it effectively to communicate in a social context. Leo Kanner (1943), one of the 
first clinicians to classify and explore ASD, asserted that the core feature of ASD was a sense of 
“aloneness”, whereby children presented as profoundly disconnected and socially separated from 
others. He described how the children he worked with struggled to connect and relate themselves 
to people around them, and that this was evident from the very beginning of life. Based on his 
work with children with ASD and their families, he concluded that “we must then assume that 
these children have come into the world with an innate inability to form the usual, biologically 
provided affective contact with people, just as other children come into the world with innate 
physical or intellectual handicaps” (Kanner, 1943, p. 250). Further research and a greater 
understanding of ASD has shown that this apparent lack of social drive is present for many of the 
children on the spectrum, and we see persistent difficulties in understanding reciprocal 
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interactions, in relating to and understanding others, and possibly a decreased or absent desire, or 
atypical ability, to enter social interactions (American Psychiatric Association, 2013).  
While some children with ASD desire social relationships, others seem to show no social 
interest at all. When first conceptualising ASD as a disorder, Kanner (1943) noted that the 
children he worked with did not simply withdraw from social participation – they appeared to 
disregard, ignore, and completely shut themselves off from social situations. In many cases 
social aloofness is not a preference but seems to result from an early failure to develop a social 
interest, and this in turn leads to a failure to develop social attachments. These children struggle 
to make and maintain friendships. It is not uncommon for the child to fail to develop friendships 
at all, and often if they do develop friendships these are shallow and inappropriate for their age 
(American Psychiatric Association, 2013; Lauritsen, 2013). Interaction is often awkward and can 
be characterised by socially maladaptive behaviours. In cases where a natural social ability does 
not develop, some children may develop strategies to navigate social situations, and these 
strategies can become more complex and refined with age. However, these strategies are 
typically still too restricted to fully compensate and approximate innate social ability, and the 
social behaviour of these individuals may therefore come across as scripted and unnatural and 
places a burden on the individual to perform in a certain way (Hull et al., 2017).  
Social deficits present differently as the child develops. As young infants, children with 
ASD may fail to exhibit anticipatory postures in order to prepare to be picked up, suggesting a 
failure even at that age to understand the basic intentions of others (Happe & Frith, 1996; Klin et 
al., 1992). At this age poor attachment with the caregiver is often noted and can be characterised 
by little to no comfort seeking (Rutgers et al., 2004; Rutgers et al., 2007). Failure to initiate or 
maintain eye contact often becomes more evident as these children develop, and difficulties in 
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joint attention mark their social isolation when surrounded by others (Meyer & Minshew, 2002). 
Many children with ASD struggle to read the non-verbal cues and body language of others, and 
often respond inappropriately. They may demonstrate unusual body postures and gestures in 
social situations, as well as inappropriate facial expressions (American Psychiatric Association, 
2013). Impaired ToM can be a component of the difficulty in understanding others (Baron-Cohen 
et al., 1985). The lack of understanding of others inevitably translates into incomprehension of 
social norms and conventions, and ultimately results in a socially isolated childhood.  
While ASD is predominantly diagnosed in males, research with female children with 
ASD has found several differences across the sexes which could suggest differential phenotypes 
with different developmental trajectories and outcomes (Van Wijngaarden-Cremers et al., 2014). 
In particular, female children with ASD may have a social advantage over male children with 
ASD. Sedgewick et al. (2016) explored friendship experiences and social motivation in a mixed 
sex sample of children from special education schools, both with and without ASD. They found 
that female children with ASD displayed similar friendship quality and social motivation to 
female children without ASD. By contrast, male children with ASD displayed less motivation for 
social interaction, and their friendships were qualitatively different to the female children with 
ASD and to the children without ASD. Further, the female children with ASD reported higher 
levels of relational aggression within friendships when interviewed. Similarly, a qualitative study 
using semi-structured interviews with a sample of 11 female children with ASD between 11-17 
years old found that the participants were interested in having friendships. Female children with 
ASD appeared to have an understanding of what was required for successful friendships, and 
derived enjoyment from these social relationships (Cook et al., 2017; Vine Foggo & Webster, 
2017). Finally, female children with ASD appear to display more behaviours indicating a desire 
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and understanding of friendship than male children with ASD, such as a better understanding of 
empathy, entering multiple social interactions flexibly, and staying in the proximity of their peers 
when together (Dean et al., 2014; Dean et al., 2017; Head et al., 2014).  
In addition to difficulties with understanding social situations and struggling to relate to 
others, social communication difficulties can also include language deficits which further 
undermine their ability to function in a social context (American Psychiatric Association, 2013; 
Lauritsen, 2013).  
Language Deficits 
Language deficits represent one aspect of a more general deficit in verbal and non-verbal 
communication in ASD (Verhoeven et al., 2012; Zillmer et al., 2008). The ability to 
communicate with gestures is regarded as a precursor to the development of language and the 
skills needed for social interactions, yet children with ASD with impaired language often fail to 
utilise non-verbal behaviours to compensate when trying to communicate.  
Language deficits in ASD can present as impairments in the expression and/or 
comprehension of language (American Psychiatric Association, 2013; Mody et al., 2013). 
Approximately 25% of individuals with ASD fail to develop functional language, while those 
who develop language may have a significant delay in this development (Mody et al., 2013). As 
mentioned above, the rate of non-verbal children with ASD is even higher in under-resourced 
and developing countries (Bakare & Munir, 2011b). 
When language is present, it is often unusual (Zillmer et al., 2008). It can be 
characterised by stereotyped content, tangential responses, and replies to questions can be 
inappropriate or unrelated to the context of the conversation. Pronoun misuse is common and is 
most often noted in a failure to switch between pronouns referring to the self versus pronouns 
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referring to others (Happe & Frith, 1996). Children with ASD often have a very literal 
understanding of language and may therefore fail to use generalised terms. Some therefore 
struggle to understand the general uses of ‘yes’ or ‘no’, and resort to responding to questions by 
repeating them as statements. Difficulties with nonliteral language can also result in an inability 
to understand metaphor, sarcasm and irony (Happe & Frith, 1996; Meyer & Minshew, 2002). 
Research on language development in ASD has shown that many children have a very high rate 
of depending on heard sentences and repeating these rather than generating their own sentences; 
this technique can have mixed results as sentences are sometimes used appropriately and 
sometimes are not, but in severe cases this can result in echolalia (Rapin & Dunn, 2003). 
Language is fundamentally intertwined with cognitive, social, and emotional domains of 
function, and these areas develop in ways that involve ongoing influencing of one another (Mody 
et al., 2013). The development of language therefore significantly affects children’s thinking, 
learning, and their ability to form relationships. As children with ASD often fail to orient to 
speech from a young age, including when their names are called, it is likely that communication 
impairment may be, at least in part, secondary to their deficits in social competence and 
reciprocity (Mody et al., 2013).  
Language deficits in ASD could be a direct extension of the deficits in social functioning, 
as indicated by the shift from the DSM-IV-TR's separate symptom domains of "social 
interaction" and "communication" into the DSM-5 single diagnostic criteria of impairment in 
"social communication and social interaction" (American Psychiatric Association, 2000, 2013). 
A review of the state of research on non-verbal children with ASD found that these children had 
severe deficits in social motivation, supporting this association between language development 
and social interest (Tager-Flusberg & Kasari, 2013). A review of the literature on language 
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acquisition in ASD found that language was impaired in most cases of ASD, even when children 
were considered fluent (Eigsti et al., 2011).  
A direct relationship between social interaction and language development in 
neurotypical children was shown by a series of experiments by Kuhl (2010). They exposed 
English speaking toddlers to Mandarin for 12 sessions across 4-5 weeks and then used 
behavioural and event-related potential (ERP) measures to assess phonetic perception. Toddlers 
were divided into groups with various levels of social interaction included in the sessions: some 
children had no social interaction and heard the Mandarin over an audio-tape or television; some 
children were exposed via an interactive screen; and some children had a person in the room as a 
live tutor. The children in the first condition showed no language learning at all, and those in the 
final condition showed equal learning to Taiwanese children who had been exposed to Mandarin 
for 10 months, while those in the middle condition showed limited learning.  
The relationship between ASD-related social deficits and the language difficulties 
associated with this disorder is unclear. A study with 129 preschool children with ASD found that 
ASD symptom severity was the greatest contributor to variability in non-verbal communication 
skills deficits (Kjellmer et al., 2012). They also found an association between ASD symptom 
severity and verbal communication skills, although this was not as strong as the association 
between cognitive ability and verbal communication skills. 
Despite the intertwined nature of language deficits with other domains, language 
impairment is in itself a striking feature of ASD and it poses a significant challenge to the quality 
of life that individuals with ASD can attain. It is also unclear whether the absence of language 
development results in a qualitatively different ASD presentation to verbal children with ASD, or 
whether non-verbal children with ASD have the same overall presentation but at a higher 
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severity. Increased inclusion of non-verbal children with ASD in research may help clarify this 
issue. 
Non-Verbal Children in Research 
Language deficits not only influence a child with ASD’s ability to function in daily life, but also 
impact research efforts into understanding ASD. Children with ASD who are unable to 
understand instructions or communicate a response due to language deficits cannot participate in 
a great deal of research beyond initial toddler studies. This limiting effect on methodologies has 
resulted in the abundance of available psychological research being conducted with verbal ASD 
samples (Tager-Flusberg & Kasari, 2013).  
It is not standard practice for studies to report the language fluency of their participants 
and verbal capabilities must often be inferred from the selection of measures used in each study. 
Studies that do report verbal capabilities in their samples face a further problem however, as 
there is no generally accepted definition of what constitutes “non-verbal”, so these studies may 
not be comparable. As non-verbal children with ASD cannot participate in a great deal of 
research, there is the possibility that conclusions from existing studies cannot be generalised 
across the ASD spectrum (Tager-Flusberg & Kasari, 2013). 
Research methods have evolved to include non-verbal children with ASD, and eye-
tracking, physiological, and neuroimaging studies are being conducted; however, these studies 
still favour verbal children with ASD over non-verbal children with ASD due to higher 
compliance with instructions. Improvements in technology make it easier to include non-verbal 
participants in research, and organisations such as Autism Speaks and the Interagency Autism 
Coordinating Committee (IACC) (Interagency Autism Coordinating Committee, 2011; Tager-
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Flusberg & Kasari, 2013) have called for greater research with these participants. Despite this, 
however, this area remains understudied. 
Restricted and Repetitive Behaviours and Interests 
 Although ASD is a social disorder, children with ASD also have symptoms of restricted 
and repetitive interests and / or patterns of behaviour (RRB) (American Psychiatric Association, 
2013). These symptoms also affect a child’s social behaviour, their language, and how others 
respond to them, contributing to their social isolation. RRB symptoms encompass repetitive 
motor and/or sensory behaviours, such as repetitive or stereotyped motor symptoms (e.g. hand-
flapping) and those that represent a resistance to change and insistence on sameness (e.g. 
behavioural symptoms such as compulsion or atypical play characterised by the lining up of 
toys) (Cuccaro et al., 2003). Language is often affected as well, with children with ASD tending 
to display echolalia, or relying on stereotyped speech by using idiosyncratic phrases (American 
Psychiatric Association, 2013). Some children with ASD can be highly rigid in their routines, 
and an insistence on sameness can extend to all elements of their environment (Turner, 1999). 
This can include how a room is organised, an unusual attachment to a particular object or toy, 
refusal to change the route taken to school, and even a resistance to changes in the appearance of 
their family members such that a change in a parent’s hairstyle could be upsetting. This 
inflexibility can extend to thoughts as well, with some children fixating on specific subjects and 
thinking patterns, often resulting in difficulties understanding that others have different thoughts 
to their own, and resulting in stilted social interactions as they are unaware of the other’s 
disregard for their topic of interest (American Psychiatric Association, 2013; Baron-Cohen et al., 
1985).  
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Aetiology of ASD 
Our understanding of ASD has its roots in psychiatry, with research trends showing an 
initial focus on psychological explanations for the development of ASD, and more recently a 
focus on medical and genetic contributions to the disorder. ASD was identified as a unique 
disorder in the 1940s when American child psychiatrist Leo Kanner (1943) and German scientist 
Hans Asperger (1944) published their findings from working with children with social disorders 
and they recognised autism and Aspergers as unique disorders rather than a form of childhood 
schizophrenia. Despite the decades of research since then, the full aetiology of ASD remains 
unknown.  
Kanner (1943) stated that all the children he observed showed social disinterest from 
early development and he believed this was an innate inability to form social relationships that 
the children were born with. He also noted, however, that these children had highly intelligent 
parents with obsessive tendencies but who lacked warmth. He commented that he was unsure 
what effect, if any, the absence of parental warmth had on the overall presentation of ASD. 
Despite clearly stating that ASD was the result of an organic cause, later clinicians latched onto 
his comments on the parents and hypothesised that ASD arose from cold parenting styles, 
ultimately leading to the popularisation of the “Refrigerator Mother” theory for ASD 
(Bettelheim, 1972). Bettelheim (1972) was a strong advocate for removing children with ASD 
from their parents’ care and argued that the abnormalities seen in these children were the result 
of cold parenting.  
This initial focus on psychological influences being the cause of ASD was challenged by 
Bernard Rimland (1964) and led to great debate on whether parenting or genetics were the cause 
of ASD. Rimland (1964) stated that children with ASD presented with brain damage, and the 
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root of the disorder was therefore neurological, and he became a strong advocate for stopping the 
removal of these children from their parents.  
In the 1970s twin studies pointed to a high heritability statistic if one twin had ASD, 
which indicated that it was a hereditary condition (Folstein & Rutter, 1977). This research helped 
shift our understanding of ASD further away from the psychodynamic theories and toward 
medical explanations. Research then moved to focusing on medical causes for ASD, with 
psychological studies tending to focus on interventions or better characterising the ASD 
phenotype. The shift to considering ASD as a medical disorder also resulted in a shift in 
treatment approaches as it became a disorder that clinicians believed could be treated with 
medical intervention.  
Several medical theories have been proposed, with mixed support. One of the most well-
known theories was that of Wakefield (1999) who proposed that the measles, mumps and rubella 
(MMR) vaccine caused ASD. This theory was ultimately rejected when the research was found 
to be fraudulent (Godlee et al., 2011). Due to the heterogeneity of the ASD phenotype, research 
on its aetiology is being conducted in several medical disciplines. Research focusing on the 
prenatal period has found associations between a higher incidence of ASD and severe viral 
infections during pregnancy (Libbey et al., 2005), to exposure to certain drugs during pregnancy 
(Dufour-Rainfray et al., 2011), and to high levels of intrauterine testosterone (James, 2014). 
Factors considered during the prenatal period and early childhood have included: the role of poor 
nutrition and/or gastrointestinal issues; the role of environmental and medical toxins; the effects 
of early infections; the role of metabolic irregularities; and, the role of the neuroendocrine 
system (Inglese & Elder, 2009). While this research has led to some useful findings in regard to 
symptom alleviation in ASD, the full aetiology of ASD is still unknown.  
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While more recent research still considers how the factors above could influence the ASD 
phenotype, researchers generally now consider ASD a genetic disorder. The specific genetic 
basis of ASD has remained elusive, but the high heritability estimate and equally high 
concordance of ASD between identical twins indicate the importance of genetic research for this 
disorder (Kendler, 2010; Muhle et al., 2004).  
While initial studies focused on a singular cause for ASD, more recent research has been 
marked by a shift toward conceptualizing ASD as a disorder that arises from multiple genetic 
contributions, with Happe, Ronald, and Plomin (2006) suggesting that different elements of 
impairment should be studied separately. Current research focuses on establishing which genes 
contribute to a predisposition to ASD, which genes contribute to specific symptoms in ASD, and 
the likely outcomes of interactions between gene products (Poelmans et al., 2013). Genome-wide 
studies have compared the genomes of individuals with ASD to genomes of control subjects and 
have identified an estimated 400 candidate genes (Cho et al., 2011; Cross-Disorder Group of the 
Psychiatric Genomics, 2013). A recent review noted that the progress being made in genetic 
research has led to identifying the genetic etiology of ASD cases in 25-35% of cases 
(Wisniowiecka-Kowalnik & Nowakowska, 2019), with another review finding the rate to be as 
high as 40% of cases (Genovese & Butler, 2020). These reviews noted that newer studies 
included methods such as newer chromosomal SNP microarrays, whole-exome sequencing, and 
next generation sequencing (NGS). The sheer number of genes implicated in ASD, and the 
overlapping contributions of numerous genes to specific elements of ASD, add to the argument 
that no single gene will be found to underlie ASD (Happe et al., 2006).  
While genotype-phenotype association studies and genome-wide association studies 
(GWAS) are the current techniques of choice in research in many medical and psychiatric 
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disorders, and in ASD research specifically, these studies do have their limitations. Generally, 
there is concern that GWAS studies are too broad, and will ultimately implicate the entire 
genome in different disorders, as well as directly implicate genes in disorders where there is no 
biological mechanism to explain such associations (Tam, 2019). Further, the complexity of 
psychiatric disorders means that any determinant of predisposition toward that disorder is likely 
to be subtle (Sher, 2001). SNPs and genotype prevalence are unevenly distributed in different 
ethnicities (Dvornyk et al., 2004), and research findings are therefore difficulty to replicate (Sher, 
2001). However, these difficulties can be overcome by focusing on narrowly defined phenotypes 
(Sher, 2001), and ensuring ethnicity data is included where appropriate.  
 Despite the above limitations, further genetic research into the underlying mechanisms 
of ASD can make valuable contributions to our understanding of this disorder, and to improve 
diagnostics and refine treatment programmes. The Autism Genetic Resource Exchange (AGRE), 
a repository for ASD phenotypic and genotypic data, has therefore been established to aid ASD 
research (Geschwind et al., 2001). AGRE was established in 1997 and is the largest private, 
open-access repository of clinical and genetic information dedicated to ASD research, with over 
150 research groups using the resource (Autism Speaks, 2020). The National Institute of Mental 
Health has placed an emphasis on phenomic research in mental health, and in response to the 
growing number of genes implicated in ASD, they support research that will result in improved 
phenotyping and that will elucidate the underlying neurobiology and mechanisms of ASD 
specifically (National Institute of Mental Health).  
ASD-related genetic research in South Africa is an emerging field in this context and is 
therefore limited. To my knowledge, only two genes have been assessed for possible roles in 
ASD, and collectively only four studies have been conducted. Three studies explored the allelic 
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distribution of 5-HTTLPR in typically developing and ASD samples locally (Arieff et al., 2010; 
Esau et al., 2008; Hamilton, 2014) and one study explored associations of specific single-
nucleotide polymorphisms for the reelin gene (i.e. rs736707 and rs362691) with ASD (Sharma et 
al., 2013). South African researchers are therefore still heavily reliant on findings from 
international studies which may consist of primarily Caucasian or European participants and 
therefore under-represent samples comparable to those in South Africa.  
Treatment of ASD 
As the genetic and psychological aetiology of ASD is not fully understood, ASD 
treatments focus on symptom alleviation more than on cure. Treatments regimens can include 
psychological interventions, medications, or both, and vary depending on the child’s phenotype. 
Psychological interventions tend to focus on social and learning deficits, while medical 
treatments tend to focus on the amelioration of symptoms associated with ASD.  
Psychological interventions are recommended from early childhood for best effects, with 
some programmes being available to children from as young as 12 months. Most ASD 
interventions tend to fall into one of two categories, as some take a naturalistic developmental 
behavioural approach, while others follow a structured, consistent programme format based on 
educational methods. The naturalistic, developmental approach delivers intervention through 
social interactions in a common environment (Schreibman et al., 2015). These interventions use 
child-directed teaching strategies that allow for intervention with familiar materials in a familiar 
environment, thereby using the child’s natural behaviours and interests to build social 
competence and target other deficits. By contrast, structured interventions typically rely on 
applied behaviour analysis which aims to alter problematic behaviours by identifying the 
antecedents and consequences of these behaviours to understand why they occur, and through 
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altering the consequences of behaviours using positive reinforcement for desired behaviours. 
More recently some interventions have merged these approaches, such as the Early Start Denver 
Model (ESDM), and have shown positive long-term outcomes (Dawson et al., 2010; Estes et al., 
2015). Outcomes, however, remain varied.  
Children with ASD are frequently prescribed medications for their symptoms, and 
research has found a very high incidence of polypharmacy throughout childhood (Barnette et al., 
2019). Medical treatments for ASD often include the use of antipsychotics and antidepressants 
for anxiety and mood symptoms (Birch et al., 2018; Madden et al., 2017). ADHD medication is 
also prescribed due to the high comorbidity rate between ASD and ADHD (Hazell, 2007). 
Doctors also frequently prescribe medication for gastrointestinal symptoms, neurological 
symptoms and epilepsy, sleep disturbances, skin disorders, and urologic disorders (Jones et al., 
2016). While medications can alleviate symptoms to some degree, and can make the overall 
disorder more manageable, they do not cure core deficits of ASD.  
Numerous interventions and medical plans therefore exist to provide support for children 
with ASD. However, while interventions aim to target core deficits, clinicians cannot always 
identify which children would best benefit from which type of intervention – understanding the 
relationships between core deficits and the overall ASD phenotype could assist with this. 
Further, while medical treatments are common in ASD, they tend to focus on symptoms 
associated with this disorder rather than with core elements of the disorder itself – by not 
focusing on core elements, the possible effects of medication on overall ASD severity are 
limited. Ultimately a better understanding of the development of ASD and the relationships 
between symptoms and core deficits would help with appropriate targeting of interventions and 
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understanding which medical processes could support the interventions may greatly improve 
their efficacy.  
Summary and Conclusion 
ASD is a neurodevelopmental disorder with a high prevalence rate that has lifelong 
effects. The widely heterogenous presentations of this disorder have undermined research into its 
aetiological pathways (both developmental and biological), and we therefore lack a full 
understanding of the underlying mechanisms of ASD. Many biological theories have been 
proposed as explanations for the development of ASD and more recently genome-wide 
association studies have found hundreds of genes that are implicated in this disorder. While 
progress in research has shifted our understanding of this disorder so that we believe it has an 
organic cause, we cannot simply dismiss the knowledge gained through psychological research. 
The next step should therefore be to consider psychological and medical / genetic findings and 
theories together, and move toward understanding ASD in the context of both of these fields. 
Well-supported psychological theories should not be disregarded, but should instead be expanded 
to include genetic components, while well-supported genetic research should include 
psychological theories when assessing genotype-phenotype relationships.  
It is unlikely that a single theory, or a single cause, will fully explain the range of clinical 
presentations seen in ASD. However, some theories, and some genes or interactions between 
genes, could account for specific aspects of ASD. All these theories and genetic contributions 
cannot be assessed collectively, but two theories and two genes stand out as having potential to 
explain, at least in some part, the deficits seen in ASD. The first is the Social Motivation Theory 
of ASD, and OPRM1 as implicated in this theory, and the second is the ToM Theory of ASD, and 
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5-HTTLPR as implicated in this theory. This protocol focused on these theories in the two 
studies that follow.
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Chapter 3: The Social Motivation Study 
Panksepp (1979) stated that ASD arises due to emotional, rather than cognitive, 
difficulties. Specifically, he stated that it arose due to an innate dysfunction in the drive to 
socially engage with others; he called this drive “social motivation”. This eminent psychological 
theory has long been supported by animal research, and has directly implicated the mu-opioid 
system in the aetiology of ASD. Despite this, however, studies investigating associations 
between ASD-related deficits, levels of social motivation, and the functioning of mu-opioids 
have not been adequately explored in human ASD samples. This study provides a first step in 
rectifying this situation by exploring associations between ASD-related symptoms, social 
motivation levels, and the mu-opioid receptor gene (OPRM1).  
This chapter reviews our current knowledge regarding the Social Motivation Theory of 
ASD, and the potential role of mu-opioids in ASD. Thereafter I detail my study methodology 
and results and provide a discussion of my findings.  
Literature Review 
Humans are social beings and much of our survival depends on our ability to connect 
with others. Panksepp (1979) referred to social motivation as one of the earliest social 
behaviours; he believed we have an innate drive to seek social engagement and to avoid social 
isolation. Social motivation is a drive that develops in response to the experiences of the 
SEPARATION-DISTRESS system1. He proposed that ancient pain pathways evolved to facilitate 
social bonding through the SEPARATION-DISTRESS system, and that these opiate-based 
pathways facilitated the development of our earliest social relationships, namely those between 
 
1 SEPARATION-DISTRESS is capitalized, as are all Panksepp’s basic emotion systems, to avoid confusion with 
general emotion terms, and to indicate that this term refers to a system that is evident across different mammalian 
species 
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infants and their caregivers. Panksepp (1979) proposed that the core ASD symptom of poor 
social interest and attachment could be explained by excessive opioid activity undermining the 
functioning of this system, which thus undermines our innate social motivation system.  
Panksepp (1979) proposed that ASD was essentially a disorder of emotional disturbance, 
and that it arose from dysfunction of the opioid systems in the brain. He stated that the 
fundamental problem in ASD is that the child is unable to properly experience the emotions that 
usually arise from social relationships. He pointed to the earliest signs of ASD, including those 
of failure to cling to parents, lack of crying, and low desire for social interaction, as indications 
that a child with ASD does not experience typical emotions arising from social relationships, and 
that this deficit is present from the start of life. He noted that many of these children not only fail 
to seek their caregivers, indicating low social motivation, but they often fail to show any signs of 
comfort when re-united with their caregivers - he took these as signs of a failure of the 
SEPARATION-DISTRESS system in these children.  
Panksepp (1979) hypothesised that children with ASD are born with increased mu-opioid 
activity, and this undermines their experience of social reward in terms of their need for, and 
development of, social motivation. As the SEPARATION-DISTRESS system is dependent on the 
functioning of mu-opioid systems, Panksepp (1979) drew further support for his theory that this 
system was disrupted by noting that some children with ASD are insensitive to pain, and these 
children often show higher levels of mu-opioids than neurotypical individuals (Gottfried & 
Riesgo, 2011; Panksepp, 1979; Panksepp et al., 1978; Sahley & Panksepp, 1987); it is thought 
that this excessive brain mu-opioid activity may be present as early as the neonatal period, 
resulting in a very early reduction of social motivation (Gottfried & Riesgo, 2011). 
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This review will therefore start by outlining Panksepp’s (1979) SEPARATION-
DISTRESS Theory, and the role of OPRM1 in social motivation within this theory. This is 
followed by a review of research regarding social motivation in ASD, and the role of mu-opioids 
in ASD.  
SEPARATION-DISTRESS Theory 
Panksepp’s (1997) overarching basic emotion theory states that core emotion systems 
have evolved in mammalian species to promote survival. These systems each have unique 
neurochemical and / or neuroanatomical correlates, with associated patterns of behavioural, 
physiological, and psychological responses that occur when these systems are activated. These 
systems are genetically coded and activate in response to events that could affect survival. The 
affective state that arises from the activation of such a system results in the person (or other 
mammal) experiencing the event as “good” if it promotes survival and “bad” if it threatens 
survival. These responses therefore serve to encode value to events in order to promote survival, 
and the SEPARATION-DISTRESS system does this by supporting social cohesion. 
One of the basic emotion systems identified by Panksepp’s (1997) core emotion theory is 
the SEPARATION-DISTRESS system (previously PANIC/GRIEF), which mediates social 
attachment by making social isolation undesirable and social cohesion desirable, and facilitates 
the basic drive for social engagement, termed social motivation. This system is thought to have 
two associated feeling states: contact comfort, associated with positive social experiences, and 
SEPARATION-DISTRESS, associated with social distance or social loss. SEPARATION-
DISTRESS is an adaptive warning system to prevent separations that could prove fatal for those 
entirely dependent on their caregivers. 
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Panksepp’s (1997) core emotion theory proposes that the SEPARATION-DISTRESS 
system evolved from the body’s primitive pain and reward mechanisms to reinforce social 
bonding. The proposed neurochemistry underlying the SEPARATION-DISTRESS system is 
therefore dominated by endogenous opioids, which are known to reduce the physical sensation of 
pain (Nelson & Panksepp, 1998; Panksepp et al., 1997). The theory states that events that 
promote social bonds have an associated mu-opioid release, and those that threaten social bonds 
have an associated decrease in mu-opioid levels, in oxytocin levels, and an increase in 
corticotropin releasing hormones (Nelson & Panksepp, 1998; Panksepp et al., 1997; Panksepp & 
Watt, 2011). In typically functioning mu-opioid systems, an increase in mu-opioid levels is 
associated with decreased pain sensation and elevated mood. Social contact is experienced as 
pleasurable when mu-opioids are released and is therefore comforting after a period of separation 
or isolation. However, if the system is not operating typically, then this release of mu-opioids is 
either blocked or the body is insensitive to it, preventing one from experiencing pleasure during 
social interaction. In contrast, social separation is experienced as painful, akin to the state 
experienced during opioid withdrawal, with an acute panic phase, and this phase is either 
terminated naturally by social contact, medically through opioid administration, or enters a 
chronic depressive phase characterised by withdrawal and behavioural shutdown. Infants find 
separation from a caregiver painful, and as they will have previously experienced the pleasurable 
mu-opioid release during contact with their caregiver, they will actively attempt to end the 
separation – this drive is social motivation. Infants therefore instinctively seek their caregiver 
through crying, calling, or attempting to look for or follow the caregiver. These signs of seeking 
social engagement are signs of their social motivation, and it is believed that if the mu-opioid 
system is atypical it will not adequately reinforce the SEPARATION-DISTRESS system. If the 
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SEPARATION-DISTRESS system is not reinforced, social motivation may fail to develop fully 
or will present in an atypical or inconsistent manner. 
OPRM1 in the SEPARATION-DISTRESS Theory. One of the mechanisms implicated 
in the SEPARATION-DISTRESS system is OPRM1 due to its role in regulation of mu-opioids 
(Butler et al., 2014). OPRM1 encodes mu-opioid receptors, which are the primary site for mu-
opioids. These receptors bind with natural opioids such as beta-endorphin and enkephalins, and 
synthetic opioids, including morphine, fentanyl, methadone, and heroine (Moles et al., 2004). 
The endogenous opioids that bond with mu-opioid receptors are shown to mediate natural 
rewards by creating a pleasurable mood while also decreasing the experience of negative 
emotion states and physical pain. These opioids therefore generate the experience of contact 
comfort as described in the SEPARATION-DISTRESS system. The role of OPRM1 in social 
motivation and the SEPARATION-DISTRESS system can therefore be assessed through genetic 
modification of this receptor in animal models, which alters the availability of mu-opioid 
receptors, through assessing the transmission of mu-opioids, or through manipulation of mu-
opioid levels with synthetic opioids, making it an ideal gene for research purposes.  
OPRM1 is located in human chromosome 6q24-q25 (Fillingim et al., 2005). This 
receptor has two common alleles, the A and G alleles, allowing for three common genotypes, 
namely: A/A, A/G, and G/G. The G allele is less common than the A allele, making the A/A 
genotype the most commonly occurring. Having one or more G alleles (i.e. the A/G or G/G 
genotype) is associated with an increased response to endogenous opioids through mu-opioid 
receptors (Mura et al., 2013). This allele may be associated with a greater binding affinity at mu-
opioid receptor sites, so individuals carrying this allele could have higher opioid “tone” when 
receptors are activated – that is, once activated, it takes longer for the effect to deplete, and also 
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makes one less sensitive to fluctuations in mu-opioid levels while in this analgesic state (Bond et 
al., 1998; Fillingim et al., 2005).  
OPRM1 allelic distributions are not associated with sex (Troisi et al., 2011), although 
different ethnic groups do present with different distribution patterns. A Swedish study with the 
LifeGene biobank found that 77% of their sample of 18 963 people had the A/A genotype, while 
the remaining 23% carried at least one G allele (Persson et al., 2019). By comparison, the G/G 
genotype tends to occur in only 1-4% of samples, with an allelic frequency rate of between 0.07 
and 0.22 (Bart et al., 2004; A. C. Chen et al., 2013; Way et al., 2009). The exceptions to these 
studies are some of those with Asian samples, where the incidence of the G allele has been as 
high 0.35 (A. C. Chen et al., 2013; Way et al., 2009; Wei et al., 2017). A local study with 640 
women from the Western Cape (364 African participants and 276 mixed race participants) 
revealed an incidence of 0.05 for the G allele, which is in keeping with the internationally 
reported prevalence (D. Stein and S. Dalvie, personal communication, May 23, 2019). 
OPRM1 is implicated in the SEPARATION-DISTRESS system, and therefore in the 
pathway to ASD according to Panksepp’s (1979) theory that ASD arises from atypical social 
motivation. The G allele is associated with greater sensitivity to endogenous opioids (Mura et al., 
2013), but also with strong binding, which could essentially leave one in a state of opioid 
bondage – that is, as receptors are already activated, any other changes meant to activate them 
cannot take effect. Following Panksepp’s (1979) theory, carriers of the OPRM1 G allele would 
therefore be insensitive to the changes in opioid levels during social interactions or separations. 
If one is insensitive to the fluctuations in mu-opioid levels associated with the SEPARATION-
DISTRESS system, social motivation may fail to fully develop. This could result in the social 
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behaviour typical of children with ASD. Research regarding the role of mu-opioids in social 
motivation are reviewed below. 
Non-Primate Animal Studies. Evidence supporting the existence of the SEPARATION-
DISTRESS system and the role of opioids in this system is primarily drawn from non-primate 
animal studies. Studies show that when separated from the mother, these animals tend to display 
signs of "social pain" such as crying. These behaviours are often used to draw the attention of the 
mother with the intention of initiating a reunion. As predicted by the theory, research shows that 
opioids are released during positive social interactions, such as during social grooming, during 
sexual behaviour, during maternal nurturance, and during play (Machin & Dunbar, 2011; 
Panksepp, 1979; Panksepp et al., 1997). 
Studies manipulating opioids have also supported their role in social motivation. Opiates 
have been administered to infant mice when they show distress after being separated from their 
mothers, and it was found that administration of a low dose of an morphine effectively reduced 
the distress calls as long as the drug was active, prompting Panksepp to note that opiates were 
“neurochemically equivalent to the presence of the mother” (Panksepp, 1979, p. 175). This 
relationship between opioids and reduction in social motivation, as seen by reduced distress calls 
in infant animals on separation after administration of opioids, has been consistent across 
multiple species, including dogs (Panksepp et al., 1978), guinea pigs (Herman & Panksepp, 
1978), rats (Carden et al., 1991), and chickens (Warnick et al., 2005).  
Warnick et al. (2005) recognised that although research had repeatedly found opioids 
played a role in mediating social attachment processes, there was a need for more work to 
identify whether specific opioid agonists and opioid antagonists influenced distress behaviour on 
separation, and therefore whether there were roles for specific types of opioids. Using chicks 
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from domestic fowl, they administered various opioid agonists and opioid antagonists to the 
chicks at 7 days post-hatching. They then placed the chicks in low- or high-stress scenarios using 
mirrors, which have similar effects to social companionship for chicks. They found that only the 
mu-opioid receptor played a role in the processes of social attachment as administration of a mu-
opioid agonist resulted in a decrease in distress vocalisations. However, administration of a mu-
opioid antagonist did not show a significant increase in vocalisations. This led them to suggest 
that mu-opioids modulate, rather than mediate, social attachment processes.  
Genetic knockout of the mu-opioid receptor in mice results in considerable changes in 
social behaviour in keeping with the Social Motivation Theory. These mice fail to selectively 
approach their mothers and do not exhibit distress calls when separated from their mothers 
(Cinque et al., 2012; Moles et al., 2004), juvenile mice have reduced interest in social interaction 
with other mice (Cinque et al., 2012), young adult male mice showed reduced responsiveness 
and interest in female vocalisations (Gigliucci et al., 2014; Wöhr et al., 2011), and adult mice of 
both sexes had reduced social interest and rates of social interaction (Becker et al., 2014).  
There is therefore an abundance of support for the existence of the SEPARATION-
DISTRESS system in non-primate animals, and for the role of mu-opioids and OPRM1 in this 
system. However, the above studies were limited to animal models that did not include primates. 
Social motivation research for primates and humans is reviewed below. 
Primate and Human Studies. Despite the clear support for the Social Motivation 
Theory from non-primate animal studies, research on primates has been less clear. Primates carry 
a mu-opioid receptor gene (OPRM1 C77G) that has the same functionality as the human mu-
opioid receptor gene (OPRM1 A118G), and research in primates allowed for a close 
approximation of the role of OPRM1 in humans. Although some studies support the role of mu-
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opioids in social motivation in a similar manner to that seen in the smaller animal studies 
reported above, others suggest a reversal of this relationship in human studies (Loseth et al., 
2014; Pellissier et al., 2018). 
Studies Supporting the Social Motivation Theory. As with previous literature, mu-
opioids are sometimes implicated in social motivation in primates and humans. Mu-opioids 
actively play a role in the processing of pain in the anterior cingulate cortex and insula, and older 
research with monkeys has illustrated the role of these areas in the SEPARATION-DISTRESS 
system. Monkeys with lesions to these areas, who therefore could not experience the fluctuations 
of mu-opioids that result from the SEPARATION-DISTRESS system, showed an indifference to 
social contact and did not produce distress calls when experiencing a separation (Hadland et al., 
2003; MacLean & Newman, 1988).  
In a human study, Zubieta et al. (2003) investigated the involvement of mu-opioids in the 
regulation of affective states in a sample of 14 healthy female participants. Using positron 
emission tomography they studied neurotransmission of mu-opioids while the participants 
recalled an autobiographical event of profound social sadness (i.e. sadness state condition) 
compared to when they were asked to relax (i.e. neutral emotion state condition). Participants 
showed reduced mu-opioid activity during the sadness state condition, indicating that mu-opioid 
levels drop during the experience of social pain, which is in keeping with the Social Motivation 
Theory.  
Troisi et al. (2012) assessed the relationship between early maternal care and anxious 
attachment in 112 Caucasian psychiatric patients. They specifically looked at an anxious 
attachment style in adults characterised by anxious and avoidant behaviours, as well as increased 
sensitivity to social rejection; they referred to this as fearful attachment. The avoidant behaviours 
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and lack of social interest seen in their participants can be equated with those of low social 
motivation. The OPRM1 allelic distribution in their sample was in keeping with reported 
population norms: 69% carried the A/A genotype; 29% carried the A/G genotype; and 2% carried 
the G/G genotype. For analyses they merged the A/G genotype and G/G genotype groups. They 
found a crossover interaction between OPRM1 and maternal caregiving: carriers of the G allele 
showed high rates of fearful attachment regardless of the quality of maternal care, while non-
carriers of the G allele showed that higher levels of maternal care correlated with lower levels of 
fearful attachment. This finding supports the Social Motivation Theory by indicating that G 
allele carriers were insensitive to the influence of maternal care, possibly due to their 
indifference to the pain of social separation and the pleasure of social interactions.  
Finally, human studies looking at the effects of prolonged elevation of opioid levels have 
shown that former opiate addicts who were being treated with opioid maintenance (i.e. chronic 
low dose of opiates) displayed reduced social interaction and had social cognition deficits 
(McDonald et al. 2013). This suggests that, much like in the non-primate animal models, mu-
opioids could substitute for social interaction by providing an alternate cause for increased 
opioid levels or by making one insensitive the mu-opioid fluctuations underlying the 
SEPARATION-DISTRESS system.  
Studies Contradicting the Social Motivation Theory. Some studies, however, have 
shown results which appear to contradict the expected role of mu-opioids in the social motivation 
system. Barr et al. (2008) conducted a study on infant rhesus monkeys that compared attachment 
behaviour across OPRM1 genotypes. They found that monkeys carrying a G allele showed 
greater persistence of distress calls when they were separated from their mothers and they 
showed a higher preference for social contact with their mothers when reunited than the monkeys 
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with the A/A genotype. Barr et al. (2008) hypothesised that this was due to a "gain-of-function" 
of the G allele as it would allow greater sensitivity to mu-opioids. This, however, would result in 
greater social motivation if Panksepp’s (1979) theory is correct regarding the role of mu-opioids 
in the SEPARATION-DISTRESS system.  
Similarly, a study by Higham et al. (2011) with free-ranging female rhesus monkeys 
found that females carrying the G allele for OPRM1 tended to prevent separations from their 
young by restraining them more so than females not carrying the G allele. This suggests that 
these rhesus monkey mothers showed a greater sensitivity to separations if they had the G allele, 
perhaps supporting the “gain-of-function” hypothesis (Barr et al., 2008), rather than the 
decreased sensitivity consistently seen in non-primate animal models.  
Way et al. (2009) investigated the possible relationships between OPRM1, dispositional 
pain, and neural sensitivity to social rejection. They recruited 122 neurotypical university 
students to complete self-report inventories regarding dispositional sensitivity to social rejection, 
genotyped them for OPRM1, and a subsample of 31 participants underwent an fMRI scan while 
playing Cyberball, a social rejection game. The OPRM1 allelic distribution of their sample was 
in keeping with reported frequencies: 73 participants with A/A genotype (60% of sample), 44 
participants with A/G genotype (36% of sample), and 5 participants with G/G genotype (3% of 
sample). Although ethnicity data was provided, the OPRM1 genotype distribution across these 
groups was not reported. They merged the A/G genotype and G/G genotype groups due to the 
small size of the latter group. They found that carriers of the G allele showed higher reactivity to 
social rejection than non-carriers; they also found an association between the G allele and 
increased trait-like tendencies to be concerned about social rejection. This does not support a role 
for OPRM1 in the SEPARATION-DISTRESS system as the theory would predict that having a 
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G allele would result in insensitivity to social rejection due to higher baseline mu-opioids. 
However, during the social rejection game the fMRI showed increased activity in the dorsal 
anterior cingulate cortex, which is known to be involved in the processing of physical and social 
pain. Way et al. (2009) suggested that this region may mediate the relationship between OPRM1 
and social pain sensitivity, rather than a direct relationship existing between the two.  
The literature examining the role of mu-opioids in social motivation in primates and 
humans is therefore mixed. Studies that support the theory are those that show changes in mu-
opioid activity when experiencing sadness, which show that lesions preventing typical mu-opioid 
neurotransmission undermine social motivation, and which show that increased mu-opioid 
baseline levels indicated by the G allele for OPRM1 are associated with an indifference to 
maternal care. However, some studies indicate a gain of function for OPRM1 G allele carriers 
that makes carriers more sensitive to social separations - which contradicts the Social Motivation 
Theory. If OPRM1 and the SEPARATION-DISTRESS system are implicated in ASD, it appears 
that human studies with ASD samples are needed to start clarifying their roles.  
Social Motivation Theory and ASD. Despite the mixed support for mu-opioids’ role in 
the Social Motivation Theory in primates and humans, the interest in this theory as an 
explanation for ASD has persisted. Panksepp (1979) stated that if the neurochemical foundation 
of SEPARATION-DISTRESS system was disrupted it would undermine the child’s social 
motivation capabilities, which would result in atypical psychosocial development. This reduced 
social motivation might result in considerable social and language acquisition deficits. He 
therefore hypothesised that children with ASD may have disruptions in their mu-opioid systems 
that undermine their social motivation. Some of the studies reviewed above supported the role of 
mu-opioids in the social motivation system. Further, manipulation of the mu-opioid system in 
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animals not only resulted in changes in social motivation behaviour, but it resulted in symptoms 
typically associated with ASD as well.  
The research above has highlighted behaviours that are analogous to those required to 
fulfil the DMS-5 ASD diagnostic criteria for the first symptom domain regarding deficits in 
social communication and social interaction (Appendix A; American Psychiatric Association, 
2013) Most notably, the absence of distress calls during separation in infant animals after 
receiving mu-opioids is considered to represent an equivalence to the absence of observed 
distress noted in many children with ASD when separated from their caregivers (Carden et al., 
1991; Herman & Panksepp, 1978; Panksepp et al., 1978; Pellissier et al., 2018; Warnick et al., 
2005). This behaviour is often accompanied by a lack of desire for social companionship and 
poor response to cuddling with the caregiver, behaviours typically reported by parents of 
children with ASD (Vostanis et al., 1998).  
Interestingly, OPRM1 knockout mice also showed the behaviours required to fulfil the 
diagnostic criteria for the second symptom domain for ASD, namely restricted and repetitive 
patterns of behaviour, interests, or activities (American Psychiatric Association, 2013). The 
animals in these mu-opioid studies exhibited unusual learning effects characterised by extreme 
persistence of behaviour in the absence of external rewards, which can be equated to the 
restricted and repetitive behaviours seen in ASD. A review of the literature on OPRM1 knockout 
mice by Pellissier et al. (2018) noted the following symptoms similar to those in children with 
ASD were present in these mice: increased aggression; increased anxiety; poor motor 
development or clumsiness; poor spatial learning; and higher susceptibility to seizures. Knockout 
mice also showed an insensitivity to pain, which is frequently reported in ASD, and unusual 
body posturing such as toe walking was present after young animals received morphine.  
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Therefore, despite the mixed results for the role of mu-opioids in the SEPARATION-
DISTRESS system and typical development of social motivation in primates, there is sufficient 
evidence from non-primate animal studies to indicate that atypical mu-opioid processes may 
underlie some aspects of the ASD presentation. There have been very few studies of social 
motivation within ASD samples, but those that have been conducted have supported the theory. 
Human studies have approached social motivation and opioid research by studying social 
motivation behaviours in children with ASD, and in assessing the results of medications that 
lower mu-opioid levels in these children.  
Social Motivation Behaviours in ASD. Positive attachment behaviours may be seen as 
indications of social motivation and therefore provide further insight into the role of social 
motivation in ASD. Deficits in attachment in ASD have been noted from as early as two years of 
age (Van Ijzendoorn et al., 2007), and include behaviours such as failing to cuddle, lack of eye 
contact, low responsiveness to social interaction, failure to direct smiles socially, and 
indifference to affection (Rutgers et al., 2004); these behaviours are similar to those described in 
social motivation research (Panksepp et al., 1979).  
It was previously believed that children with ASD cannot develop secure attachment at 
all, but a review of 40 articles investigating attachment in ASD found that some children with 
ASD can be securely attached, which could indicate typical social motivation processes (Teague 
et al., 2017). However, other reviews have found that although secure attachment may be 
present, children with ASD tended to show less secure attachment than children without ASD, 
possibly indicating low or atypical social motivation (Kahane & El-Tahir, 2015; Rutgers et al., 
2004). Further, even when children with ASD showed secure attachment behaviours, their 
overall attachment behaviour was disorganised and considered atypical (Buitelaar, 1995; Capps 
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et al., 1994; Rutgers et al., 2004). It is possible that if mu-opioid systems are atypical, they could 
undermine functioning of the SEPARATION-DISTRESS system as the opioid release associated 
with social contact may not always, or consistently, be sufficient to provide the necessary 
pleasurable sensation during social contact, and this could be an important contributor to the 
disorganised attachment seen in some children with ASD.  
Although a great deal of research has focused on quality of attachment in ASD, there has 
been less research focusing on the role of attachment in ASD, and specifically the relationship 
between attachment and ASD deficits. Those that have looked at these relationships have done 
so from the perspective of how other factors influence attachment in ASD rather than how 
attachment could impact psychosocial development as part of the manifest spectrum. An early 
study by Shapiro et al. (1987) found no relationship between ASD deficits and attachment, but a 
review focused on more recent literature found that attachment behaviours were related to the 
severity of ASD as well as the severity of comorbidities (Kahane & El-Tahir, 2015). Although 
this lacks specificity, it is in keeping with the notion that atypical, or indeed low, social 
motivation would relate to more severe deficits in ASD.  
Klintwall et al. (2014) investigated the relationship between a child’s social interest, or 
social motivation, and ASD outcomes. They noted that level of interest during ADOS assessment 
when the child was 2 years old was a good predictor of deficits at age 3 years. Specifically, lower 
interest in the assessment and in the person conducting the assessment was related to poor skill 
acquisition in verbal, non-verbal, and adaptive skills. This low social interest suggests poor 
social motivation, and as these children would have less desire to engage socially, they are likely 
to show less improvement with age than the children who engaged with others.  
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Children with ASD therefore frequently present with low social motivation as indicated 
by poor or atypical secure attachment. Further, this low social motivation is not only related to 
ASD deficits but may be a predictor of the severity of some symptoms across development.  
Mu-Opioids in ASD. As early as the 1980s, research emerged showing that individuals 
with ASD had atypical levels of endogenous opioids, and tended to show higher levels of these 
opioids in their cerebrospinal fluid compared to neurotypical children (Gillberg et al., 1985). 
Very few human studies are available, but some that use naltrexone, an opioid receptor 
antagonist that specifically targets the mu-opioid receptor to reduce mu-opioid levels, have 
shown positive effects in ASD (Bouvard et al., 1995; Leboyer et al., 1992). There are however 
very few studies of this kind, and a review article noted that while Naltrexone could improve 
some symptoms seen in ASD, it was not clear that there was a direct influence on core symptoms 
(i.e. the core diagnostic criteria) (Roy, Roy, Deb, & Unwin, 2015). Instead, the review suggests 
that a subgroup of children with ASD may show positive responses to Naltrexone treatment, and 
that identifying such a cohort and understanding the role of mu-opioid processes in this sample 
could be significant and should be a research priority. As social motivation deficits are not a core 
diagnostic criterion for ASD, but could be an important feature of this disorder, better 
understanding the possible relationship between social motivation and mu-opioids in the context 
of ASD could contribute to our understanding of this disorder.  
Bouvard et al. (1995) assessed the response to administration of naltrexone in a pilot 
study including 10 children with an ASD diagnosis. The participants were between 5-14 years of 
age, with five female and five male participants. The participants were recruited through a 
Parisian hospital where they were receiving out-patient treatment. Six of the ten participants had 
no expressive language (2 male; 4 female), and none of the children exhibited significant current 
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self-injurious behaviours, although 6 had previously shown mild self-injurious behaviours. 
Bouvard et al. (1995) conducted a naltrexone-placebo crossover study over four weeks, where 
the first group of participants received two weeks of placebo treatment followed by two weeks of 
treatment with naltrexone, and the second group received the trial medication in reverse order. 
Blood levels were drawn throughout the experiment to measure the whole blood levels of 
serotonin, dopamine, norepinephrine, and epinephrine, and neuropeptides. The clinical 
observations for behavioural markers were made with the Childhood Psychiatric Rating Scale 
(CPRS), the Behavioural Summarised Evaluation (BSE), and the abbreviated Conners Parents 
Teacher Rating Scale (Conners). They found that only a subset of their sample responded to the 
active drug with changes in behavioural outcomes, and that these participants showed the most 
marked normalisation of plasma parameters in the sample. Assessment of the subscales for two 
of the behavioural measures showed a mixed picture: for the CPRS, the largest improvements 
were seen in hyperactivity, hostility and restraint; and for the BSE, the largest improvements 
were seen for sociability, communication, object relations, and attention. ASD-specific 
diagnostic measures were not used to clinically profile the participants, so it is unclear how these 
findings relate to the core elements of ASD. However, it would appear that social 
communication was influenced, which would support Panksepp’s (1979) theory that 
normalisation in opioid levels may promote social motivation. Unfortunately, there was no 
control group of neurotypical children to assess the general effects of this medication trial.  
Herman et al. (1987) described a smaller case series that specifically explored the effects 
of naltrexone on self-injurious behaviours in three male participants, two of whom had diagnoses 
of ASD. The participants were in their adolescence and had showed severe self-injurious 
behaviours for at least five years prior to the study. Each participant was administered naltrexone 
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in tablet form. The researchers hypothesised that individuals who exhibit self-injurious 
behaviours do not experience the pain typically experienced from these behaviours due to an 
opioid analgesic state. They further hypothesised that as naltrexone has an affinity for mu-opioid 
receptors, the administration of naltrexone would decrease opioid levels and these behaviours 
would then elicit a pain response, hence reducing their frequency. They found that naltrexone 
significantly decreased self-injurious behaviours, with the greatest difference found for the 
participant with ASD with the most severe presentation of self-injurious behaviours: he showed a 
50-fold decrease in said behaviours. By contrast, the participant without ASD showed the lowest 
response, but still showed a 33% decrease in these behaviours. Herman et al. (1987) therefore 
concluded that a mu-opioid antagonist could be a viable treatment option for cases of self-
injurious behaviours, perhaps particularly those seen in ASD.  
There is therefore some evidence indicating that decreasing mu-opioids in ASD may 
result in an improvement in symptoms, suggesting that the elevated baseline levels of mu-opioids 
may be related to core aspects of ASD. To my knowledge, no studies have assessed OPRM1 
directly in an ASD sample, and certainly not in the sub-Saharan context. The possible role of 
OPRM1 in ASD, and its allelic distribution in this population, are therefore unknown.  
Conclusion 
Panksepp (1979) proposed that ASD was a social disorder that resulted from disruptions 
to the SEPARATION-DISTRESS system due to atypical mu-opioid levels, and the undermining 
of this system resulted in absent or low social motivation developing. He stated that children 
with ASD had reduced social motivation early in life which led to deficits in later psychosocial 
development. The role of mu-opioids in the SEPARATION-DISTRESS system is well supported 
by non-primate animal studies, as is the association between alteration in this system and low 
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social motivation. These studies showed that the atypical functioning of the mu-opioid is 
associated with the emergence of an ASD-like presentation in non-primate animal models. 
Although results from primate and human studies are mixed in their support, with some 
contradicting the Social Motivation Theory for ASD, the ASD-like presentation in OPRM1 
knock-out mice is startlingly similar to behaviours seen in children with ASD - and these 
behaviours cover both core symptom domains for ASD in the DSM-5. Studies with ASD 
samples indicate that mu-opioids are implicated in the presentation of ASD and could be linked 
to specific symptoms or overall severity of ASD; although these relationships are suggested, they 
are still unclear. Further, given the heterogeneity across ASD presentations, it is possible that 
reduced social motivation, and by association mu-opioid processes, could contribute to 
explanations for common symptoms across ASD cases, or perhaps a core deficit identifying a 
subset of cases.  
It would therefore be of interest to explore the main tenets of the Social Motivation 
Theory for ASD directly in an ASD sample: namely, that children with ASD have lower social 
motivation than neurotypical children; how social motivation relates to core symptoms in ASD 
and overall severity of the disorder; and, as strongly suggested by OPRM1 knockout studies, 
whether OPRM1 is linked to reduced social motivation and / or ASD-related deficits. As 
medication already exists to alter mu-opioid levels, improving our knowledge in this area could 
have implications for ASD management. The Social Motivation Theory for ASD suggests that 
early disruptions social motivation lead to impairment in later psychosocial development. 
Exploring the strength of this theory could therefore allow for early, targeted medical 
interventions being developed for children with ASD. 
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Rationale 
ASD is a prevalent neurodevelopmental disorder, but its cause(s) and underlying 
mechanism(s) are not fully understood. Despite the heterogeneous nature of ASD, social deficits 
are a core feature of the disorder that appear early in life and may underlie development of later 
deficits. The overall role of reduced social motivation in ASD, however, is still unknown. ASD is 
a complex disorder with a diverse range of presentations and is therefore unlikely to arise from a 
single cause; instead, it is likely to have various mechanisms contributing to specific deficits, 
which jointly account for the diverse presentations seen. There is strong evidence for a genetic 
basis for ASD, and it is therefore likely that specific genes underlie specific deficits. OPRM1 is 
strongly implicated in the development of social motivation and is therefore of interest when 
assessing the Social Motivation Theory for ASD.  
Research exists supporting a role for OPRM1 in the SEPARATION-DISTRESS system 
and the development of social motivation, and for reduced social motivation in ASD, but there is 
insufficient human research in ASD samples to assess the exact role of OPRM1 and social 
motivation in the ASD phenotype. Generally psychological research has omitted organic 
explorations, and genetic studies rarely feature comprehensive psychological data to provide 
phenotypic profiles. Further, research to date often excluded non-verbal children with ASD and 
overlooked the role of expressive language in ASD phenotypes. Several research gaps therefore 
need to be addressed in genotype-phenotype research for OPRM1, as research needs to directly 
assess levels of social motivation in human ASD samples, and this must be done alongside 
assessment of the ASD-phenotype,  
Psychological and biological research programmes have often run in parallel, but there is 
a clear need to converge data from these two research areas and to further study the relationships 
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between these different levels of investigation. This study aimed to comprehensively assess 
social deficits in ASD, and specifically reduced social motivation, alongside genetic data for 
OPRM1. This study is unique in the scope and depth of assessment of social deficits, in its 
consideration of differences between verbal and non-verbal presentations of ASD, and in its aim 
to bring together several possibly related lines of existing research in biological and 
psychological fields to empirically assess the integrity of relationships that have so far remained 
hypothetical. 
Aims and Hypotheses 
This study aimed to explore the role of social motivation in ASD, using attachment 
behaviour as a proxy for social motivation. I hypothesised that the ASD groups would have 
lower social motivation than the neurotypical group. Within the ASD groups, I anticipated that 
lower social motivation would relate to greater ASD deficits. I hypothesised that reduced social 
motivation and ASD-related deficits would be associated with the presence of the OPRM1 G 
allele as this allele is associated with greater bonding and an opioid analgesic state that would 
undermine the SEPARATION-DISTRESS system. I anticipated differences between the non-
verbal ASD group and the verbal ASD group in these relationships due to the role expressive 
language plays in social abilities but did not have any specific hypotheses for these group 
differences.  
To explore Panksepp’s (1979) Social Motivation Theory for ASD, I researched three 
tenets of his argument. The first is that children with ASD would have lower social motivation 
than neurotypical children. The second tenet is that reduced social motivations would relate to 
ASD-related deficits. And finally, that the mu-opioid system would relate to social motivation 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 54 
levels and ASD-related deficits. I therefore asked the following questions, and addressed them 
with the associated hypotheses:  
Question 1. Do children with ASD exhibit lower levels of social motivation, as indicated 
by attachment behaviours, than neurotypical children? 
Hypothesis 1.1. Children with ASD will have lower secure attachment scores than 
neurotypical children.  
Question 2. Is reduced social motivation related to ASD-related deficits, and does 
language ability have a role in this relationship? 
Hypothesis 2.1. Non-verbal ASD children will have either higher or lower secure 
attachment scores than verbal ASD children. 
Hypothesis 2.2. Non-verbal ASD children will have either higher or lower ADOS2 scores 
than verbal ASD children, indicating different symptom profiles.  
Hypothesis 2.3. Low social motivation, indicated by low secure attachment score, is 
related to higher ADOS2 scores. 
If hypotheses 2.1 – 2.2 are supported, indicating significant differences in social 
motivation and/or ASD deficits between ASD groups, hypothesis 2.3 would be extended to look 
for differences in relationships between social motivation and ASD deficits in the non-verbal 
ASD sample and the verbal ASD sample separately. 
Question 3. Could OPRM1 play a role in social motivation levels and ASD-related 
deficits, and does the acquisition of language influence these relationships? 
Hypothesis 3.1. Children with ASD will show a higher rate of the OPRM1 G allele than 
reported in neurotypical samples.  
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Hypothesis 3.2. ASD children carrying the OPRM1 G allele will present with higher 
ADOS2 scores than those who do not carry a G allele. 
Hypothesis 3.3. ASD children carrying the OPRM1 G allele will present with lower 
social motivation (i.e. lower secure attachment scores) than those who do not carry a G allele. 
Method 
Research Design 
The Social Motivation Study was the first of two studies conducted in the overall PhD 
protocol (see Chapter 4: The Theory of Mind Study, pg.125, for second study). This study 
assessed whether children with ASD had reduced social motivation, whether OPRM1 was 
implicated in social motivation, and whether social motivation and OPRM1 linked to specific 
aspects of ASD symptomatology. The protocol reported here constituted a cross-sectional, 
relational design.  
Context 
This protocol was conducted in the Western Cape, South Africa, as part of the research 
work done by the UCT Autism Research Group, ACSENT Lab, University of Cape Town. Data 
collection was conducted in and around Cape Town. Children with ASD were either assessed at 
their schools or, in cases where the child was not attending school, at their homes. Children were 
seen individually for several sessions in distraction-free environments, and care was taken to see 
the children with ASD in environments in which they were comfortable.  
Participants 
This study incorporated three groups of male participants with similar SES backgrounds: 
two clinical groups were of male children with ASD, one with non-verbal children and one with 
fluently verbal children; and a group of neurotypical male children. A child was considered 
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neurotypical if they had no medical or psychiatric diagnoses and were typically developing. The 
neurotypical group served as a control group. ASD participants were divided according to verbal 
ability for three reasons: first, due to the possible relationship between social motivation and 
language acquisition; second, to ensure equal inclusion of non-verbal participants as they have 
previously been overlooked in research; and third, due to the language demands of measures 
used in the second study of this protocol, the Theory of Mind Study (Chapter 4: The Theory of 
Mind Study - Method - Measures pg.151). 
This protocol recruited a total of 176 male children between 4 and 16 years old. Of these, 
108 children had ASD diagnoses and 68 were neurotypical. The ASD participants were grouped 
by expressive language ability: 53 of these children were classified as non-verbal and 55 children 
were classified as verbal. Children were considered verbal if they had flexible, fluent speech (as 
required for the ADOS2 Module 3), while those in the non-verbal group had no expressive 
language (as required for the ADOS2 Module 1), or limited phrase speech (as required for the 
ADOS2 Module 2). A subsample of the neurotypical group were selected to form a control group 
that matched the verbal ASD group on age, language, and SES.  
ASD Participants. The ASD sample was built using purposive sampling. These children 
were recruited from ASD-specific and special needs schools in the Western Cape, and through 
the UCT Autism Research Group’s database of families willing to participate in ASD research. 
Snowball sampling was also utilised, as parents in the study were encouraged to share the study 
information with any friends that they thought would also be willing to participate. The 
neurotypical children were recruited using purposive sampling as well, but through mainstream 
primary schools in the Western Cape. The study was also featured on the UCT Autism Research 
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Group blog site, and parents who heard about the study there were able to contact the researcher 
for more information. 
Of the 53 children who were recruited to the non-verbal ASD group, two were excluded 
due to missing demographic data (i.e. unable to confirm date of birth and family household 
income). The remaining 51 children were included in the study as all had data for at least two of 
the three measures, and each research question only required one or two measures. Of the 55 
children who were recruited to the verbal ASD group, three were excluded due to new 
medication use during the study, and one was excluded due to a new diagnosis of conduct 
disorder. As with the non-verbal ASD group, the remaining 51 children were included in the 
study as they had sufficient data for at least one of the research questions. 
All 51 children in the non-verbal ASD group had complete demographic and ADOS2 
datasets. Three of the families refused the parent interview but did consent for DNA collection so 
they were not excluded. Of the 51 participants, 34 provided DNA samples and all samples were 
successfully genotyped for OPRM1. This resulted in a sample size of 48 children for Questions 1 
and Question 2 (i.e. ADOS2 and parent interview data), and Question 3 had a sample size of 34 
for hypotheses 3.1 and 3.2 (i.e. ADOS2 and OPRM1 data) and 31 for hypothesis 3.3 (i.e. 
OPRM1 and parent interview data).  
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Figure 1. Non-verbal ASD group data collected per measure, and sample available for each 
research question 
 
The 51 children in the verbal ASD group had complete demographic dataset and had all 
completed ADOS2 assessment. The parents of three children refused the parent interview, but the 
children had data for other critical measures, so they were not excluded. Of the 51 children, 42 
provided DNA samples; all 42 samples were successfully genotyped for OPRM1. This resulted 
in a sample size of 48 children for Questions 1 and Question 2 (i.e. ADOS2 and parent interview 
data), and Question 3 had a sample size of 42 for hypotheses 3.1 and 3.2 (i.e. ADOS2 and 
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Figure 2. Verbal ASD group data collected per measure, and sample available for each research 
question. 
 
Neurotypical participants. Neurotypical children were included in the protocol to assess 
for differences in levels of social motivation between neurotypical and ASD children (Question 1 
of this study). There were 68 male children recruited for the neurotypical group. For inclusion in 
the study, demographic data needed to be complete and parents needed to complete the parent 
interview. Ten children were excluded from the study (see Figure 3), including two who were 
familiar with the measures due to recent assessment by an Education Psychologist, and two 
children with possible medical conditions who were in the process of being diagnosed (1 
participant was undergoing speech therapy and one child was being treated for poor muscle 
tone). This resulted in a sample size of 58 children, none of whom were missing any data. As 
each ASD group consisted of only 51 children, I opted to have a neurotypical group of 51 
children as well. I included all neurotypical children from low to middle income schools (21 
participants), as the majority of the ASD children were not from high-income families, and then 
randomly filled the remaining slots with children from the higher income schools (30 of the 
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Figure 3. Selection of 51 male neurotypical children for inclusion in this protocol. 
 
Sample size. The sample size for this study was selected based on similar studies which 
explored genotype-phenotype relationships in ASD. There is a sparsity of research available for 
genotype-phenotype relationships for OPRM1 in ASD samples, with research on naltrexone use 
in ASD using samples of ten or fewer participants (Bouvard et al., 1995; Herman et al., 1987), 
and these have not been replicated or further explored in more recent years. Studies similar to 
those for the second study of this protocol (see Chapter 4: The Theory of Mind Study – Method – 
Participants, pg.147) were therefore reviewed; genotype-phenotype studies reviewed had 71 
children (Tordjman et al., 2001) to 73 children (Brune et al., 2006). The current protocol 
68 neurotypical male children recruited
10 male children excluded due to data issues: 
- 1 missing demographic data
- 3 changed schools before completion of data collection 
- 2 parents refused interview
- 2 children familiar with test measures
- 2 children with possible diagnoses that would meet exclusion criteria
Final group compilation of 51 male children: 
- 21 children from low to middle income households
- 30 children randomly selected from 37 children from high income households 
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therefore aimed to recruit a minimum of 80 child-parent pairs; a total of 102 ASD child-parent 
pairs were recruited, and DNA was obtained from 76 children within this sample. 
The inclusion of non-verbal children in the protocol was considered essential, as research 
frequently only represents higher functioning children with ASD, and generally does not include 
non-verbal children (Tager-Flusberg & Kasari, 2013). The inclusion of children with ASD who 
had a range of capabilities, including those on the more severe end of the symptom spectrum, 
was therefore necessary to ensure that my research outcomes could be validly generalised to the 
ASD population, and not just to a higher functioning subsample. To obtain the largest possible 
sample, data collection took place over three and a half years, until the lack of response to 
recruitment requests through schools and the UCT Autism Research Group’s database indicated 
that all families who would be willing to participate in the study in the region had been 
approached, and finding further participants would be unlikely. 
Inclusion and Exclusion Criteria. Only male children were recruited as there is some 
debate regarding whether females on the spectrum present with a different phenotype to males 
(Rivet & Matson, 2011). Further, research within ASD has found that female children with ASD 
appear to have a social advantage relative to male children with ASD (Van Wijngaarden-Cremers 
et al., 2014). ASD is also universally four times more prevalent in males than females (Kogan et 
al., 2009). As I wanted to ensure clear phenotyping, I did not want sex to be a confounding 
variable, and it was not possible to ensure equal recruitment of male and female participants to 
try control for this statistically. As an exploratory study, it was arguably justifiable to conduct 
this initial investigation in a cleaner phenotype (i.e. males only) in the hope that later 
confirmatory studies could expand to include females. 
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This protocol focused on social impairment in childhood and early adolescence. 
Recruitment was therefore restricted to children who were in pre-primary or primary school. For 
neurotypical children, this limited the age range to 4-13 years old, and the children in the ASD 
groups were between 4 and 16 years of age, although those over 13 years of age had mental ages 
younger than their chronological ages. All children had to be fluent in English or, in the case of 
non-verbal children, had to come from English-speaking homes or schools. This was due to the 
ADOS2 only being standardised in English and not in other South African languages. Parents 
had to be fluent in English or Afrikaans to complete the interviews.  
Children were excluded if they had a history of head injury. Children with ASD were 
excluded if they had any other neurological or psychological diagnoses, although ADHD was 
allowed due to the high comorbidity in children with ASD. All measures were administered in 
such a way that the effects of inattention or hyperactivity were minimized. Neurotypical children 
could not have any reported medical, neurological, or psychiatric diagnoses. Children with ASD 
were excluded if they used any medication that could influence opioid or serotonin processing, 
due to the biological nature of this study; neurotypical children did not use medication as all 
children with any medical conditions were excluded.  
 
 ASD participants Neurotypical participants 
Inclusion criteria - Male 
- 4-16 years old 
- Fluent in English (or 
from English school or 
home if non-verbal) 
- Male 
- 4-16 years old 
- Fluent in English 
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Exclusion criteria - Head injury or 
neurological disorder 
- Medical disorders 
- Psychiatric disorders 
(excl. ADHD) 
- Medications which 
influence mu-opioid or 
serotonin processes (e.g. 
SSRIs and anti-anxiety 
medications) 
- Head injury or 
neurological disorder  
- Medical disorders 
 
- Psychiatric disorders  
 
 
- Medications which 
influence mu-opioid or 
serotonin processes (e.g. 
SSRIs and anti-anxiety 
medications) 
Figure 4. Inclusion and exclusion criteria per group for this protocol. 
 
Limitations on Sample Size. This protocol faced several challenges regarding 
recruitment of children with ASD, which limited the sample size obtained. ASD is a complex 
neurodevelopmental disorder with several common comorbidities, including depression or 
anxiety disorders; and seizures or epilepsy (American Psychiatric Association, 2013; Bolton et 
al., 2011; Peacock et al., 2012; Simonoff et al., 2008). As these comorbidities might have 
confounded the relationships explored in this protocol, children with comorbidities were 
excluded, significantly reducing my recruitment pool.  
The sample was further limited by the decision to restrict recruitment to only male 
children. Prevalence rates estimate that 1 out of every 4 children with ASD is female, so 
excluding all female children meant a possible 20% reduction in the recruitment pool. However, 
cleaner phenotyping added robustness to analyses, a justified approach for exploratory studies.  
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As a South African study, I also limited my recruitment pool by having to restrict all 
recruitment to English speaking families, as the ADOS2 was not standardized in any other 
common languages spoken in South Africa at the time. The ADOS2 is the gold-standard for 
research and diagnostics in ASD, and often a necessary measure when seeking to publish ASD 
research, so it’s inclusion in the protocol was considered essential for assessing participants’ 
ASD phenotypes.  
Although the collection of DNA did not limit recruitment, it did place restrictions on the 
sample sizes for aspects of the study using genetic data as DNA collection and processing in 
ASD faces further limitations. ASD often includes sensory integration difficulties, and this can 
result in some children being unable to tolerate swabbing. These children’s lowered verbal 
activity had an associated low salivation rate which undermines the volume of DNA collected by 
swabbing. Further, poor oral hygiene results in high bacteria counts that prevent successful 
genotyping (Hansen et al., 2007). Non-verbal children who tolerated the swab were, in some 
cases, later excluded from DNA analyses due to poor DNA yield. 
Finally, data collection was restricted to the Cape Town area, and after multiple rounds of 
recruitment I had exhausted the willing recruitment pool. Further rounds of data collection were 
unlikely to identify more participants and time and budgetary constraints prevented recruitment 
outside of Cape Town.  
Procedure 
Children and their families were recruited through their schools with letters, or via email 
or telephone if they were recruited through the UCT Autism Research database. All respondents 
were screened with a demographic and medical history form. Children who were included were 
then seen for assessment and their primary caregiver was interviewed telephonically or in person.  
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 65 
Recruitment. Children with ASD were recruited via special needs or ASD-specific 
schools, or through the UCT Autism Research database which had a list of participants from 
previous studies who were interested in participating in further research. Parents were sent 
information sheets (Appendix B), a screening questionnaire that collected demographic data and 
medical information (Appendix C), and a consent form that required consent for the 
psychological data collection and optional additional consent to participation in the DNA aspect 
of the study (Appendix D). These forms were sent via schools in sealed envelopes or via email 
for participants from the database. Parents then returned these forms via the school psychologist 
or via email as they preferred. Recruitment for participants with ASD was conducted from 
January 2015 through to September 2017, at which point the low response rate indicated that 
most possible participants at these schools and on the database had been approached and further 
recruitment was terminated.  
Neurotypical children were all recruited through mainstream schools. They were sent 
information packs that included an information sheet (Appendix E), the same demographic 
questionnaire and medical history form as the ASD participants (Appendix C), and a consent 
form for psychological data collection but not DNA collection (Appendix F). These forms were 
also returned via email or the school psychologist. Recruitment of neurotypical children began in 
February 2017 and was terminated in September 2017 as recruitment of ASD participants was 
terminated and more neurotypical children had enrolled for the protocol than verbal children 
with ASD (i.e. the group the neurotypical sample would be matched against). 
Screening and ADOS2 Assessment. Once parents returned the above forms, screening 
was conducted based on the medical and demographic data received (see Inclusion and 
Exclusion Criteria, pg. 58). Children with ASD had further screening: ADOS2 assessment by 
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this doctoral candidate had to confirm ASD diagnosis, and children were then placed in the non-
verbal ASD group or verbal ASD group based on their ability to consistently understand two-
stage commands on the Developmental Neuropsychological Assessment, Second Edition 
(NEPSY-II) Comprehension of Instructions Task.  
Parent Interview. Parent interviews for all three groups were conducted after screening 
and concurrently to the child sessions for the verbal ASD and neurotypical groups. These were 
conducted via telephone at a time selected by the parent, or in the case of home visits for 
children with ASD, these interviews were conducted at the participant’s home on the same day 
as the ADOS2 assessment.  
DNA Collection. DNA samples were collected from ASD participants in November and 
December 2017. Only children whose parents had given additional consent for DNA collection 
were approached, and DNA was only collected if the child gave verbal assent in the case of 
verbal children with ASD, or if the child willingly participated in the process in the case of non-
verbal children with ASD. DNA was collected in the form of buccal cells obtained from cheek 
swabs. Children were allowed to practice the procedure using normal earbuds if they wished, and 
then the researcher conducted the proper swabs. Two swabs were collected for each child and 
were delivered to the University of Cape Town Human Genetics Laboratory on the same day as 
collected. DNA was extracted and preserved, and then processed when all samples were 
collected. DNA was destroyed after processing. 
Measures 
This study had three phases of data collection: first children were recruited and screened, 
then their parents were interviewed, and finally DNA was collected from a subsample of 
participants. This protocol divided participants into three groups: a non-verbal ASD sample, a 
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verbal ASD sample, and a neurotypical sample. All three groups completed the screening and 
parent interview, but only the two ASD groups completed ADOS2 assessment.  
Screening. Demographic and medical data was collected for each participant during 
recruitment for screening purposes (Appendix C). Demographic data included age, sex, home 
language and socioeconomic status. Additional questions were asked to ascertain whether the 
child had a history of medical or psychiatric difficulties or had experienced any head traumas. 
This survey also established if participants were using any medication that could affect their mu-
opioid or serotonin functioning. The demographic data was used for aggregate matching of 
participants across groups and the medical data was used to screen participants according to my 
inclusion and exclusion criteria.  
The demographic forms also asked the ASD participants to list their ethnicity if they felt 
comfortable doing so. South Africa is a diverse country, but with a history of inequality based on 
racial injustice. Asking participants their ethnicity is therefore a sensitive topic and only 
considered appropriate for certain procedures; in this protocol, ethnicity was only considered 
relevant for the DNA aspects of the protocol. Ethnicity was therefore not considered during 
recruitment or matching of participants but was reported alongside the allelic frequency of 
OPRM1 due to the possibility of different ethnic groups having different allelic frequencies for 
this gene.  
Language and Group Allocation. Children who were included in the protocol based on 
the initial screening from the demographic survey then completed the Comprehension of 
Instruction subtest from the NEPSY-II to screen for difficulties in language comprehension 
(Brooks et al., 2009). All neurotypical children were able to consistently follow two-stage 
commands; if any had not been able to, they would have been excluded. Participants with ASD 
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were divided into ASD sub-groups based on their language ability: children who were non-
verbal or had limited language and could not consistently follow two-stage commands were 
placed in the non-verbal ASD group; participants with ASD who were verbally fluent and were 
able to consistently follow two-stage commands were placed in the verbal ASD group.  
The Comprehension of Instruction task was developed for children aged 3-12 years, and 
has since been adapted for children aged 3-16 years (Brooks et al., 2009). This subtest assesses 
auditory comprehension of verbal commands and ability to process and then execute these 
instructions. Children have to point to pictures according to instructions from the examiner. 
These instructions begin as simple single stage commands, and then increase in complexity. For 
this protocol ability to follow instructions beyond two-stage commands was not assessed as this 
level of comprehension was deemed sufficient for the instructions of the ToM battery.  
The NEPSY-II has established psychometric properties as a battery, and the 
Comprehension of Instructions subtest derives its validity from the battery as a whole (Brooks et 
al., 2009). The reliability for the Comprehension of Instructions subtest ranges ranging from .71 
to .82 depending on the age of the sample. The NEPSY-II has been translated and validated into 
several languages, although I only administered it in English due to the ADOS2 only being 
appropriate for use in English-speaking local samples. The first and second editions of the 
NEPSY showed acceptable psychometric properties in samples from Iran and Zambia (Abedi et 
al., 2012). These studies with non-Western samples showed that cultural differences could 
undermine performance on the NEPSY and result in lowered scores compared to Western norms, 
although this did not significantly undermine the validity of the test. As I only used the 
Comprehension of Instructions Task, and only to assess pass/fail on two-stage commands rather 
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than overall performance for the task with a norm-based scoring, this bias was unlikely to 
undermine my protocol and the subtest was considered appropriate for screening purposes. 
ADOS2. Children in the ASD groups had their ASD diagnosis confirmed and ASD-
related deficits were assessed and characterized with the Autism Diagnostic Observation 
Schedule, Second Edition (ADOS2; Lord et al., 2012). The ADOS2 is a semi-structured, 
standardised observation tool for ASD diagnostics and for research purposes that has been 
adapted for all levels of language ability and ASD severities. The ADOS2 has improved 
psychometric properties compared to the first edition ADOS and is the gold-standard for use in 
diagnostics and research (Lord et al., 2012; Lord et al., 1989). The ADOS2 has sensitivity ratings 
in the upper 90% range and specificity in the upper 80% to lower 90% range. Internal 
consistency ranges from .47-.96, but all lower scores were for non-social domains. Test-retest 
reliability is high for social domains, and acceptable for non-social domains.  
The ADOS2 has specific modules that are administered to the child based on their age 
and language ability. There are five modules, with the Toddler Module being appropriate for 
children from 12months of age, Module 1 for non-verbal children over 30 months of age, Module 
2 for children who have developed phrase speech, Module 3 for verbally fluent children and 
adolescents, and Module 4 for adults. This protocol administered modules 1,2 or 3 based on the 
child’s abilities, and these assessments took between 40 and 60 minutes.  
The ADOS2 assesses core symptom domains and key ASD characteristics and returns 
three main scores: the Comparison score indicates overall level of ASD severity; Social Affect 
(SA) score indicates level of deficit related to social communication and interaction; and 
Restricted Repetitive Behaviours (RRB) score indicates level of deficit for the restricted and 
repetitive behaviours and interests symptom domain. The Comparison score takes age into 
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account and was comparable across all ADOS2 modules, while the Social Affect and RRB 
scores are comparable across modules due to having the same scoring range although they did 
not explicitly take age into account.  
The ADOS2 was developed in English and has been translated and validated into several 
languages internationally, including French, German, and Japanese (Western Psychological 
Services, 2019). I administered the ADOS2 in English as there were no validated translations for 
other South African languages at the time of data collection. All ADOS2 assessments were 
conducted by the PhD candidate, who had completed her ADOS2 training in English and had 
achieved research reliability (Appendix G).  
The ADOS2 is considered the gold-standard for ASD diagnostics, and for research 
purposes. As such, many journals require the ADOS2 be included in research protocols when 
seeking publication. As a measure of choice in diagnostics and in research, it is an ideal measure 
for assessing core and essential aspects of ASD. Other measures exist for identifying and 
quantifying ASD-related symptoms and behaviours and are often used in research, including the 
Social Communication Questionnaire (SCQ; formerly the Autism Screening Questionnaire) 
(Rutter, Bailey, et al., 2003) and Social Responsiveness Scale (SRS) (Constantino & Grber, 
2005).  
These measures, however, rely on interviews with caregivers and teachers, rather than 
direct observation of the child. Further, recent research found that both these measures did not 
perform reliably with families of low SES, low maternal education, or when the child showed 
lowered developmental functioning and greater behavioural difficulties (Moody et al., 2017). 
Clinically, it is recommended that these measures be paired with the ADOS (or ADOS2 more 
recently) for diagnostic purposes (Corsello et al., 2007). As the ADOS2 is a direct observational 
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measure, and was administered only after receiving clinical and research training, I deemed this 
measure to be better suited to my phenotyping needs. For phenotyping, I wanted to identify 
ASD-related behaviours that were considered core characteristics of the ASD phenotype and that 
align with the overall diagnosis, and the ADOS2 identifies these across both symptom domains.  
Parent Interview. The parents of all participants were interviewed telephonically or 
face-to-face, as they preferred. In this interview parents completed the Attachment Style 
Classification Questionnaire (ASCQ; Appendix H; Finzi-Dottan et al., 2012). Although the 
ASCQ is designed to assess attachment styles in children, I used this measure to assess 
behaviours indicative of social motivation. When this study was designed, there were no 
standard measures available to assess social motivation in children with ASD, so I relied on 
indicators of social interest, which are similar to those assessed in measures of attachment. Since 
then, and to my knowledge, two measures have been developed. The first is a 28 item 
questionnaire, the Social Motivation Questionnaire, developed as part of a doctoral dissertation 
from the Palo Alto University (Schapp, 2016). More recently, the Social Motivation Interview 
was developed (Elias & White, 2019). These measures indicate progress in the field but require 
further validation. However, had they been available at the start of the current protocol, it is 
likely that they would also have been adapted to parent interviews as neither are appropriate for 
use with non-verbal children.  
I therefore had to look to other measures that assessed behaviours indicative of social 
motivation, and I found that questions usually indicating secure attachment also reflected social 
interest. The ASCQ is a 15 item questionnaire that rates a child’s level of secure attachment, 
anxious-avoidant attachment, and anxious-ambivalent attachment, rather than categorising a 
child into one predominant attachment style. The ASCQ was developed as a self-report measure 
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for children between 7 and 14 years. In the current protocol the measure was administered to 
parents in an interview format instead of as a self-report measure for the children. This change 
was made so that data could be collected for both the ASD groups and the neurotypical group in 
a consistent manner. The non-verbal children with ASD were unable to complete self-report 
measures, and because many of the verbal children with ASD lacked insight into social 
interactions and social norms it would be inappropriate to rely on their self-report on social 
behaviours. This change also allowed the same measure to be administered to the full group of 
participants as the initial minimum age for the ASCQ was based on when a child would be 
capable of reliable self-report, which was no longer an issue. Some of the children with ASD 
were older than 14, however they were still in a primary school environment and were 
developmentally delayed, so this measure was considered appropriate for these children.  
Ideally direct observation would be used to assess social motivation, but I preferred to 
have the parents provide this information as they had a long-term overview of behaviours 
whereas the time and budget constraints of this protocol would have meant that any observation 
of social motivation would be limited to single observation. I did not think that a single 
observation would be representative of a child’s overall level of social interest, especially in the 
case of children with ASD who are often anxious when their routines are disrupted or if they are 
placed in novel situations.  
The ASCQ assessed secure attachment based on a child’s behaviour with their family and 
peers. Some questions asked if the child seeks out social contact (Item 6: “My son would like to 
be really close to some children and always be with them”) as well how the child responds when 
others initiate contact (Item 15: “Usually when anyone tries to get too close to my child, it does 
not bother him”). While parent-report is open to some bias, my team required parents to support 
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their answers with examples and often with descriptions of typical behaviours in social 
situations. For example, when asked Item 5 “Sometimes my son is afraid that other kids won’t 
want to be with him” we asked for descriptions of how engaging and secure (or anxious) the 
child was when entering a social group. Ultimately these questions allowed us to assess how 
interested the child was initiating social interaction, how comfortable they were with this 
interaction, and whether they engaged socially when given the opportunity. Where students were 
not sure the answers were accurate, these could be followed up with a further discussion with the 
parent.  
The ASCQ was initially designed in Hebrew, and an English version has since been 
translated and adapted. The ASCQ has test retest reliability ratings between .87-.95, internal 
consistency ratings between .69-.81, and validity has been consistently established in clinical and 
non-clinical samples (Al‐Yagon & Mikulincer, 2004; Finzi-Dottan et al., 2012). 
DNA Collection and Genotyping. All ASD participants in this protocol were approached 
to provide DNA but this was an optional aspect of the study. Of the 102 children with ASD who 
participated, 76 children provided assent and had parental consent to provide DNA samples. 
These samples were collected at the end of the child sessions, when the children were more 
comfortable with the researcher. All DNA was processed by the UCT Human Genetics 
Department.  
Neurotypical children were not approached for DNA samples for two reasons. First, this 
protocol had limited funding and I was not able to cover the costs of DNA processing for the full 
study sample. As the primary interest was in the ASD phenotype, I chose to focus on collecting 
samples from the ASD participants for comparison to their phenotypes. The neurotypical sample 
was not phenotyped – they did not complete ADOS2 assessment (i.e. the assessment used to 
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quantify ASD-related deficits for the ASD phenotype), as they were unlikely to have sufficient 
variability in their scoring on this measure, and were likely instead to show a floor effect. 
Second, I was interested in social motivation levels and expected that while low levels were 
likely prominent in the ASD samples, they were unlikely to be common in the neurotypical 
sample. The possible absence of scoring variability in the variables of interest in the neurotypical 
sample would therefore undermine any possible genotype-phenotype analyses. I chose instead to 
use the funding only for the ASD samples to ensure a larger number of DNA samples for 
inclusion in the ASD analyses, and to have a comparable sample size to other genotype-
phenotype studies with ASD samples  
DNA Extraction. Buccal cells were collected with sterile check swabs. DNA was 
extracted from samples by a modified salting-out method (Freeman et al., 2003; Meulenbelt, 
Droog, Trommelen, Boomsma, & Slagboom, 1995), quantified with a NanoDrop 1000 (Thermo 
Fisher Scientific, Johannesburg, South Africa) and normalised for genotyping. 
OPRM1 Genotyping. All reagents and kits were used according to the manufacturer’s 
instructions. OPRM1 genotyping was performed with a customised TaqMan™ assay (assay ID 
c_8950074_1) and TaqMan™ Genotyping Master mix (Thermo Fisher Scientific, Johannesburg, 
South Africa) on a Bio-Rad CFX96 real-time PCR system (Bio-Rad Laboratories, Johannesburg, 
South Africa). Selected genotypes were confirmed by direct sequencing. 
Direct (Sanger) Sequencing. Selected OPRM1 samples were confirmed by direct 
sequencing. All reagents and kits were used according to the manufacturer’s instructions. 
OPRM1 was amplified with primer sequences from (L. K. Chen et al., 2013) using GoTaq G2 
Taq polymerase (Promega, Madison, WI, USA); aliquots were used to confirm PCR quality by 
agarose gel electrophoresis. Amplicons were digested with 1U each of ExoI and FastAP (Thermo 
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Fisher Scientific, Johannesburg, South Africa). Cycle sequencing was performed with the 
BigyDye™ Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, Johannesburg, 
South Africa). Sequencing was performed on an Applied Biosystems 3130xl Genetic Analyzer 
(Thermo Fisher Scientific, Johannesburg, South Africa), using standard conditions. Sequencing 
traces were analysed with Sequencing Analysis v5.4 software (Thermo Fisher Scientific, 
Johannesburg, South Africa). 
Ethical Considerations. This protocol was conducted in line with the ethical guidelines 
for human subjects as per the Health Professional Council of South Africa (HPCSA), the 
University of Cape Town (UCT) Codes for ethical research, and the International Declaration of 
Helsinki (World Medical Association, 2013). Ethical approval was obtained from the UCT 
Psychology Department Ethics Board (ref: PSY2014-024; Appendix I), and from the UCT 
Faculty of Science Research Ethics Committee (ref: HREC 076-2014; Appendix J). Further 
ethical approval for DNA collection and analyses was obtained from the UCT Faculty of Health 
Sciences Human Research Ethics Committee (ref: HREC 346/2017; Appendix K).  
Permission to approach schools for participation in the study was obtained from the 
Western Cape Government Education Department (ref: 20150422-46598; Appendix L). Informed 
consent was obtained in writing from parents for participation in the study, with separate consent 
for the collection of psychological data and DNA data for ASD participants (Appendix D) and 
only for psychological data for the neurotypical participants (Appendix F). Verbal participants 
provided oral assent for participation in the study at the start of each session. Assent was 
considered obtained for non-verbal ASD participants if they willingly engaged in the protocol as 
the behavioural rigidity inherent in ASD makes it unlikely that these children would unwillingly 
complete any tasks or social interactions (American Psychiatric Association, 2013).  
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All data collected in this study was only used for research purposes and access was 
restricted to members of the UCT Autism Research Group, and confidentiality was maintained at 
all times. All physical psychological data was stored in sealed boxes in a locked storage area in 
an access-controlled room in the UCT Psychology Department. Electronic data was stored in a 
password protected file and all identifying information was removed when participants were 
allocated a participant number, with only the doctoral candidate having access to the master file 
linking identifying data with the allocated participant number. All DNA was processed by the 
UCT Human Genetics Department and was immediately destroyed after processing; this 
department only received buccal samples marked with participant numbers, ensuring complete 
confidentiality.  
This protocol did not harm the participants in any way. Children from the ASD groups 
were seen once to complete the Comprehension of Instructions task and ADOS2 assessment. The 
ADOS2 is designed for use with children with ASD and is therefore appropriate. The children 
were given breaks where necessary to prevent fatigue, and children were able to end the session 
and/or withdraw from the study at any time. Neurotypical children did not need to complete any 
child measures for this study. Parents were given contact details for the doctoral student, as well 
as for the relevant ethics boards and for the UCT Psychology Department so they could withdraw 
from the study at any time, or lodge a complaint if necessary. Schools were also able to contact 
the researcher at any time if they wished to withdraw from the study or limit access to their 
students.  
ASD participants whose parents gave consent for DNA collection also had to give assent 
to this DNA collection in the same way as with the psychological data collection. If a child was 
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not completely comfortable, they were able to “practise” the collection procedure with a cotton 
earbud and could withdraw at any point. The actual collection was painless and rapid.  
On completion of data collection each ASD child received an individualised research 
report that parents could share with their child’s school or clinician, and I was available to 
answer any queries. This report provided information from the ADOS2 assessment. Neurotypical 
participants received a research report as part of their participation in the Theory of Mind Study 
(Chapter 4: The Theory of Mind Study - Methods, p. 73).  
Analyses 
All statistical analyses were run using IBM SPSS Statistics, Version 25 (IBM, 2017). 
Participant characteristics were first compared across groups to ensure they were appropriately 
matched on relevant demographic variables. The questions for the Social Motivation Study were 
then addressed. For all the following analyses, assumptions were tested and the analyses were 
only conducted if they were upheld; or, if assumptions were violated, tests were only continued 
if the analyses would be robust against this violation, such as when homogeneity of variance was 
violated for ANOVA with equal group sizes (Field, 2013). 
This study was an exploratory analysis of the relationships between ASD-related deficits, 
social motivation, and OPRM1 alleles, and was the first of its kind. As an exploratory study, 
there were a high number of analyses, which could increase the probability of a Type 1 error. 
However, given the novelty of the research, especially in terms of combining psychological and 
genetic fields, I wanted to find possible relationships that could then be further investigated in 
later confirmatory studies. To ensure any possible relationships could emerge, alpha was kept at 
0.05 in all analyses. Although my approach may increase the risk of spurious findings, effect 
sizes were included in all analyses to provide an additional estimation of the associations present. 
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Participant Characteristics. This protocol had three participants groups: a non-verbal 
ASD group, a verbal ASD group, and a neurotypical group. All participants were male and first 
language English speakers (or in the case of non-verbal participants they came from English 
speaking homes and schools). ANOVA was used to assess whether all three groups were 
aggregate matched on SES and age. It was anticipated that the non-verbal ASD group could be 
younger than the other two groups, so post-hoc tests were used to assess whether the verbal ASD 
and neurotypical groups were matched on age. Ethnicity was recorded for use in reporting DNA 
results for the ASD subsamples that provided DNA samples, but was not used in recruiting or 
reported for the neurotypical group, so no analyses were conducted on this data.  
Social Motivation Study Questions. The Social Motivation Study had three main 
questions, each with their own analyses. For this study, secure attachment scores were 
continuous and were a proxy for level of social motivation such that higher scores indicated 
higher levels of social motivation. ADOS2 scores indicated ASD-related deficits and were also 
continuous, but here higher scores indicated greater deficits. OPRM1 genotypes and alleles were 
reported for a subsample of the ASD participants, and the presence of one or more G alleles 
indicated higher sensitivity to, and binding of, mu-opioids, likely generating an analgesic state 
that would undermine the SEPARATION-DISTRESS system.  
For the first question on whether children with ASD had lower social motivation than 
neurotypical children, hierarchical regression was conducted with age, SES, and group (in two 
dummy variables) as predictors of secure attachment scores (i.e. the proxy for level of social 
motivation).  
The second question related to whether social motivation related to ASD-deficits. From 
the above analyses, the dummy variable coding for group would also reveal whether there were 
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group differences in social motivation between the non-verbal ASD group and the verbal ASD 
group. As there was, I also assessed for ADOS2 score differences between the groups using 
ANCOVA for three analyses, where age was the covariate; these analyses compared ADOS2 
Comparison scores, ADOS2 Social Affect scores, and ADOS2 RRB scores across the two ASD 
groups. As group differences were found for both social motivation and ADOS2 scores across 
the ASD groups, further analyses for this question were conducted separately for the two ASD 
groups. Multiple regression analyses (MRAs) were conducted for each group with age, SES, and 
secure attachment scores as predictors for each of the ADOS2 outcome scores (i.e. Comparison 
score, Social Affect score, and RRB score).  
The third question of this study assessed the role of OPRM1 in ASD-related deficits and 
in social motivation levels. The OPRM1 genotype and allelic frequencies were reported for each 
ASD group for comparison against reported rates for neurotypical samples; these were also 
reported for each ethnic group in these samples. I planned to use MRA to assess for relationships 
between OPRM1 and ASD-related deficits, where age, SES, and OPRM1 genotypes were 
assessed as predictors of ADOS2 scores, but these analyses could not be conducted due to the 
unanticipated low incidence of the A allele. Similarly, MRA was going to be conducted for each 
ASD group with age, SES, and OPRM1 genotypes as predictors of secure attachment scores, but 
was abandoned due to the same limitation.  
Results 
Participant Characteristics 
This research protocol included 153 male children, divided equally into three groups of 
51 children (i.e. non-verbal ASD, verbal ASD, neurotypical). To limit potential bias, the groups 
were assessed for differences in age and socio-economic status (SES; total annual household 
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income) with a one-way MANOVA. As all children were male, sex would not be a confounding 
factor. For age there was a significant difference across groups, F(2,150) = 14.65, p < 001, with a 
large effect, 2 = .151(Kirk, 1996). Post-hoc comparisons using Games-Howell showed that 
while the non-verbal ASD group was significantly younger than the verbal ASD group, p <.001, 
and the neurotypical group, p < .001, the verbal ASD group and the neurotypical group did not 
differ significantly on age, p = .599. It was anticipated that the non-verbal ASD group might be 
slightly younger than the verbal ASD group and the neurotypical group, as children with ASD 
often have delayed speech development (Mody et al., 2013), so where the non-verbal ASD group 
was included in further analyses, age was considered as a covariate. For SES, the 3 groups did 
not differ, F(2,150) = 2.01, p = .138, 2 = .013. The groups were therefore equal in size and 
matched on sex and SES. The verbal ASD group and neurotypical group were also matched on 
age.  
 
Table 1.  
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Notes. ASD = Autism Spectrum Disorder. SES = Socio-economic status (total annual household income in Rands per 
year).  = Mean. SD = Standard deviation. 
 
 My demographic questionnaire also recorded ethnic data for the sample. This data was 
not used in participant recruitment or matching but was recorded for the ASD samples for 
inclusion in the DNA analyses. My non-verbal and verbal ASD samples showed similar ethnic 
distributions, as Fisher’s Exact test was non-significant, p = .703. 
 
Table 2. 









Caucasian 34 (33.33%) 16 (31.37%) 18 (35.29%) 
Mixed race 52 (50.98%) 26 (50.98%) 26 (50.98%) 
African 10 (9.80%) 6 (11.76%) 4 (7.84%) 
Asian 5 (4.90%) 2 (3.92%) 3 (5.88%) 
Other 1 (0.98%) 1 (1.96%) 0 (0.00%) 
Notes. ASD = Autism Spectrum Disorder.  
 
Question 1: Do Children with ASD Exhibit Lower Levels of Social Motivation than 
Neurotypical Children?  
The Social Motivation Study started by exploring the integrity of Panksepp's (1979) 
theory by assessing whether children with ASD have lower levels of social motivation than 
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neurotypical children. Hierarchical regression was conducted to assess the relationship between 
group and social motivation. As language in ASD was of interest, the grouping variable had 
three levels: neurotypical, non-verbal ASD, and verbal ASD.  
Hypothesis 1.1 Children with ASD Will Have Lower Social Motivation Scores than 
Neurotypical Children. This study investigated the role of secure attachment as an indication of 
level of social motivation, starting by comparing secure attachment levels in ASD to a 
neurotypical sample. Descriptive statistics indicated that the group means for social motivation 
as indexed by secure attachment scores showed the predicted pattern with the neurotypical 
sample having higher levels of secure attachment, M = 8.25, SD = 1.59, than the ASD samples. 
The verbal ASD group, M = 6.56, SD = 2.39, followed, with the non-verbal ASD group showing 
the lowest levels of secure attachment, M = 4.77, SD = 2.68.  
 
Table 3. 
Secure Attachment Scores Across Groups 
Group 
Secure Attachment Score 
Mean SD Rangea  
Non-Verbal ASD (n = 48) 4.77 2.68 0-10 
Verbal ASD (n = 48) 6.56 2.39 0-10 
Neurotypical (n = 51) 8.35 1.59 4-10 
Notes. ASD = Autism Spectrum Disorder. SD=Standard deviation. 
a Possible score range of 0-10 
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Figure 5. Mean secure attachment scores across groups with 95% confidence intervals. 
 
To assess whether the grouping variable had a significant association with levels of 
secure attachment, a hierarchical regression analysis was conducted. Due to the grouping 
variable having three levels, two dummy variables were used. Group was placed subsequent to 
age and SES in the regression model to ensure that any association seen was over and above the 
influence of the demographic variables.  
The variables were assessed for correlations. The outcome variable, secure attachment 
score, was significantly correlated with the two group dummy variables as predicted. No issues 
with multicollinearity were noted (Table 4). All tolerance scores and variance inflation factor 
(VIF) scores were acceptable, confirming no multicollinearity (Field, 2013). 
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Table 4. 
Zero-Order Correlation Matrix for All Participants: Secure Attachment Score 
 1 2 3 4 5 
1. Age (Months) -     
2. SES -.20** -    
3. Group: Neurotypical v ASD -.17* -.08 -   
4. Group: Neurotypical &Verbal v Non-
Verbal ASD 
-.43** .07 .51** -  
5. Secure Attachment Score .05 .05 -.48** -.48** - 
Notes. SES = Socio-Economic Status (total annual household income). ASD = Autism Spectrum 
Disorder. 
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
The overall model was significant, F(4,142)= 17.28, p < .001, and the adjusted R2 value 
showed that the model explained 30.8% of the variance in secure attachment, and the R2 change 
value of .32 showed that this was accounted for by the group variable (i.e. non-verbal ASD, 
verbal ASD, or neurotypical; Table 5). This model had a large effect size, f2 = .49 (Selya et al., 
2012), and an observed power of .95. Table 6 showed that age was a significant predictor of 
secure attachment. It also showed that both dummy variables for group were significant 
predictors for secure attachment as well.  
The first dummy variable for group, which indicated ASD diagnosis by giving 
neurotypical participants a score of zero and all ASD participants a score of one, had a 
significant negative beta value, indicating that the difference between neurotypical versus ASD 
participants was such that ASD participants had lower secure attachment scores. The second 
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dummy variable, which considered language deficit by allocating a zero to neurotypical and 
verbal ASD participants and a one to non-verbal ASD participants, also showed a significant 
negative beta value, indicating that having a language deficit was associated with lowered secure 
attachment scores compared to both the verbal ASD group and the neurotypical group. This 
supported the hypothesis that children with ASD have lower secure attachment scores, indicating 
lower levels of social motivation, than neurotypical children.  
 
Table 5. 









  Change Statistics 
R Square 
Change 
F Change df 1 df 2 
Sig. F 
Change 
1 .08 .01 -.01 2.69 .01 0.42 2 144 .66 
2 .58 .33 .31 2.23 .32 33.94 2 142 <.001 
Notes.  
Model 1: Constant, Total Annual Family Income (SES), Age 
Model 2: Constant, Total Annual Family Income (SES), Age, Group (Dummy variables used) 
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Table 6. 









Model Predictors B Std. Error β  t p Tolerance VIF 
2 (Constant) 9.77 0.91  10.81 <.001   
 Age (months) -0.01 0.01 -0.17 -2.19 .030 .78 1.28 
 SES <0.01 <0.01 0.02 0.26 .796 .95 1.06 
 
Group (NT v 
ASD) 
-1.71 0.45 -0.30 -3.77 <.001 .73 1.38 
 
Group (NT & 
Verbal v 
NonVerbal) 
-2.26 0.50 -0.40 -4.53 <.001 .62 1.62 
Notes. SES = Socio-Economic Status (total annual household income). NT = Neurotypical. ASD = Autism 
Spectrum Disorder. 
 
Question 2: Is Reduced Social Motivation Related to ASD-Related Deficits, and Does 
Language Acquisition Play a Role in This Relationship?  
The hypothesis for Question 1 was supported, indicating that the two ASD groups had 
lower social motivation scores than the neurotypical group. Question 2 focuses on social 
motivation in ASD; this focus is on both the role of language in social motivation, and possible 
links between social motivation levels and ASD deficits. As the focus of these analyses was on 
ASD-related deficits, the neurotypical sample was excluded. 
Hypothesis 2.1 Non-verbal Children with ASD Will Have Higher or Lower Social 
Motivation Scores Than Verbal Children with ASD. Under hypothesis 1.1, the multiple 
regression model presented above compared secure attachment scores across the three groups 
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(i.e. neurotypical vs verbal ASD vs non-verbal ASD). In addition to showing that the 
neurotypical group had higher secure attachment (i.e. social motivation) than both ASD groups, 
the second dummy variable also showed a significant difference between the two verbal groups 
(i.e. neurotypical group and verbal ASD group) compared to the non-verbal ASD group. The 
non-verbal ASD group therefore had significantly lower secure attachment scores, M = 4.77, SD 
= 2.68, than the verbal ASD group, M = 6.56, SD = 2.39. 
Hypothesis 2.2 Non-Verbal Children with ASD Will Have Higher or Lower ADOS2 
Scores Than Verbal Children with ASD. ASD deficits quantified by ADOS2 scores were 
assessed across the ASD groups to ascertain what role, if any, verbal abilities played in ASD 
presentations. As all ASD participants completed ADOS2 assessments to confirm ASD 
diagnosis, all 102 ASD participants (i.e. 51 non-verbal ASD, 51 verbal ASD) were included in 
these analyses. ANCOVAs were utilised to assess for differences across all three of the ADOS2 
outcome scores, namely: Comparison score, Social Affect score, and RRB score.  
 For ADOS2 Comparison scores, age was not significant as a covariate, F(1,99) = 3.75, p 
= .056. ASD group had a significant association with ADOS2 Comparison scores over and above 
the role of age, F(1,99) = 4.42, p = .038, 2 = .032, although this was a small effect. The non-
verbal ASD group therefore scored significantly higher for ADOS2 Comparison scores, M = 
6.18, SD = 1.45, than the verbal ASD group, M = 5.69, SD = 2.00. 
For ADOS2 Social Affect scores, age was not significant as a covariate, F(1,99) = 2.54, p 
= .114. ASD group had a significant association with ADOS2 Social Affect scores over and 
above the role of age, F(1,99) = 68.27, p < .001, with a large effect, 2 = .391. The non-verbal 
ASD group therefore scored significantly higher for these deficits, M = 13.49, SD = 3.95, than 
the verbal ASD group, M = 7.55, SD = 3.27. 
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For ADOS2 RRB scores, age was not significant as a covariate, F(1,99) = 2.69, p = .104. 
ASD group had a significant association with ADOS2 RRB scores over and above the role of 
age, F(1,99) = 11.34, p = .001, with a moderate effect 2 = .093. Once again, the non-verbal 
ASD group scored significantly higher for these deficits, M = 3.02, SD = 2.12, than the verbal 
ASD group, M = 1.96, SD = 1.15.  
 
Table 7. 









Comparison scorea    (SD)] 6.18 (1.45) 5.69 (2.00) 4.42 .038 .032 
Social Affect scoreb    (SD)] 13.49 (3.95) 7.55 (3.27) 68.27 <.001 .391 
RRB scorec    (SD)] 3.02 (2.12) 1.96 (1.15) 11.34 .001 .093 
Notes. ASD = Autism Spectrum Disorder.  = Mean. SD = Standard deviation. RRB = Restricted and 
Repetitive Behaviours and Interests Symptom Domain.  
a Possible score range 1-10; b Possible score range 0-20; c Possible score range 0-8. 
 
Summary of Hypotheses 2.1-2.2: Group Differences. The above analyses showed that 
the non-verbal ASD group had lower secure attachment scores, indicating lower social 
motivation, compared to the verbal ASD group. The non-verbal ASD group also showed greater 
severity of all areas of ASD-related deficits, namely, ADOS2 Comparison score, ADOS2 Social 
Affect scores, and ADOS2 RRB scores, than the verbal ASD group. All these differences were 
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significant, and although age was considered, it did not play a significant role when considering 
any group differences in social motivation or ADOS2 scores. As group differences were 
supported (hypotheses 2.1-2.2), relationships between social motivation levels and ASD deficits 
were assessed for each ASD group individually as these groups presented as qualitatively 
different. 
Hypothesis 2.3 Low Social Motivation is Related to Higher ADOS2 Scores. To assess 
whether social motivation levles, as indicated by level of secure attachment, was related to ASD-
related deficits, hierarchical regression analyses were conducted. I was also interested in whether 
language acquisition within ASD, as defined in my study as those with fluent speech (i.e. verbal) 
versus those with little-to-no expressive speech (i.e. non-verbal), played a role in these 
relationships as Hypotheses 2.1 and 2.2 showed significant differences in ASD presentations 
between the non-verbal ASD group and the verbal ASD group. I therefore ran separate 
regression models for the non-verbal ASD group and the verbal ASD group to avoid 
multicollinearity issues, and to allow any differences in the relationship between secure 
attachment and ADOS2 scores between the groups to be exposed that may otherwise not have 
been revealed through full group regression analyses.  
Social Motivation and ADOS2 Comparison Scores. To assess whether secure attachment 
was associated with ADOS2 Comparison score, which indicated overall ASD severity, 
hierarchical regression analyses were conducted. Each model therefore had age and SES in the 
first block, followed by secure attachment, and with ADOS2 Comparison score as the outcome.  
For the non-verbal ASD group (n = 48) multicollinearity was not an issue, as all tolerance 
and VIF scores were acceptable (Field, 2013). The outcome variable, ADOS2 Comparison score, 
was significantly and inversely correlated with secure attachment, r = -.48, p <.001. 
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Table 8. 
Zero-Order Correlation Matrix for Non-Verbal ASD Participants: ADOS2 Comparison Score 
 1 2 3 4 
1. Age (Months) -    
2. SES -.18 -   
3. Secure Attachment -.23 .01 -  
4. ADOS2 Comparison Score .20 -.17 -.48** - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income).  
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
The first model, with only age and SES as predictors, was not significant, F(2,45)= 1.35, 
p = .271. When the second block containing secure attachment was added, the model became 
significant, (3,44) = 5.19, p = .004. This model had a large effect size, f2 = .35, and an observed 
power of .92.The adjusted R2 value showed that the final model explained 21.1% of the variance 
in ADOS2 Comparison score, and the R2 change value of .20 showed this variance was mainly 
accounted for by secure attachment scores (Table 9).  
Table 10 shows that in the final model, only secure attachment had a significant 
association with ADOS2 Comparison score. The inverse relationship indicated that lower levels 
of secure attachment (i.e. lower social motivation) related to higher levels of ASD deficits, as 
was predicted.  
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Table 9. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .238 .056 .015 1.47 .056 1.35 2 45 .271 
2 .511 .261 .211 1.32 .201 12.22 1 44 .001 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 










  Collinearity Statistics 
Model Predictors B 
Std. 
Error 
β t p Tolerance VIF 




<0.01 0.01 .06 0.47 .643 0.92 1.09 




-0.26 0.07 -.47 -3.50 .001 0.95 1.06 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
 
The above hierarchical regression was repeated for the verbal ASD group (n=48). Zero-
order correlations, tolerance scores, and VIF scores indicated no issues with multicollinearity 
(Field, 2013). The outcome variable, ADOS2 Comparison score, did not correlate with the 
predictor secure attachment, r = .04, p = .407, suggesting that a relationship would not emerge. 
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Table 11. 
Zero-Order Correlation Matrix for Verbal ASD Participants: ADOS2 Comparison Score 
 1 2 3 4 
1. Age (Months) -    
2. SES -.22 -   
3. Secure Attachment -.09 <.01 -  
4. ADOS2 Comparison score .25* -.17 .04 - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). 
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
 The first model, with only age and SES as predictors, was not significant, F (2,45)= 1.89, 
p = .163. When the second block containing secure attachment scores was added the model was 
still not significant, F (3,44)= 1.29, p = .291. Table 13 confirmed that there were no significant 
predictors in the final model. The absence of a relationship between secure attachment and ASD 
deficits was unexpected and revealed a difference in the association between secure attachment 
and ADOS2 Comparison score for the non-verbal ASD group compared to the verbal ASD 
group.  
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Table 12. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .278 .077 .036 2.02 .077 1.89 2 45 .163 
2 .284 .081 .018 2.03 .003 0.15 1 44 .701 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income).  
Model 1: Constant, SES, Age 













Model Predictors B Std. Error β t p Tolerance VIF 




0.02 0.01 .23 1.55 .128 0.94 1.06 




.05 0.13 .06 .39 .701 0.99 1.01 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income).  
 
Social Motivation and ADOS2 Social Affect Scores. To assess whether secure 
attachment was associated with ADOS2 Social Affect scores, hierarchical regression analyses 
were conducted for each ASD group. The models had age and SES in the first block, followed by 
secure attachment score, and with ADOS2 Social Affect score as the outcome. 
 The model for the non-verbal ASD group (n = 48) showed no issues with 
multicollinearity, as shown by acceptable tolerance and VIF scores (Field, 2013). Table 14 
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shows the zero-order correlations. The outcome variable, ADOS2 Social Affect score, was 
significantly correlated with my predictor, secure attachment, as hypothesised, r = -.54, p <.001. 
The direction of this correlation was also as hypothesised: lower social motivation (i.e. lower 
secure attachment) correlated with increased deficit in ASD, shown by higher ADOS2 Social 
Affect scores.  
 
Table 14. 
Zero-Order Correlation Matrix for Non-Verbal ASD Participants: ADOS2 Social Affect Score 
 1 2 3 4 
1. Age (Months) -    
2. SES -.18 -   
3. Secure Attachment -.23 .01 -  
4. ADOS2 Social Affect Score .10 -.05 -.54** - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income).  
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
The first regression model, with only age and SES as predictors, was not significant, 
F(2,45) = 0.23, p = .794. When secure attachment was added, the model became significant, 
F(3,44) = 17.25, p < .001. The adjusted R2 value for this final model showed that it explained 
24.0% of the variance in ADOS2 Social Affect score, and the R2 change value of .28 showed this 
variance was mainly accounted for by secure attachment. This model had a large effect size, f2 = 
.41, and an observed power of .96. Table 16 shows that in the final model only secure attachment 
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had an association with ADOS2 Social Affect score. The inverse relationship, indicating that 
lower levels of secure attachment related to higher levels of ASD deficits, was predicted.  
 
Table 15. 














df 1 df 2 
Sig. F 
Change 
1 .101 .010 -.034 4.10 .101 0.23 2 45 .794 
2 .538 .289 .240 3.52 .279 17.25 1 44 <.001 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income).  
Model 1: Constant, SES, Age 














Model Predictors B Std. Error β  t p Tolerance VIF 
2 (Constant) 18.15 2.29  7.92 <.001   
 Age (months) -0.01 0.01 .04 0.28 .781 0.92 1.09 
 SES <-0.01 0.00 -.05 -0.39 .702 0.97 1.03 
 Secure Attachment -0.82 0.20 -.54 -4.15 <.001 0.95 1.06 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
 
The above analysis was repeated for the verbal ASD group (n = 48). Zero-order 
correlation, VIF and tolerance scores showed that multicollinearity was not an issue (Field, 
2013). The outcome variable, ADOS2 Social Affect score, did not correlate with secure 
attachment, r = -.01, p = .481. It was therefore unsurprising that the regression model was not 
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significant, F(3,44) = 1.45, p = .240. The relationships found in the non-verbal ASD group 
analysis did not show for the verbal ASD group, and the hypothesis regarding a relationship 




Zero-Order Correlation Matrix for Verbal ASD Participants: ADOS2 Social Affect Score 
 1 2 3 4 
1. Age (Months) -    
2. SES -.22 -   
3. Secure Attachment -.09 <.01 -  
4. ADOS2 Social Affect score .29* -.15 -.01 - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
*. Correlation is significant at the .05 level (1-tailed). 




Predictors of ADOS2 Social Affect Score for Verbal ASD: Model Summary 
Model R R Square 
Adjusted 
R Square 
Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .300 .090 .049 3.29 .090 2.22 2 45 .120 
2 .300 .090 .028 3.32 <.001 0.02 1 44 .903 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 
Model 2: Constant, SES, Age, Secure Attachment 
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Table 19. 






  Collinearity Statistics 
Model Predictors B 
Std. 
Error 
β t p Tolerance VIF 
2 (Constant) 4.52 2.78  1.63 .110   
 Age (months) 0.03 0.02 .23 1.80 .080 0.94 1.06 




0.03 0.20 .02 0.12 .903 0.99 1.01 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
 
Social Motivation and ADOS2 RRB Scores. The final analyses for relationships between 
social motivation and ASD-related deficits were for ADOS2 RRB scores. Hierarchical regression 
was run for each ASD group, with age and SES placed first, followed by secure attachment, with 
ADOS2 RRB score as the outcome.  
 The regression model for the non-verbal ASD group (n = 48) showed no issues with 
multicollinearity, as shown by the correlation table (Table 20), VIF scores, and tolerance scores 
(Field, 2013). The outcome variable, ADOS2 RRB score, was significantly correlated with my 
predictor secure attachment, r = -.41, p =.002. The direction was as hypothesised: lower social 
motivation (i.e. lower secure attachment) correlated with increased deficit in ASD, shown by 
higher ADOS2 RRB scores.  
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Table 20. 
Zero-Order Correlation Matrix for Non-Verbal ASD Participants: ADOS2 RRB Score 
 1 2 3 4 
1. Age (Months) -    
2. SES 
-.18 
-   
3. Secure Attachment 
-.23 .01 
-  
4. ADOS2 RRB Score .28* -.30* -.41** - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income).  
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
The first model with age and SES as predictors was significant, F(2,45) = 3.78, p = .030, 
with SES as the significant predictor although with a small influence. When secure attachment 
was added the model remained significant, F (3,44) = 5.63, p = .002. This final model explained 
22.8% of the variance in ADOS2 RRB score as per the adjusted R2 value. This model had a large 
effect size, f2 =.38, and an observed power of .95. The R2 change value of .13 showed that just 
under half the variance was accounted for by secure attachment, with SES remaining a 
contributor (Table 21).  
Table 22 shows that in the final model secure attachment had a significant association 
with ADOS2 RRB score. SES also had an association with ADOS2 RRB score, although this 
relationship had a smaller standardised beta value than for secure attachment. The inverse 
relationship between secure attachment and ADOS2 RRB score, indicating that lower levels of 
secure attachment related to higher levels of ASD deficits, supported my hypothesis.  
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Table 21. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .379 .144 .106 2.06 .144 3.78 2 45 .030 
2 .527 .277 .228 1.91 .133 8.12 1 44 .007 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 













Model Predictors B Std. Error β t p Tolerance VIF 
2 (Constant) 5.22 1.25  4.19 <.001   
 Age (months) 0.01 0.01 .15 1.09 .283 0.92 1.09 




-0.31 0.11 -.38 -2.85 .007 0.95 1.06 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
 
The above hierarchical regression was repeated for the verbal ASD group (n = 48). Zero-
order correlations showed that the outcome variable, ADOS2 RRB score, was not correlated with 
secure attachment r = .01, p =.484 (Table 23). The absence of a correlation indicated that there 
was no relationship between social motivation and ADOS2 RRB scores for the verbal ASD 
group, and this was confirmed as the hierarchical regression model was not significant. The first 
model with age and SES as predictors was not significant, F(2,45) = 0.49, p = .615. When the 
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second block, containing secure attachment, was added the model remained non-significant, 
F(3,44) = 0.32, p = .810. This finding did not support the hypothesis that lower social motivation 
would relate to higher ASD deficit, and again shows a different pattern of associations in the 
verbal vs non-verbal ASD groups. 
 
Table 23. 
Zero-Order Correlation Matrix for Verbal ASD Participants: ADOS2 RRB Score 
 1 2 3 4 
1. Age (Months) -    
2. SES -.22 -   
3. Secure Attachment -.09 .01 -  
4. ADOS2 Social Affect Score -.02 -.14 .01 - 
ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
Table 24. 
Predictors of ADOS2 RRB Score for Verbal ASD: Model Summary 
Model R R Square 
Adjusted 
R Square 
Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .146 .021 -.022 1.52 .021 0.49 2 45 .615 
2 .146 .021 -.045 1.54 <.001 0.00 1 44 .994 
ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 
Model 2: Constant, SES, Age, Secure Attachment 
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Table 25. 









Model Predictors B Std. Error β t p Tolerance VIF 
2 (Constant) 2.69 1.28  2.10 .041   
 Age (months) <-0.01 0.01 -.05 -0.35 .732 0.94 1.06 




0.01 0.09 .01 0.01 .994 0.99 1.01 
ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
 
Summary of Findings for Social Motivation and ASD-Related Deficits. The above 
analyses focused on relationships between social motivation, as assessed through secure 
attachment behaviours, and ASD-related deficits. A further interest was whether the verbal 
abilities of a child with ASD, specifically differences between non-verbal children with ASD and 
verbal children with ASD, played a role in the relationships between these variables as these two 
groups showed significant differences in attachment scores and ADOS2 scores.  
For the non-verbal ASD group, there were significant relationships between secure 
attachment and all three ADOS2 scores, while for the verbal ASD group no significant 
relationships between secure attachment and ADOS2 scores emerged. The hypothesised 
relationship between low social motivation, indicated by low secure attachment, to higher 
intensity of ASD deficits was therefore upheld for the non-verbal ASD group but not for the 
verbal ASD group. 
Question 3: Could OPRM1 Play a Role in Social Motivation and/or ASD-Related Deficits?  
This study aimed to assess for relationships between OPRM1 genotypes, low social 
motivation and increased ASD deficits. I predicted that the G allele would be linked to increased 
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deficits as it is associated with increased mu-opioid levels, and this would undermine the 
SEPARATION-DISTRESS system. The questions and associated hypotheses are addressed 
below. 
Hypothesis 3.1 Children with ASD will present with higher rates of the OPRM1 G 
allele than reported neurotypical samples. Of the 102 children with ASD in this protocol, 76 
provided DNA samples for genotyping. All 76 of these samples were successfully genotyped for 
OPRM1; 34 were non-verbal ASD children and 42 were verbal ASD children.  
For the full ASD group, 2 children had the A/A genotype, 22 children had the A/G 
genotype, and 52 had the G/G genotype (Table 26). When considering the ASD groups 
individually, the non-verbal ASD group had 7 children with the A/G genotype, and 27 children 
with the G/G genotype. The verbal ASD group had 2 children with the A/A genotype, 15 children 
with the A/G genotype, 25 children with the G/G genotype. This study therefore found a 
considerably higher rate of the G allele compared to neurotypical samples reported in the 
literature, where the G/G genotype tended to only occur in 1-4% of the population (Bart et al., 
2004; A. C. Chen et al., 2013; Way et al., 2009), with the highest incidence being reported at 
16% in a female Taiwanese sample (L. K. Chen et al., 2013). This is also a higher incidence of 
the G allele compared to the rate of 0.05 found for another local sample of 640 African and 
mixed race women from the Western Cape (D. Stein and S. Dalvie, personal communication, 
May 23, 2019). This finding therefore supported the hypothesis that there would be a higher 
incidence of the G allele in the ASD population.  
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Table 26. 
OPRM1 Genotypes and Allelic Distribution in ASD 
 Genotypes Allelic Distribution 
 A/A A/G G/G A G 
Total (n = 76) 2 (2.63%) 22 (28.95%) 52 (68.42%) .17 .83 
Non-Verbal ASD (n = 34) 0 (0.00%) 7 (20.59%) 27 (79.41%) .10 .90 
Verbal ASD (n = 42) 2 (4.76%) 15 (35.71%) 25 (59.52%) .23 .77 
Notes. ASD = Autism Spectrum Disorder. 
The genotype and allelic frequencies for OPRM1 across ethnic groups in the ASD 
samples are shown below (Tables 27-29). The increased rate of the G and of the G/G genotype is 
consistent across all ethnic groups, although some samples are too small for their findings to be 
representative of the population. No obvious disparities in allelic or genotype distributions across 
ethnicities were noted.  
Table 27. 
OPRM1 Genotypes and Allelic Distribution in ASD Across Ethnic Groups 
 Genotypes Allelic Distribution 
 A/A A/G G/G A G 
Caucasian (n = 27) 1 (3.70%) 7 (25.93%) 19 (70.37%) .17 .83 
Mixed race (n = 39) 1 (2.56%) 13 (33.33%) 25 (64.10%) .19 .81 
African (n = 6) 0 (0.00%) 0 (0.00%) 6 (100%) .00 1.00 
Asian (n = 3) 0 (0.00%) 2 (66.67%) 1 (33.33%) .33 .67 
Other (n =1) 0 (0.00%) 0 (0.00%) 1 (100.00%) .00 1.00 
Notes. ASD = Autism Spectrum Disorder. 
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Table 28. 
OPRM1 Genotypes and Allelic Distribution in Non-Verbal ASD across Ethnic Groups 
 Genotypes Allelic Distribution 
 A/A A/G G/G A G 
Caucasian (n = 12) 0 (0.00%) 2 (16.67%) 10 (83.33%) .08 .92 
Mixed race (n = 16) 0 (0.00%) 4 (25.00%) 12 (75.00%) .13 .88 
African (n = 4) 0 (0.00%) 0 (0.00%) 4 (100.00%) .00 1.00 
Asian (n = 1) 0 (0.00%) 1 (100%) 0 (0.00%) .50 .50 
Other (n = 1) 0 (0.00%) 0 (0.00%) 1 (100.00%) .00 1.00 
Notes. ASD = Autism Spectrum Disorder. 
 
Table 29. 
OPRM1 Genotypes and Allelic Distribution in Verbal ASD Across Ethnic Groups 
 Genotypes Allelic Distribution 
 A/A A/G G/G A G 
Caucasian (n = 15) 1 (6.67%) 5 (33.33%) 9 (60.00%) .23 .77 
Mixed race (n = 23) 1 (4.35%) 9 (39.13%) 13 (56.52%) .24 .76 
African (n = 2) 0 (0.00%) 0 (0.00%) 2 (100%) .00 1.00 
Asian (n = 2)  0 (0.00%) 1 (50.00%) 1 (50.00%) .25 .75 
Other (n = 0) - - - - - 
Notes. ASD = Autism Spectrum Disorder. 
 
Hypothesis 3.2 Children with ASD Carrying the OPRM1 G Allele Will Present with 
Higher ASD-Related Deficits than Those Who Do Not Carry This Allele. I had initially 
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hypothesised that ASD deficits, as measured by the ADOS2 assessment, would be greater for 
children carrying the G allele. However, due to the entirely unanticipated finding of only two of 
my participants being A/A genotype carriers, I was unable to assess this hypothesis. I have 
presented the descriptive statistics for the ADOS2 scores across genotypes below.  
 All 76 of the participants who provided DNA samples also had ADOS2 assessments. 
Their ADOS2 scores across OPRM1 genotypes are shown below (Tables 30-32), and no clear 
patterns of association emerge even when the low frequency of the A allele is considered.  
 
Table 30. 
OPRM1 Genotypes and ADOS2 Scores for All ASD Participants 
 
A/A 




(n = 52) 
Comparison scorea  (SD) 7.00 (1.41) 5.59 (1.76) 5.87 (1.87) 
Social Affect scoreb  (SD) 10.00 (2.83) 8.91 (4.32) 10.27 (4.84) 
RRB scorec  (SD) 1.50 (0.71) 2.41 (1.82) 2.75 (2.05) 
Notes. ASD = Autism Spectrum Disorder.  =Mean. SD=Standard deviation. RRB = Restricted 
and Repetitive Behaviours and Interests symptom domain. 
a Possible score range 1-10; b Possible score range 0-20; c Possible score range 0-8. 
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Table 31. 
OPRM1 Genotypes and ADOS2 Scores for Non-Verbal ASD Participants 
 
A/A 
(n = 0) 
A/G 
(n = 7) 
G/G 
(n = 27) 
Comparison scorea  (SD) - 5.71 (1.254) 6.37 (1.445) 
Social Affect scoreb  (SD) - 13.14 (4.319) 13.11 (3.856) 
RRB scorec  (SD) - 2.43 (2.070) 3.67 (2.075) 
Notes. ASD = Autism Spectrum Disorder.  =Mean. SD=Standard deviation. RRB = Restricted 
and Repetitive Behaviours and Interests symptom domain. 




OPRM1 Genotypes and ADOS2 Scores for Verbal ASD Participants 
 
A/A 




(n = 25) 
Comparison Scorea  (SD) 7.00 (1.414) 5.53 (1.995) 5.32 (2.135) 
Social Affect Scoreb  (SD) 10.00 (2.828) 6.93 (2.576) 7.20 (3.851) 
RRB Scorec  (SD) 1.50 (0.707) 2.40 (1.765) 1.76 (1.508) 
Notes. ASD = Autism Spectrum Disorder.  =Mean. SD=Standard deviation. RRB = Restricted 
and Repetitive Behaviours and Interests symptom domain. 
a Possible score range 1-10; b Possible score range 0-20; c Possible score range 0-8. 
 
Hypothesis 3.3 Children with ASD Who Carry the OPRM1 G Allele Will Present 
with Lower Social Motivation than Those Who Do Not Carry This Allele. As per Panksepp’s 
(1979) Social Motivation Theory, I hypothesised that children carrying the OPRM1 G allele 
would have lower social motivation than those without a G allele; that is, the G allele carriers 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 107 
would have lower secure attachment scores than non-carriers. Of the 76 ASD children who 
provided DNA samples, 70 of these children had complete data sets for attachment and were 
included in this analysis; 31 of these children were in the non-verbal ASD group, and 39 were in 
the verbal ASD group.  
Due to the unexpectedly low number of children in my sample who were homozygous for 
the A allele, I only presented descriptive statistics for secure attachment across OPRM1 alleles 
and genotypes. Descriptively, Table 33 shows that the carriers of the A/A genotype tend to have 
higher secure attachment scores than carriers of the G allele. Carriers of the G allele showed 
similar scores for secure attachment regardless of whether they were heterozygous (i.e. A/G 
genotype) or homozygous (i.e. G/G genotype). It therefore appears that carrying a G allele is 
related to lower social motivation, as hypothesised, although I again note caution due to the 
small group size for the A/A genotype group, and due to the large standard deviations.  
 
Table 33. 
OPRM1 Genotypes and Secure Attachment Scores for ASD Participants 
 A/A A/G G/G 
Full ASD Samplea  (SD) 8.00 (2.83) 5.35 (2.74) 5.79 (2.59) 
Non-verbal ASDa  (SD) - 5.33 (3.08) 4.76 (2.67) 
Verbal ASDa  (SD) 8.00 (2.83) 5.36 (2.71) 6.91 (2.02) 
Notes. ASD = Autism Spectrum Disorder.  =Mean. SD=Standard deviation. 
a Range: 0-10  
 
Summary of Findings for Question 3. The above analyses were limited by the 
unexpectedly small number of carriers of the A/A genotype. A higher incidence of the G allele in 
the ASD population was suggested by Panksepp’s (1979) Scial Motivation Theory, however this 
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has never been assessed in human ASD samples. My study found an unprecedentedly high rate 
of the G allele, which suggests a role for OPRM1 in ASD. Indeed, the rate of the G allele was 
such that I lacked sufficient carriers of the A/A genotype for statistical investigations into the 
possible relationships between OPRM1 and ASD deficits. I was therefore unable to test my 
hypotheses that the G allele would be linked to greater ASD deficits or to lowered social 
motivation, as would be indicated by low secure attachment scores. 
Summary of Findings 
The above analyses found that the ASD samples had lower levels of social motivation 
than the neurotypical sample. Further, I found that the non-verbal ASD group showed lower 
social motivation than the verbal ASD group. The non-verbal ASD group also showed greater 
ASD-related deficits in all domains, namely, ADOS2 Comparison scores, ADOS2 Social Affect 
scores, and ADOS2 RRB scores.  
In the non-verbal ASD group, associations were evident between secure attachment 
scores and all three ADOS2 outcomes, although this effect was smallest for ADOS2 RRB scores. 
My hypothesis that low social motivation, as indicated by low secure attachment, would link to 
greater ASD-related deficits were therefore upheld for the non-verbal ASD group. The verbal 
ASD group showed no relationships between attachment scores and ADOS2 score, indicating a 
difference in social functioning between non-verbal ASD and verbal ASD samples, both of 
which were male, to the extent that none of the hypothesised relationships between social 
motivation levels and ASD-related deficits were upheld. The extent of the differences in the role 
of social motivation between ASD groups is a novel finding.  
Exploration of the role of the G allele for OPRM1 in ASD was limited by the small 
incidence of the A/A genotype. I confirmed a higher incidence of the G allele in my ASD sample 
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compared to reported incidence rates for neurotypical samples, but the extremely high rate of the 
G allele in my sample was unprecedented. The proposed link between the G allele and greater 
ASD deficits and lowered social motivation could not be explored in this sample due to the 
unforeseen finding of too few children with the A/A genotype.  
Discussion 
The Social Motivation Study provided mixed support for Panksepp’s (1979) Social 
Motivation Theory for ASD. His theory has three main tenets, which I explored individually. The 
first tenet is that children with ASD will have reduced social motivation compared to 
neurotypical children, and this was supported by this study. The second tenet is that lower social 
motivation will be associated with the higher severity of ASD-related deficits. I found this to be 
true for non-verbal children with ASD, but not for verbal children with ASD. The final tenet of 
Panksepp’s (1979) theory is that mu-opioids underlie social motivation and are therefore 
associated with ASD-related deficits. The remarkably high rate of the OPRM1 G allele in my 
ASD sample supports a role for the mu-opioid system in ASD, and possibly in social motivation, 
but the low rate of the A allele meant I could not clarify the role of OPRM1 in ASD.  
The most remarkable finding in this study was that male children with ASD have a 
substantially higher incidence of the G allele for OPRM1 when compared to the reported 
prevalence of this allele in neurotypical samples. Further, only the non-verbal ASD group 
performed as predicted by the Social Motivation Theory. To date, the role of mu-opioids in the 
social motivation system has not been examined directly in ASD samples in such a 
comprehensive manner (i.e. generally only one tenet of the theory is explored). This study 
therefore provides important direct insight into the role of social motivation in an ASD sample 
with consideration of the role of OPRM1. 
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Overall, I sought to contribute to a shift in ASD research, one where psychological 
theories and genetic theories are not researched in isolation but are rather explored together to 
support valid results. I emphasise the need to consider the phenotypes of research participants, 
especially in terms of language capabilities, and to ensure that human studies are conducted 
following proof-of-concept work in animal studies.  
Participant Characteristics 
One of the most significant trends throughout my protocol was that the all-male non-
verbal ASD sample and the all-male verbal ASD sample showed different relationships between 
variables of interest. These differences between the two groups, which are discussed in detail 
later, indicated that the groups were qualitatively different. The categorical difference between 
these groups was language ability, which could suggest that language acquisition and 
development is an important phenotypic, and possibly diagnostic, element of ASD. My study 
reports evidence strongly suggesting that the ability to develop language has ongoing 
developmental implications, at least for male children with ASD. My research could indicate the 
need to differentiate ASD subtypes by language ability as one cannot generalise research based 
on one group to the other, and hence that ignoring language ability within ASD samples could 
confound results.  
Participant Grouping. My protocol had three participant groups, and these groups were 
closely matched on several demographic variables to avoid sampling bias. Participants were 
grouped as follows: 51 fluently verbal male children with ASD; 51 male children with ASD who 
were fully non-verbal or unable to use phrase speech; and 51 neurotypical male children who had 
no medical or psychiatric diagnoses. All three groups were matched on SES and were all male. 
Ethnicity data was collected for the ASD groups due to the possible relationships between 
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ethnicity and different allelic distribution for the gene of interest, and the ASD groups showed a 
similar ethnic composition. Ethnicity data was not collected for the neurotypical group as it was 
not deemed necessary, and ethnicity is a sensitive issue in South Africa due to our history of 
race-based oppression. The verbal ASD group and neurotypical group were matched on age, but 
the non-verbal ASD group had a younger mean age than these two groups. The younger age for 
the non-verbal ASD group is likely due to the nature of language development in ASD as many 
children have delayed language development rather than permanent deficits, so it is more 
common to have non-verbal children with ASD in younger samples (American Psychiatric 
Association, 2013; Mody et al., 2013). It is possible then that some of my non-verbal ASD 
participants could develop language at a later age, but as the mean age for this group was over 7 
years old this is unlikely for most of these participants. My participants were therefore matched 
on several demographics, and as age could be controlled for statistically when the non-verbal 
ASD group was included in analyses, any group differences noted in this study are unlikely to be 
due to sampling bias.  
Inclusion of Non-Verbal ASD Participants. The inclusion of a non-verbal ASD group 
and of ASD participants with severe deficits increased my protocol’s generalisability to other 
male children with ASD, and helped reduce the current underrepresentation of these children in 
research. I included all male children with ASD without comorbidities other than ADHD who 
scored three or above on the ADOS2 Comparison score, which indicates ASD severity or 
intensity of symptoms, regardless of language capability. Research tends to exclude children with 
severe ASD presentations and/or with limited language ability as these children are more 
challenging to work with and frequently used measures are not always appropriate for them 
(Tager-Flusberg & Kasari, 2013).  
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I found that the language capability of my ASD participants was associated with the 
severity of their ASD as well as the nature of the interactions between variables of interest in my 
protocol. This expands our current understanding of the relationships between language and 
other social and cognitive domains by indicating that language may be a foundational skill upon 
which later developmental interactions between domains depend. If in ASD, the development of 
language results in different interactions between social and cognitive domains throughout 
development, rather than simply influencing ASD severity, it means that research based on 
verbal children with ASD cannot be generalised to non-verbal children with ASD, and vice versa. 
Recognising these as two distinct groups could mean a great deal of existing research should 
only be generalised to verbal children with ASD rather than all children with ASD, at least in the 
case of male children with ASD.  
Secure Attachment as a Proxy for Social Motivation 
I approached this study in a novel way by using attachment behaviours as a proxy for 
social motivation. Panksepp et al. (1997) describe social motivation behaviours as those that 
facilitate social engagement. Behaviours typical of secure attachment can be considered to 
indicate positive social motivation as securely attached children are consistently pleased by 
social interaction, they seek out their caregiver appropriately, and they are aware of, and 
displeased by, separation from the caregiver (Rutgers et al., 2004). As children age, however, 
their attachment behaviours and indicators of social motivation become more complex. Children 
develop friendships, and signs of social interest and pleasure extend beyond crying when alone, 
or seeking out their primary caregiver throughout the day. There is limited research available on 
social motivation in children with ASD, and there is not a standard measure available for 
assessing social motivation, especially in the context of ASD and beyond toddler age for these 
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children. By using attachment as a proxy for social motivation I was able to identify behaviours 
indicative of social motivation. 
Further, I wanted to assess social motivation, through attachment, in childhood rather 
than at a younger age. The attachment measure I used, the ASCQ (Finzi-Dottan et al., 2012), 
asked parents about their son’s behaviour around other children, as well as around people in 
general. This does not focus on the relationship to the primary caregiver, unlike most of the 
literature, but does allow for an age-appropriate measure of a child’s social interest. However, it 
was based on parent responses, which could be limited in their insight into what their child feels 
about social relationships. This limitation is particularly true for the non-verbal children with 
ASD, who have never been able to discuss their social experiences with their parents.  
When conducting the interviews, my team members prompted parents to give examples 
and reasons for their answers, and in this way we tried to ensure that answers reflected accounts 
of observable behaviours and to maintain consistency across participants. I was therefore able to 
assess social motivation levels in children with ASD based on behaviour patterns in their daily 
environment and used a measure that was appropriate for my full sample despite their varying 
abilities. The ASCQ is typically administered to children and adolescents directly, but this was 
not possible as a third of my sample was non-verbal. I also had concerns regarding the children 
with ASD’s abilities to answer the questions due to the social deficits inherent in ASD. I 
therefore considered parent interview to be more appropriate than self-report from the children in 
my study. An interview also allowed us to query parents’ answers to ensure consistency in the 
ratings assigned to specific responses. 
I was able to assess attachment behaviours in children rather than toddlers, and without 
exposing children with ASD to novel environments. Observation is generally preferable for 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 114 
assessing attachment and some researchers have found that children with ASD can complete the 
Strange Situation Procedure or an adaption thereof (Rutgers et al., 2004). However, as children 
with ASD may struggle with changes in routine and/or new environments (American Psychiatric 
Association, 2013), I was concerned that an observational measure would be confounded by 
increased anxiety and would possibly lead to the exclusion of the more severely affected 
participants (Kahane & El-Tahir, 2015). Further, observation measures like the Strange Situation 
Procedure would not be appropriate for older children and would likely offer a restricted range of 
scores for the neurotypical sample. Therefore, although the ASCQ did have these limitations, it 
was able to assess social motivation behaviours across my three samples in a comparable way 
that was appropriate for my study.  
Social Motivation in ASD vs. Neurotypical Samples 
My study found that male children with ASD had considerably lower social motivation 
levels than male neurotypical children, and that non-verbal male children with ASD had lower 
social motivation than verbal male children with ASD. Lowered social motivation in ASD has 
been theorised, and research has been conducted noting specific behaviours indicative of low 
social motivation (Klintwall et al., 2014; Pellissier et al., 2018). As standardised measures to 
quantify levels of social motivation are not available, this is the first study to my knowledge to 
measure overall levels of social motivation in a male ASD sample and directly compare it to a 
neurotypical sample. Using this continuous measure for social motivation also allowed us to 
assess confounding variables such as SES, age, and even verbal ability. I found that male 
children with ASD showed significantly lower social motivation than neurotypical male children 
over and above all these variables.  
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My study also found that reduced social motivation was present throughout childhood in 
ASD. I found that social motivation was lower for both the ASD groups compared to the 
neurotypical group over and above the effect of age. Further, there was no correlation between 
level of social motivation and age. To date research has noted behaviours indicative of low social 
motivation in ASD samples from toddler age through to early childhood (Rutgers et al., 2004), 
but this protocol expanded this with a more comprehensive assessment of social motivation. The 
current study showed that low social motivation is still present in later childhood. The absence of 
a negative correlation between age and social motivation also suggests that one will not “out 
grow” these deficits, and these deficits may be a core aspect of ASD.  
As I used attachment as a proxy for social motivation, it is worth noting that my research 
is consistent with the attachment literature which generally shows that children with ASD present 
with reduced secure attachment when compared to neurotypical samples (Kahane & El-Tahir, 
2015; Rutgers et al., 2004; Teague et al., 2017). Attachment literature also notes that children 
with ASD present with a different quality of attachment compared to neurotypical children 
(Teague et al., 2017). Reviews of the literature have noted that even those children with ASD 
who met the criteria for secure attachment still presented with less secure attachment behaviours 
than neurotypical children, and their attachment behaviour tended to be more disorganised 
(Kahane & El-Tahir, 2015; Rutgers et al., 2004). In keeping with this, my study found that 
children with ASD did sometimes display behaviours indicating positive attachment / positive 
social motivation, but parents reported these were not consistent. Further, the ASD samples were 
not heterogenous in their presentations for social motivation, as some presented with far greater 
lower social motivation than others. My study is therefore aligned with the general attachment 
research regarding attachment in ASD, but also highlights that low social motivation and 
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attachment deficits present like most other ASD deficits: these deficits present on a spectrum and 
may not be conducive to categorial ratings.  
Social Motivation and ASD-Related Deficits 
I found the hypothesised relationship between reduced social motivation and ASD-related 
deficits was present in ASD, but only for non-verbal male children with ASD. Low social 
motivation was associated with both social and non-social symptom domains. My findings also 
support a critical role for language acquisition in the relationship between social motivation and 
ASD-related deficits.  
In the non-verbal ASD group social motivation was strongly associated with ADOS2 
Social Affect score, but was significantly associated with ADOS2 Comparison score and ADOS2 
RRB score as well. This indicates that low social motivation could be a core element of ASD and 
may underlie development primarily in the social domain, but also extends to non-social 
domains. Reduced social motivation in ASD may not have a set phenotype, but instead could 
have a pervasive influence across all levels of functioning. This is in keeping with research on 
OPRM1 knockout mice, as these mice not only showed disinterest in social engagement, but also 
showed repetitive behaviours analogous to the restricted and repetitive behaviours and interests 
symptom domain in ASD (Pellissier et al., 2018). To date much of the research on social 
motivation has focused on social interest and / or disinterest, but these results indicate that a 
broader frame should be adopted for future work in this area.  
I found that language ability was a critical variable when assessing social motivation in 
ASD. The presence of an association between social motivation and ASD-related deficits for the 
non-verbal male ASD group and not the verbal male ASD was not explained by any group 
difference other than language ability. As the non-verbal ASD group was matched to my verbal 
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ASD group on SES and the groups had a similar ethnic breakdown, and all participants were 
male and came from English speaking homes or schools, the only group differences were 
language ability and that the non-verbal group was younger overall. I found that age did not 
correlate with social motivation level, and the ADOS2 scoring takes age into account to some 
degree by having different modules for different ages. Further, I did consider age as a possible 
covariate when assessing possible associations between social motivation levels and ASD-related 
deficits and found that age did not have any significant effects. It thus seems reasonable to 
conclude that the group difference that emerged was associated with language ability. 
The asssociation between social motivation and ADOS2 Comparison score, indicating 
overall ASD severity, aligns with a previous study with toddlers. Klintwall et al. (2014) found a 
relationship between interest in ADOS assessment at 2 years old and level of ASD-related 
deficits at age 3, which is in keeping with my findings. They found associations between low 
interest and lower non-verbal mental age, lower verbal mental age, and reduced adaptability 
skills. The young age of their sample and assumed limited language ability at that age makes 
their sample comparable to my non-verbal ASD group rather than my verbal ASD group.  
Although a relationship between social motivation levels in ASD and language ability is 
supported by my study, the exact nature of this relationship is unclear. My non-verbal ASD 
group had lower social motivation than my verbal ASD group, but the presence low social 
motivation in this latter group indicates that language deficits alone cannot account for low social 
motivation. Attachment literature for ASD has found correlations between ASD severity and 
level of secure attachment. The review by Teague et al. (2017) noted that attachment deficits 
were higher for ASD samples compared to neurotypical children, children with intellectual 
disability without ASD, and children with language delay without ASD. The inclusion of 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 118 
comparisons between children with ASD and children with language delay without ASD shows 
that the decreased attachment in the ASD samples, indicative of low social motivation, was not 
due to language deficits alone. This aligns with my study and suggests that within ASD there 
could be an additional relationship between social motivation and language development.  
A possible explanation for my group difference regarding social motivation levels in 
ASD is that social motivation levels may have a threshold effect that may prevent language 
acquisition. Panksepp (1979) proposed that lowered social motivation could play a role in 
language acquisition deficits. My study supports this hypothesis, as the non-verbal ASD group 
had lower social motivation than the verbal ASD participants, and both ASD groups showed 
lower social motivation than the neurotypical group. The decreased levels of social motivation in 
the verbal group could have allowed or facilitated language acquisition. The absence of 
associations between social motivation levels and ASD-related deficits in the verbal ASD group 
could also indicate that when language is able to develop in ASD, it serves a protective function 
and limits the effects of reduced social motivation. Social motivation levels may therefore be an 
essential target for interventions for non-verbal children with ASD.  
OPRM1 in ASD 
I found very strong evidence for OPRM1, and by extension the mu-opioid system, being 
implicated in ASD in this study sample. I had a startling allelic rate of .83 for the OPRM1 G 
allele in my ASD sample, and while this unexpectedly high rate of this allele strongly implicates 
OPRM1 in ASD, the relatively low rate of the A allele meant I was limited in my ability to 
explore associations between OPRM1 and ASD-related deficits in this group. The Social 
Motivation Theory for ASD suggests that mu-opioids play a key role in social motivation in 
ASD, and that mu-opioid levels would relate to the level or type of deficit presented. There is a 
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shortage of literature assessing the Social Motivation Theory for ASD in human samples, and 
those that do explore the role of opioids, tend to do so by recording the outcomes of 
administering opioid-antagonists (Bouvard et al., 1995; Herman et al., 1987). To my knowledge, 
this is the first study to assess the role of OPRM1 specifically in an ASD sample. Further, the 
allelic frequency of OPRM1 in an ASD sample has not been assessed before, and a frequency 
this high has never been reported for any neurotypical samples. This therefore provides 
exceptionally strong support suggesting a role for OPRM1 in ASD as this finding is 
unprecedented.  
Allelic Distribution of OPRM1 in an ASD Sample. My sample of 76 male children 
with ASD presented with an allelic frequency of 0.83 for the OPRM1 G allele. The non-verbal 
ASD sample had a higher rate of this allele at 0.90 and had no instances of the A/A genotype, 
while the verbal ASD group had an allelic rate of 0.77 for the G allele and only 2 of the 42 
children presented with the A/A genotype. The presence of the OPRM1 G allele is associated 
with increased transcription of mu-opioids, so the increased frequency of this allele supports 
Panksepp’s (1979) assertion that atypical mu-opioid transmission is implicated in ASD.  
The allelic rate of the OPRM1 G allele in my ASD sample far surpasses even previously 
“high” rates of the G allele and strongly supports the potential role of OPRM1 as a candidate 
gene for important biological pathways in males with ASD. In my sample of 76 male children 
with ASD, 52 (68.42%) of the boys presented with the G/G genotype and the sample had an 
allelic frequency of 0.83 for the G allele. The G allele for OPRM1 is reported as rarer than the A 
allele in the literature, and the A/A genotype is the most commonly occurring genotype in non-
ASD samples (Fillingim et al., 2005). The G/G genotype is reported as only occurring in 1-4% of 
samples, with the allelic frequency of the G allele ranging from 0.07 to 0.22 (Bart et al., 2004; A. 
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C. Chen et al., 2013; Way et al., 2009). Some studies have found a higher frequency of the G 
allele in samples of Asian descent (L. K. Chen et al., 2013; Wei et al., 2017), although the rate of 
the G allele did not exceed 0.35, which is substantially less than in my samples.  
My sample was racially diverse due to the diversity inherent in the South African 
population. The ethnic breakdown of my sample of ASD participants was 33% Caucasian, 51% 
mixed race, 10% African, 5 Asian, and 1% reported themselves as “other”. The mixed race sample 
(n = 39; allelic rate of .81) has mixed heritage and some cases could include Asian heritage. 
Although the literature found higher rates of the G allele in Asian samples compared to non-
Asian samples, I do not believe the inclusion of mixed race participants accounts for the high 
rate of this allele in my sample. If I restrict my sample to the Caucasian (n = 27; allelic rate 
of .83) and African participants (n = 6; allelic rate of 1.00), who are not of Asian descent, they 
still showed a much higher rate of the G allele than is reported in the literature. Further, in a local 
study of 640 mothers in the Western Cape (57% African; 43% Mixed race), the allelic frequency 
for the G allele was within the typical range at 0.05 (D. Stein and S. Dalvie, personal 
communication, May 23, 2019). As my sample was also drawn from the Western Cape, this 
serves to emphasize the novelty of my finding in a local sample of children with ASD.  
A further consideration is sex, but again this does not account for the high rate of the G 
allele in my sample. A different allelic frequency for OPRM1 based on sex has not been 
suggested in the literature, and a study that did consider the role of sex found that there was no 
association between sex and OPRM1 alleles (Troisi et al., 2011). Indeed, it is noted that the two 
studies with Asian samples that showed allelic rates of above 0.30 for the G allele were both 
female samples (L. K. Chen et al., 2013; Wei et al., 2017). I found three studies that reported 
OPRM1 allelic distributions separately for male and female participants, and two showed a 
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slightly lower rate of the G allele in the male participants compared to the female participants 
(Fillingim et al., 2005; Way et al., 2009), and one found the reverse (Bond et al., 1998), although 
the differences were not significant. The sex of my sample therefore does not explain the high 
frequency of this allele.  
The surprisingly high rate of the OPRM1 G allele is therefore not fully accounted for by 
sex or ethnicity. As this allele is associated with increased mu-opioid transcription my study 
strongly supports the role of mu-opioids as an important biological pathway in ASD, and 
therefore offers some support for the Social Motivation Theory for ASD. As the first study to 
explore the allelic distribution of OPRM1 in an ASD sample, this finding shows the importance 
of this gene as an ASD candidate gene.  
OPRM1 and Social Motivation in ASD. In terms of descriptive statistics, my study 
appeared to support the hypothesis that lowered social motivation is linked to atypical mu-opioid 
systems, but an exploration of possible relationships between OPRM1 and social motivation was 
limited by the low incidence of the OPRM1 A allele, preventing genotype-phenotype analyses. 
Descriptively, it appeared that social motivation was lower for carriers of the G allele. This 
would provide support for Panksepp’s (1979) Social Motivation Theory for ASD by supporting 
the hypothesis that disruptions in the mu-opioid system underlie, at least to some degree, the 
development of ASD. However, with only two carriers of the A/A genotype it is impossible to 
know if this relationship is valid. A larger study is needed, both to make comparisons across 
genotypes, and to confirm the high incidence rate of the G allele. It would also be useful to 
assess the relationship between social motivation levels and OPRM1 distribution in a 
neurotypical sample, although this is likely to face the reverse limitation: an underrepresentation 
of the G allele.  
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My non-verbal ASD sample showed no incidence of the A/A genotype, and had 
significantly lower social motivation and higher ASD-related deficits. I found that social 
motivation levels were good predictors of ASD-related deficits as measured by all three of the 
ADOS2 scores for the non-verbal ASD group. The higher allelic frequency of the G allele for the 
non-verbal ASD group alongside their higher level of deficits compared to the verbal ASD group 
also supports the theory, possibly suggesting that this theory is more appropriate for non-verbal 
male ASD samples. However, I again note the limitation of the sample as it was not possible to 
compare social motivation across genotypes. 
OPRM1 and ASD-Related Deficits. I faced the same limitation for genotype-phenotype 
analyses when assessing relationships between OPRM1 and ASD-related deficits. The over-
representation of the G allele, and therefore an underrepresentation of children with the A/A 
genotype, did not allow me to assess how non-carriers of this allele would possibly differ from 
the G allele carriers. For my sample, ADOS2 scores did not appear to differ across genotypes, 
and no pattern was apparent for either of the ASD groups. DNA was not collected for the 
neurotypical group due to financial constraints, and because assessing this group with the 
ADOS2 was deemed inappropriate as it was unlikely to result in any variance in scores across 
these participants, resulting in a floor effect.  
My ASD samples both showed social deficits, and almost all of the participants presented 
with the G allele. Although the two non-carriers of the G allele in my study also showed high 
ADOS2 scores, the high incidence of the G allele is sufficient to warrant further investigation 
and any interpretation of the two A/A carriers must be considered cautiously as there is a large 
possibility of a sampling bias where these two children do not adequately represent all non-
carriers of the G allele. Non-primate animal research found that administration of opioids 
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resulted in ASD-like behaviours, and OPRM1 knockout mice presented with the full behaviour 
repertoire required for a DSM-5 diagnosis for ASD (Becker et al., 2014). Primate and human 
studies were mixed: some found a gain-of-function for carriers of the G allele that made them 
appear more socially motivated rather than less so (Barr et al., 2008; Way et al., 2009), while 
other studies found that this allele was associated with an indifference to the effects of maternal 
care (Troisi et al., 2012) and long term administration of opiates resulted in ASD-like deficits in 
social interaction and social cognition (McDonald et al., 2013). Despite the limitations I faced in 
having so few non-carriers of the G allele, my results can contribute to the current understanding 
of this topic.  
OPRM1 in Future ASD Research. The high incidence of the G allele in my sample 
indicates that OPRM1 must be involved in at least some aspect of ASD. The failure to link 
genotypes or alleles to specific symptom domains or overall severity of ASD in my sample could 
be due to the low rate of the A allele preventing us from seeing group differences. Similarly, 
although my findings suggest that the OPRM1 G allele is related to reduced social motivation, 
this needs to be further explored. I therefore suggest two important directions for future research 
– first, better specificity in phenotyping, and second, aiming to recruit a mixed sample with a 
higher representation of the OPRM1 A allele.  
This study was exploratory in nature and I lacked specificity in how I measured ASD-
related deficits. I aimed to establish which aspects of ASD, in terms of diagnostic domains, 
related to OPRM1, and whether there was a link to overall ASD severity. OPRM1 may be linked 
to very specific aspects of ASD that were seen in animal models, such as the reduced 
responsiveness to others, poor clinging to a caregiver, pain insensitivity, or restricted behaviour. 
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Future studies should identify specific behaviours of interest (e.g. poor eye-contact, failure to 
respond to name, etc.) and include them in their phenotyping.  
The largest limitation of my study was the low representation of the OPRM1 A allele, and 
future studies will need to overcome this. I suggest that studies include children with and without 
ASD in their samples. This can be done by including genotyping for neurotypical controls and 
non-ASD clinical samples, which I could not afford in the current study. Given the low 
representation of the G allele in neurotypical samples, studies only comparing ASD and 
neurotypical samples may lead to samples with extremes that prevent statistical analyses – that 
is, the ASD group may present with a high deficit level in the ASD-related area of interest and a 
high incidence of the G allele, while the neurotypical sample would have the reverse. I think 
more could be learnt by including children without ASD, but who share phenotypic features of 
interest (e.g. include children with low social interest, atypical eye-contact, etc., based on the 
study aims), alongside children with ASD and neurotypical children. In this way, each trait and 
level of social motivation can be measured on a continuum and compared across OPRM1 alleles 
and genotypes rather than across categorical samples. This shift to a continuous measure of the 
trait of interest, rather than a categorical division of groups into ASD vs. non-ASD, could 
provide meaningful data on the role of OPRM1 social development, and then in ASD by 
extension.  
Expanding the Social Motivation Theory for ASD: A Threshold Effect. As all children 
with ASD in this protocol presented with lower social motivation than the neurotypical sample, 
and had an increased rate of the OPRM1 G allele, but only the non-verbal ASD group showed a 
relationship between social motivation levels and ASD-related deficits, I propose that the Social 
Motivation Theory for ASD could perhaps be expanded by considering a threshold effect 
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between social motivation and language development. Panksepp (1979) hypothesised that 
lowered social motivation could result in language acquisition deficits, although this was not 
further elaborated but rather included in his general expectation that social abilities would be 
undermined. I propose that the effects of reduced social motivation go beyond social and 
language deficits, as I found that social motivation levels also predicted ADOS2 RRB deficits. 
Again, however, the link between social motivation levels and ASD-related deficits was only 
found in the non-verbal ASD group, despite deficits in both these areas being present in the 
verbal ASD group.  
I propose that within ASD there are different levels of social motivation, and children 
with very low social motivation may then present with language deficits across development, 
while those with higher, but still reduced, social motivation may be able to develop language 
more efficiently. There is a direct relationship between social interaction and the development of 
language (Kuhl, 2010). Very low social motivation, and the associated reduction in social 
engagement, could underlie atypical language acquisition, thereby increasing the challenges 
these children have to face. The development of language may allow further psychosocial 
learning and development, which with time reduces the relationship between social motivation 
and ASD-related deficits. Whether language development weakens the relationships between 
social motivation and ASD-related deficits, or whether the relationship just becomes more 
complex as one needs to consider other cognitive and social domains as contributing, or 
confounding, factors, is unclear. The absence of an association between social motivation and 
ADOS2 RRB scores in the verbal ASD group indicates that there is an advantage of language 
development in both social and non-social domains.  
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This is a novel idea, and there is little research to help clarify why the non-verbal ASD 
group in this study showed associations between social motivation and severity of ASD-related 
deficits whereas the verbal ASD group did not. Klintwall et al. (2014) found a relationship 
between social motivation and both non-verbal and verbal skills which could indicate why I 
found a group difference based on language ability. My non-verbal ASD group showed 
significantly lower social motivation and higher ASD-related deficits scores compared to my 
verbal ASD group. If, as Klintwall et al. (2014) found, lower social motivation is associated with 
greater deficits in language abilities, it could account for the increased severity of deficits in my 
non-verbal ASD group. Perhaps, as I proposed, the verbal ASD group was less hindered by 
reductions in social motivation deficits, which allowed language development, and ultimately 
due to the integral nature of language in development of other social and cognitive domains 
(Mody et al., 2013), they were able to better overcome the influence of low social motivation. 
This could suggest that language acquisition in ASD provides a considerable advantage in 
developing other social skills and reducing the lifelong impact of initial lowered social 
motivation on psychosocial development. 
Summary of Findings for the Social Motivation Study 
This study investigated Panksepp's (1979) Social Motivation Theory for ASD by 
individually exploring the three main tenets of his argument: that children with ASD lower social 
motivation than neurotypical children; that social motivation levels would link to deficits in 
ASD; and, that a disruption to the mu-opioid system, in this case having increased transcriptional 
efficacy due to the G allele for OPRM1, would relate to reduced social motivation and to ASD-
related symptoms. My study was unique in that it attempted to assess all three of these tenets 
directly in an ASD sample, and in that this sample included non-verbal children. However, while 
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I was able to show that OPRM1 is most likely implicated in ASD due to the remarkably high 
incidence of the G allele, this also meant I was not able to comprehensively explore the third 
tenet of the argument – I was not able to adequately compare the phenotypes of G carriers with 
non-carriers. My findings were surprising as the overall theory was supported for the non-verbal 
ASD group, while the verbal ASD group showed decreased social motivation and an increased 
rate of the G allele, but no associations between social motivation and ADOS2 scores, and the 
role of OPRM1 could not be assessed. I also found that low social motivation persisted across 
development as this was present in children up to 16 years old, and for the non-verbal group the 
association between social motivation levels and ASD-related deficits was present over and 
above the effect of age.  
I propose that the Social Motivation Theory for ASD may need to be expanded to 
consider a threshold effect whereby those with very low social motivation are unable to develop 
language efficiently, while those with higher social motivation, although still less so than 
neurotypical children, do develop language and the effect this then has on development in other 
social and cognitive domains reduces the impact of their social motivation levels and reduces or 
eliminates the direct link between social motivation and ASD symptoms. This proposal would 
need to be empirically tested in future studies, 
The main limitation of my study was an unexpected one: that the ASD sample had an 
unprecedentedly high rate of the G allele, and therefore the A allele was under-represented. I was 
therefore unable to make statistical comparisons across OPRM1 genotypes. A larger sample size 
could perhaps help overcome this limitation, although I was restricted in my sample size due to 
my inclusion criteria (i.e. no other psychiatric or medical conditions, and no use of medication 
that could influence the neurochemical pathways of interest) and by many families not being 
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comfortable providing DNA samples. Again, a larger study would be useful in overcoming these 
limitations, although it is possible that there would still be an underrepresentation of the A/A 
genotype if the sample does not genotype neurotypical participants and other children without 
ASD but with shared phenotypic characteristics of interest. It would also be interesting to 
conduct longitudinal studies to assess whether the threshold effect is present, which would 
require assessing infants and then tracking their progress and seeing if social development does 
differ across OPRM1 genotypes, and ideally along with other measures of mu-opioid activity and 
language development.  
The aim to establish a clean phenotype in this protocol came at a cost to overall 
generalisability of this study, as well as the study in the next chapter, and is discussed in Chapter 
5 (pg. 208). Consideration of the inclusion of only male children, and therefore the exclusion of 
female children, is important given the advantage female children have in language acquisition 
and social development (Adani & Cepanec, 2019). The exclusion of children with ASD with 
comorbities also limits the generalisability, Further, within the South African context, limiting 
participants to those from English-speaking homes or schools does not reflect the diversity of our 
country.  
Despite these limitations, my study does provide insight into the relationships between 
core ASD symptoms and the role of social motivation. Supporting the Social Motivation Theory 
of ASD shows that social motivation levels are a critical aspect of ASD and that as they appear 
early in life, they should be addressed early as well. Perhaps if interventions focus on social 
motivation in younger children, we can reduce the severity of ASD symptoms across 
development.  
  
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 129 
Chapter 4: The Theory of Mind Study 
The presence, and importance, of ToM deficits in ASD have been recognised for decades 
(Baron-Cohen et al., 1985), but the underlying biological mechanisms for ToM deficits in ASD 
are unknown. Similarly, serotonin is implicated in ASD, but it’s role in the ASD phenotype is 
unclear. As serotonin is implicated in social functioning, and in ToM specifically, I hypothesised 
that an ASD candidate gene involved in the serotonin system would be a good gene for inclusion 
in my study. The serotonin transporter promoter length polymorphism (5-HTTLPR) is implicated 
in social functioning, and serotonin specific reuptake inhibitors (SSRIs) are well described in 
ASD treatment regimens. I therefore explored the relationships between core ASD symptoms 
and ToM performance, and a possible role for 5-HTTLPR genotypes in the ASD phenotype and 
in ToM performance in ASD. This chapter reviews our current knowledge regarding ToM and 
serotonin in ASD, followed my study details and a discussion of my findings.  
Literature Review 
The ToM Theory for ASD suggests that ASD is primarily a disorder in relating to and 
understanding others, and this is possibly due to ToM deficits that undermine the ability to 
understand others’ thoughts, feelings, and intentions (Baron-Cohen et al., 1985). Although these 
deficits have been consistently noted in ASD, and some links between ToM deficits and ASD-
related deficits have been explored, the exact role of ToM deficits in ASD is, as yet, not fully 
explored. Further, the mechanism underlying these ToM deficits is also unknown. As a social 
function, ToM may be sub-served by to serotonergic systems such that atypical serotonergic 
processes may relate to atypical ToM development or functioning. Serotonin is implicated in 
numerous social functions, and recent research has shown an increased interest in the role of the 
serotonin transporter promoter length polymorphism (5-HTTLPR) in social ability and in ASD as 
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a disorder, with a focus on links to ASD severity (Brune et al., 2006; Tordjman et al., 2001). 
Typical development of ToM and the known deficits in this area in ASD are explored below, 
followed by research exploring a potential role for serotonin (and 5-HTTLPR), in both ToM 
functioning and ASD-related deficits.  
Theory of Mind 
ToM refers to one’s ability to understand that other people possess their own thoughts, 
feelings, and beliefs, that these states in others are independent of one’s own mental states, and 
that these mental states influence other people’s behaviour (Baron-Cohen et al., 1985). ToM 
underlies the ability to understand social situations and predict others’ actions, making it crucial 
for adaptive social functioning (Leslie, 1987). Positive correlations between social competence 
and ToM have been noted in neurotypical children (Bosacki & Astington, 1999), and ToM 
deficits in children with ASD have been suggested as a central area of impairment that 
characterises this disorder (Baron-Cohen, 2002; Hoddenbach et al., 2012). 
One of the most striking features of ASD is typically the impairment in areas of social 
communication and interaction (American Psychiatric Association, 2013; Macintosh & 
Dissanayake, 2006; Prior et al., 1998). An aspect of social development that appears integral to 
adaptive social functioning from early development and throughout the lifespan is the ability to 
understand one’s own and others’ emotions and mental states. Clinicians have consistently found 
that children with ASD have an impaired ability to relate to others, as well as an impaired ability 
to understand reciprocal social interactions (American Psychiatric Association, 2013). There is 
thus a particular interest in the role of ToM in ASD. Research with neurotypical children 
showing the expected developmental pattern of ToM, as well as its importance in social 
functioning, helps us understand the implications of ToM deficits in ASD. 
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Theory of Mind in Neurotypical Samples. The ability to understand the relationships 
between beliefs, emotions, intentions, and behaviours, both within oneself and in others, is an 
innate ability that facilitates adaptive social functioning throughout the lifespan. ToM 
encompasses a range of social abilities that are noted from 14 months of age (ToM precursors; 
Low & Perner, 2012) and then continue to develop throughout childhood (Wellman et al., 2001). 
ToM development has been comprehensively studied in neurotypical samples, and a 
hierarchical developmental pattern has emerged (Filippova & Astington, 2008; Wellman & Liu, 
2004). At as young as 14 months, children tend to engage in pretend play and to show joint 
attention with others, skills and behaviours considered as prerequisites for later development of 
ToM, and early indications of a sense of awareness of others’ thoughts (Wellman et al., 2001). 
By 2 years of age, children will spontaneously start to talk about their own mental states and can 
show an understanding of others’ desires (Frith & Frith, 2003). Children then develop the ability 
to identify the difference between appearance and reality, as well as start to understand false 
beliefs (i.e. that others believe something to be true that is actually false) for themselves and 
others, between ages 3 and 5 years old (Low & Perner, 2012; Naito et al., 1994). The ability to 
understand second-order beliefs, meaning one’s ability to understand having beliefs about other 
people’s beliefs, emerges between 5 and 7 years old (Liddle & Nettle, 2006). Between 6- and 10-
years old, children begin to understand complex non-literal language forms such as sarcasm, 
irony, and metaphors, and can start to differentiate between lies and jokes based on recognition 
of the other person’s intentions (Ackerman, 1981; Brune & Brune-Cohrs, 2006). Finally, the 
ability to recognise social faux pas develops between ages 9 and 11 years (Baron-Cohen et al., 
1999). While these trajectories are generally recognised, a meta-analysis in 2008 did note that the 
development of false-belief reasoning in non-Western samples could differ from Western 
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samples by up to two years (Liu et al., 2008). These cultural variances make it important to 
include neurotypical groups for comparison to clinical groups when assessing ToM.  
 ToM abilities are well researched in samples of children, but there is relatively little focus 
on its possible ongoing development in adulthood (Apperly et al. 2009; Apperly, 2013). One of 
the possible reasons for this lack of research is that there are few ToM tasks that are appropriate 
for adults. As discussed above, most ToM abilities are developed in childhood, which often 
results in a ceiling effect when these tasks are presented to adults. Researchers can address this 
problem by making tasks more complex, as seen in a study looking at third-order false belief that 
found age was associated with performance when children, adolescents, and adults were 
compared across the task (Valle et al., 2015). Research can also assess accuracy in tasks, such as 
the study that compared ToM performance across four groups (child 7.3-9.7 years; child 9.8-11.4 
years; adolescent 11.5-13.9 years; adults 19.1-27.5 years) (Dumontheil et al., 2010). Age was 
associated with improved ToM performance, but perhaps more interestingly, when the adolescent 
and adult groups were compared, they showed similar performances in the control conditions of 
the task, but the adults had higher accuracy in the ToM tasks. ToM performance can be 
influenced by executive function, but this finding suggests that ToM itself became more refined 
with age. Another interesting finding from a meta-analysis is that a female advantage over men 
exists in judging emotions or mental states exists into adulthood, at least to the degree assessed 
by the Reading the Mind in the Eyes Test (Kirkland et al., 2013). Therefore, although we do not 
have an exact developmental trajectory of ToM skills through adulthood, it does appear that 
adults have more refined ToM abilities than children, suggesting continued development to some 
degree, and that childhood differences across sex may continue into adulthood.  
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Within neurotypical samples, ToM abilities have positively correlated with social 
competence in children (Liddle & Nettle, 2006). A positive association between the ability to 
maintain friendships and ToM abilities has been noted in child and adult samples (Caputi et al., 
2012; Peterson & Siegal, 2002; Slaughter et al., 2015). In adults better ToM skills were 
associated with a larger network of friends (Stiller & Dunbar, 2007) as well as with better 
employability and with career success (Hogan et al., 2013). The development of ToM in 
neurotypical samples is well researched, and the relationship between ToM and social 
competence is generally accepted. 
Theory of Mind in ASD. The ToM Theory for ASD posits that the social and 
communication difficulties seen in ASD arise from core deficits in ToM abilities (Baron-Cohen, 
2002; Baron-Cohen et al., 1999; Hoddenbach et al., 2012). When discussing social impairment in 
ASD, it is noted that these children often struggle to develop appropriate friendships, and their 
interaction is typically awkward and contains maladaptive behaviours (American Psychiatric 
Association, 2013). This behaviour may be explained by impairment in relating to and 
understanding others due to ToM deficits. ToM deficits in ASD can be seen across development 
from the initial absence of pretend play, to the later inability to understand the intentions and 
behaviours of others.  
Like other symptoms characteristic of ASD, ToM deficits present on a spectrum of 
severity within ASD. In general, children with ASD struggle to understand differences between 
appearance and reality. Problems with pretend, imaginative or symbolic play include the failure 
to initiate these types of play, or only engaging in them minimally (Lam & Yeung, 2012). When 
play is entered into, children will often resort to repetitive actions that illustrate a lack of 
comprehension of the symbolic meaning of toys (Zillmer et al., 2008). As language develops, 
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these children struggle to recognise mental state words such as “think” and “know”, and often do 
not understand non-literal speech such as irony and metaphor (Happe, 1993; Zillmer et al., 
2008).  
Formalised tests have confirmed ToM deficits in children with ASD (Baron-Cohen et al., 
1985; Fombonne et al., 1994; Hoddenbach et al., 2012). Many children with ASD fail false belief 
tasks, although between 15-55% are able to pass these tasks (Happe & Frith, 1996; Ozonoff & 
McEvoy, 1994). Children with ASD who are able to pass false belief tasks tend to have higher 
verbal IQs and Happé (1995) found that children with ASD needed a verbal mental age of 11 
years 9 months to pass first-order false belief tasks. As neurotypical children start to understand 
false beliefs at between three and five years of age, Happé (1995) argued that children with ASD 
may be more dependent on language skills than neurotypical children when solving ToM 
problems.  
The nature and degree of ToM deficits, specifically in ASD, is unclear, as some children 
appear to have delayed but otherwise typical ToM development (Scheeren et al., 2013; Steele et 
al., 2003), while others appear to have a plateau in their ToM development, although the point at 
which this occurs is not known (Holroyd & Baron-Cohen, 1993). A local study by Hoogenhout 
and Malcolm-Smith (2014) found that both theories could be true, as children with ASD who 
classified as high functioning in their samples showed delayed ToM development while those 
classified as low functioning showed atypical development, or appeared not to have developed 
ToM capabilities beyond a certain point. It is currently not known why some children with ASD 
would develop ToM abilities while others do not.  
Findings on the relationships between ToM and other ASD characteristics and abilities 
have been inconsistent. Fombonne et al. (1994) used the Vinelands Adaptive Behaviour Scale 
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(VABS) to assess real life competence in an adolescent and adult ASD sample in France. They 
found that higher mental age, as indicated by verbal and full IQ scales, and higher chronological 
age were related to better performance on ToM tasks. The VABS subscale “Maladaptive 
Behaviours” assessed dysfunctional behaviours in everyday life, and they found that participants 
who were better able to understand the mental states of others showed less of these dysfunctional 
behaviours. A similar study in an ASD sample by Frith et al. (1994) used the VABS and 
supplemented it with items designed to distinguish between social behaviours that necessitated 
ToM and those that could be learned. They found that only those participants who could pass 
false belief tasks were capable of insightful interactions in daily life. These participants also 
exhibited better verbal and communication abilities.  
More recently, Lerner et al. (2011) assessed ASD symptoms and their relationship to 
ToM scores on the Theory of Mind Inventory. They found ToM ability correlated positively with 
improved social skills, and negatively with ASD-related social impairments and ASD symptoms, 
indicating that deficits in ToM could underlie impairment in ASD. However, a previous study by 
Joseph and Tager-Flusberg (2004), which examined whether ToM ability and executive 
functions could explain the variance in ASD symptom severity, found that ToM did not explain 
the variance in impairment in social interaction or in repetitive behaviours.  
The association between ToM deficits and ASD severity is therefore controversial, as is 
the manner of ToM testing in ASD. ToM task performance may overestimate a child’s 
spontaneous ToM abilities (Hutchins et al., 2012; Scheeren et al., 2013). Tasks are often 
presented in a controlled environment and only assess certain behaviours and skills that would 
otherwise be needed collectively for spontaneous ToM. For instance, in a task a child may only 
be provided with what a character said in a story and told to infer from that what the character 
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was thinking. In a real-life scenario the child would also be presented with the experience of the 
situation, the character’s facial expression, body language, tone of voice, and their own 
impression of, and previous experiences with, that person. The simplified, focused nature of the 
ToM tasks may therefore not be capable of accurately measuring real-life functional ability.  
The reason for ToM deficits remains unclear, and these deficits cannot be fully explained 
by cognitive ability. Hill and McCune-Nicolich (1981) found a poverty of pretend play in 
children with ASD, but appropriate levels of pretend play in children with intellectual disability 
in the absence of ASD. Baron-Cohen et al. (1985) compared ToM test performance between 
children with ASD, children with intellectual disability without ASD, and typically developing 
children; they found the children with ASD were significantly more impaired compared to either 
of the other two groups. Although ToM deficits are not fully explained by cognitive deficits, 
children with ASD with better intelligence quotient (IQ) scores do tend to perform better on 
these tasks, and it is possible that children with ASD rely more on compensatory cognitive 
strategies to solve ToM tasks than neurotypical children do (Bauminger & Kasari, 1999; Tager-
Flusberg, 2007).  
A further limitation of ToM research in ASD is an over-reliance on false belief testing 
(Liddle & Nettle, 2006; Peterson, Wellman, & Slaughter, 2012). Neurotypical children are 
generally able to pass first-order false belief testing from 5-7 years old, so samples of older 
children may not show variability in their scores for this task. Although these tests have shown a 
clear delay and/or deficit in ToM development in older children with ASD, the possible absence 
in score variability for neurotypical children is a limitation in studies wishing to compare ASD 
and neurotypical children’s performances. This binary assessment of ToM ability where one 
either fails or passes false belief tasks is also far too simplistic given the recognition of ongoing 
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ToM development in neurotypical children that shows far more complex ToM skills in later 
childhood. 
ToM deficits are therefore often present in ASD, although this is not always the case. 
However, their high prevalence in ASD suggests that ToM deficits could be a core element of 
ASD. Clarity is therefore needed regarding the relationships between ToM abilities and ASD-
related deficits. As the aetiology of both ToM deficits and of ASD are unclear, further 
investigations are needed into the possible foundations of these deficits. As ASD is likely to arise 
from multiple genetic contributions, and ToM deficits appear inherent in ASD, it is possible that 
a shared genetic foundation exists; that is, it is possible that one or more ASD candidate genes 
directly underlie the ToM deficits seen in this disorder.  
Aetiology of Theory of Mind Deficits. Studies of typical and atypical development of 
ToM have revealed several factors that can affect ToM abilities. ToM development may be 
influenced by culture (Shahaeian et al., 2014) and tracking ToM development globally is 
challenging as not all ToM tests are appropriate across cultures (Hamilton et al., 2016). Socio-
economic status (SES) has also been linked to ToM abilities (Liddle & Nettle, 2006), and 
developing ToM abilities are intertwined with executive function, general intelligence, and 
language capabilities (Hamilton et al., 2016).  
Deficits in ToM are not unique to ASD and have been found in numerous other disorders, 
but the aetiology of these deficits is still poorly defined. ToM deficits have been noted in 
psychiatric conditions such as mood disorders (Wolkenstein et al., 2011), psychotic disorders 
(Pos et al., 2015), and schizophrenia (Brune, 2003). There is also a growing body of research 
noting ToM deficits in degenerative disorders such as Parkinson’s Disease (Bodden et al., 2010) 
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and Huntington’s Disease (Brüne et al., 2011), as well as after traumatic brain injury (Bibby & 
McDonald, 2005).  
Attempts to localise ToM functioning have shown numerous neural regions are 
implicated this ability, possibly due to the involvement of both affective and cognitive elements 
(Abu-Akel & Shamay-Tsoory, 2011). Regions that have consistently been associated with ToM 
processing include: frontal regions (dorsal medial prefrontal cortex, dorsal lateral prefrontal 
cortex, inferior lateral frontal cortex); posterior regions (the temporoparietal junction, posterior 
cingulate cortex, superior temporal sulcus); and, limbic and paralimbic regions (orbitofrontal 
cortex, ventral medial prefrontal cortex, anterior cingulate cortex, temporal pole, amygdala, 
striatum) (Ahmad Abu-Akel, 2003; Boomsma et al., 2008; Brunet-Gouet & Decety, 2006; 
Carrington & Bailey, 2009; Frith & Frith, 2006; Saxe, 2006). 
A purely neuroanatomical model for ToM faces limitations as these regions are not all 
implicated in the various disorders characterised by ToM deficits, and they do not explain the 
variations in ToM deficits seen within each disorder (Ahmad Abu-Akel, 2003). A “ToM 
Network” has been proposed that includes the medial prefrontal cortex, the posterior cingulate 
cortex, and bilateral temporoparietal junctions (Abu-Akel, 2003; Kana, 2015). Disruptions to 
serotonergic and dopaminergic systems have been associated with ToM deficits, and it is possible 
that differences in the transmission of these neurotransmitters within this network (i.e. between 
implicated anatomical areas) could explain the variance in ToM deficits within and across 
disorders. Serotonin is therefore of interest when assessing possible aetiologies of ToM deficits.  
Serotonin and Theory of Mind. There is some evidence that serotonin system may be 
directly involved in ToM processes. A functional brain imaging study found a relationship 
between a specific allele for the serotonin 1A receptor (5-HT1A-R) and poor performance on 
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ToM tasks in a sample of 119 clinically stable schizophrenic patients (Bosia et al., 2011). This 
allele is associated with disruptions between dopamine and serotonin in the prefrontal cortex. 
This study utilised a neuropsychological battery with a ToM picture sequencing task that 
assessed first-order false belief reasoning, second-order false belief reasoning, and tactical 
deception abilities to provide a global ToM score indicating overall ability. Serotonin may 
therefore be associated with disruptions in multiple aspects of ToM.  
Murphy et al. (2006) found a significant reduction in cortical binding of another serotonin 
receptor, the 5-HT2A receptor, in the anterior cingulate cortex, posterior cingulate cortex, and 
right frontal cortex in eight men with ASD. Using the Autism Diagnostic Interview – Revised 
(ADI-R) to rate ASD-related deficits, they found significant correlations between this reduced 
cortical binding and deficits in reciprocal social interactions, which included skills requiring 
ToM processing. This suggested that decreased serotonin levels would be associated with 
reduced ToM capabilities in reciprocal social interactions, which included skills requiring ToM 
processing. This suggested that decreased serotonin levels might be associated with reduced ToM 
capabilities 
Nakamura et al. (2010) assessed serotonin transporter binding in 22 men with ASD using 
serial PET scans. They reported lower serotonin transporter binding throughout the brain when 
compared to controls. They also found an association between impairment on a ToM faux pas 
task and this reduced transporter binding in the anterior cingulate cortex and in the posterior 
cingulate cortex. As with the previous studies, these results suggested that decreased serotonin 
may be associated with ToM abilities of varying complexities.  
There is therefore emerging evidence that serotonin is implicated in ToM processes. As 
ToM deficits appear to be a critical element of the ASD symptom presentation, it is worth 
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investigating the role of serotonin in ASD, and possibly a joint role for serotonergic transmission 
and ToM deficits as contributing factors to ASD. 
Serotonin and ASD  
Serotonin is implicated in ASD, and within the serotonergic system the serotonin 
transporter promoter length polymorphism (5-HTTLPR) has been suggested as an ASD 
candidate gene (Arieff et al., 2010; Brune et al., 2006; Tordjman et al., 2001). This 
polymorphism regulates the transcriptional efficacy of serotonin in the central nervous system. 
Serotonin is also linked to social functioning in neurotypical children and adults and has been 
implicated in ToM processing (Abu-Akel, 2003). Serotonin may therefore underlie the poor 
social functioning characteristic of ASD, and may in particular underlie the ToM deficits seen in 
this disorder. Two studies have investigated genotype-phenotype relationships for 5-HTTLPR in 
ASD (Brune et al., 2006; Tordjman et al., 2001), but further research is needed to include ToM 
ability in such studies.  
Atypical functioning of the serotonergic system is strongly implicated in ASD. 
Approximately one third of individuals with ASD present with hyperserotonemia (i.e. elevated 
serotonin levels) when whole blood is assessed (Hanley et al., 1977; Kolevzon et al., 2006). First 
degree relatives of individuals with ASD also present with hyperserotonemia in 25-50% of cases 
(Burgess et al., 2006; Cook & Leventhal, 1996). The elevated serotonin levels in ASD are 
typically detected in platelets but not in the plasma (Cook & Leventhal, 1996) or in cerebrospinal 
fluid (Adamsen et al., 2010). This may indicate that although excessive serotonin is being 
produced by some individuals with ASD, the neurotransmission is undermined at some point in 
the serotonergic system, resulting in different concentrations being detected in the plasma and 
cerebrospinal fluid.  
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Despite the hyperserotonemia seen in the platelets in ASD cases, ASD presentations are 
more in keeping with that of hyposerotonemia. ASD shares symptomatology with disorders 
associated with decreased serotonin levels, including depression, anxiety disorders, shyness, and 
social phobias (Klauck et al., 1997). ASD symptoms are also aggravated when serotonin 
transmission is decreased through tryptophan depletion (Cook & Leventhal, 1996; McDougle et 
al., 1996).  
The paradoxical picture of elevated whole blood levels of serotonin but a symptom 
presentation more in keeping with decreased serotonin levels, as well as the difference in 
serotonin levels between platelets, plasma, and cerebrospinal fluid, might be explained by poor 
transcriptional efficacy. As the 5-HTTLPR genotypes regulate the transcriptional efficacy of the 
serotonin transporter protein, this gene is therefore of interest in ASD.  
5-HTTLPR. 5-HTTLPR is a variable repeat sequence in the promoter region of the 
serotonin transporter protein (SERT, 5-HTT). SERT is located on the pre-synaptic membranes of 
serotonergic neurons (Sen et al., 2004) and acts to reabsorb serotonin by moving it from the 
synaptic space back into the presynaptic neuron (Kolevzon et al., 2006). The transcriptional 
efficacy of SERT is moderated by 5-HTTLPR genotypes which determine the different 
expressions of SERT in the pre-synaptic axonic membranes (Adamsen et al., 2010; Arbelle et al., 
2003).  
The transcriptional efficacy of 5-HTTLPR differs depending on its alleles. 5-HTTLPR 
has several rare allele variants, but the common alleles are the long (L) allele and the short (S) 
allele (Huang & Santangelo, 2008). The three most common genotypes are therefore L/L, L/S, 
and S/S. The long allele consists of 528 base pairs and 16 repeat elements, while the short allele 
consists of 484 base pairs and 14 repeat elements. The short allele has reduced transcriptional 
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efficacy compared to the long allele and can reduce the availability of serotonin by up to 50% 
(Huang & Santangelo, 2008). It is not clear whether the long allele or the short allele, if either, 
have a dominant effect.  
Although the allelic distribution of 5-HTTLPR differs to some degree across ethnicity 
groups due to different genetic heritages, the long allele is usually the most common in 
neurotypical populations (Arbelle et al., 2003; Esau et al., 2008; Jacob et al., 2004; Klauck et al., 
1997; Reneman et al., 2006). In a global comparison of the allelic distribution of 5-HTTLPR, 
Esau et al. (2008) reported that the S/S genotype tended to be present in less than 20% of 
neurotypical samples, although some Asian samples showed a higher rate of the S/S genotype. 
Asian samples reported in the Esau et al. (2008) review presented with the S/S genotype at the 
following rates: a Japanese sample at 65%; a Chinese sample at 54%; and an Indian sample at 
47%. More recent studies have replicated these high rates of the short allele for a Japanese 
sample (Endo et al., 2010) and a Korean sample (Cho et al., 2007). 
5-HTTLPR in ASD. The role of 5-HTTLPR in ASD is not clear. The 5-HTTLPR allelic 
distribution for ASD populations is not generally known, although limited research has reported 
that ASD samples have a higher prevalence of the S/S genotype than the 20% reported in most 
neurotypical samples. A local study also found a higher incidence of the short allele for an ASD 
sample compared to neurotypical samples (Arieff et al., 2010), and this was replicated in a 
master’s study (Hamilton, 2014). Table 34 below shows the 5-HTTLPR genotype and allelic 
distribution from four studies with ASD samples, including two local studies; ethnicity has been 
included where available. 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 143 
Table 34. 
Allelic and Genotype Distribution of 5-HTTLPR in ASD Samples 
Studies 




L/L L/S S/S L S  
Arieff et al. (2010)      South African; 96 males, 13 females. 
Total (N=109) 56 (51.38%) 20 (18.35%) 33 (30.28%) .61 .39 
   African (n=21) 13 (61.90%) 1 (4.76%) 7 (33.33%) .64 .36 
   Caucasian (n=40) 17 (42.50%) 7 (17.50%) 16 (40.00%) .51 .49 
   Mixed / Coloured (n=48) 26 (54.17%) 12 (25.00%) 10 (20.83%) .67 .33 
Brune et al. (2006)      American; 59 males, 14 females; Racially 
diverse (60 Caucasian, 5 African 
American, 6 Asian, 2 Hispanic). 
Total (N=73) 21 (28.77%) 36 (49.32%) 16 (21.92%) .53 .47 
Hamilton (2014)      South African; 49 males, 5 females. 
Total (N=54) 18 (33.33%) 22 (40.74%) 14 (25.93%) .54 .46 
   African (n=5) 1 (20.00%) 4 (80.00%) 0 (0.00%) .60 .40 
   Caucasian (n=22) 5 (22.73%) 10 (45.45%) 7 (31.82%) .45 .55 
   Mixed / Coloured (n=18) 9 (50.00%) 4 (22.22%) 5 (27.78%) .61 .39 
   Indian (n=5) 2 (40.00%) 2 (50.00%) 1 (20.00%) .60 .40 
   Other (n=4) 1 (25.00%) 2 (50.00%) 1 (25.00%) .50 .50 
Tordjman et al. (2001)      French; 46 males; 25 females; All 
Caucasian Total (N=71) 26 (36.62%) 35 (49.30%) 10 (14.08%) .61 .39 
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   Caucasian (n=71) 26 (36.62%) 35 (49.30%) 10 (14.08%) .61 .39 
Notes. ASD = Autism Spectrum Disorder. 
 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 145 
While genetic studies to date have tended to focus on whether ASD samples showed a 
different allelic distribution for 5-HTTLPR from neurotypical samples, some studies have moved 
toward understanding what role, if any, 5-HTTLPR genotypes play in the ASD phenotype. To my 
knowledge, only three studies have been conducted in this area: one study explored the link 
between 5-HTTLPR and brain region volumes (Wassink et al., 2007), and two have specifically 
assessed for genotype-phenotype relationships (Brune et al., 2006; Tordjman et al., 2001). 
The first study explored possible associations between 5-HTTLPR genotypes and cortical 
volume in ASD but did not attempt to assess genotype-phenotype relationships. Wassink et al. 
(2007) conducted a longitudinal MRI study with 44 male, Caucasian children with ASD, and 
assessed brain region volumes in these children across the 5-HTTLPR genotypes. They found 
that the short allele was associated with increased frontal lobe grey matter volume and total 
cortical volume. Increased cortical volume could indicate poor synaptic pruning processes, 
which undermine neuroprocessing across brain regions. The Wassink et al. (2007) study could 
therefore suggest a role for 5-HTTLPR in brain development in ASD. Although this study did not 
include a control group of neurotypical children, its findings are aligned with the literature as 
other studies have also noted increased grey matter volumes in ASD participants (Cauda et al., 
2011; Duerden et al., 2012). 
Tordjman et al. (2001) investigated whether 5-HTTLPR genotypes were associated with 
ASD severity in a sample of 71 Caucasian French children with ASD. They used the Autism 
Diagnostic Interview-Revised (ADI-R) to rate severity of impairment in the social 
communication and interaction symptom domain. They noted similar ADI-R scoring between the 
children with the L/S genotype and the S/S genotype, and therefore combined these groups for 
statistical comparisons to the L/L genotype group, with the hypothesis that there was a dominant 
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effect for the short allele and therefore one or more short alleles would undermine serotonergic 
transmission and affect ASD outcomes. ADI-R scores showed that children in the short allele 
group presented with severe impairment, while those in the L/L genotype group showed scores in 
the mild to moderate impairment range. Tordjman et al. (2001) posited that their findings 
supported a role for 5-HTTLPR in modifying the overall severity of deficits seen in ASD, 
specifically in the symptom domain of social communication and interaction.  
Brune et al. (2006) furthered this research by assessing whether 5-HTTLPR genotypes 
were associated with specific ASD-related deficits in a sample of 73 children with ASD. They 
used the ADI-R and the ADOS to rate ASD-related deficits. Their genotype distribution was 
similar to that of the Tordjman et al. (2001) study (see Table 34, pg.139), and they also merged 
all short allele carries (i.e. L/S genotype carriers and S/S genotype carriers) into a reduced 
transmission group for comparison to the L/L genotype group. Despite these similarities to the 
Tordjman et al. (2001) study, they were unable to replicate the finding that ASD severity 
indicated by overall ADI-R scores was associated with the short allele. Instead they found that 
children in the reduced transmission group had more severe impairment in the “failure to use 
non-verbal communication to regulate social interaction” ADI-R domain. By contrast, the 
children in the L/L genotype group showed greater impairment in the ADI-R domain 
“stereotyped and repetitive motor mannerism” and “aggression”, as well as for “failure to direct 
facial expressions” and for increased unusual sensory interests as assessed by the ADOS. Brune 
et al. (2006) posited that rather than the short allele being implicated in overall severity, the 
different 5-HTTLPR alleles were associated with different aspects of ASD. They suggested that 
the short allele was specifically associated with impairment in non-verbal aspects of social 
interaction.  
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In the absence of further studies which directly assessed ASD-related symptoms across 5-
HTTLPR genotypes, studies which use medications that target 5-HTTLPR in ASD samples were 
consulted to provide indirect support for these relationships. Many selective serotonin-reuptake 
inhibitors (SSRIs) alter serotonin levels by increasing the time serotonin spends in the synaptic 
cleft by influencing the function of 5-HTTLPR (Kolevzon et al., 2006). Although SSRIs are 
often included in treatment programmes for patients with ASD, there is inconsistency in the 
results regarding the efficacy of these medications in this condition. When these medications do 
show a favourable outcome in ASD patients, they are associated with improvement in 
verbalisations, increased communicative gestures, and improved motor skills (Adamsen et al., 
2010; Kolevzon et al., 2006). The effects of SSRIs on symptoms in the restricted and repetitive 
behaviours and interests symptom domain have also been mixed, with some studies supporting 
treatment (Namerow et al., 2003; Hollander et al., 2005), but another found no effect for this 
treatment (King et al., 2009). A review of the literature found that while SSRIs can have a 
general positive effect in ASD, and sometimes a specific effect on restricted and repetitive 
behaviours and interest, but the effect is usually small (Carrasco et al., 2012). 
Sugie et al. (2005) compared the effects of SSRI treatment across 5-HTTLPR genotypes 
in a sample of 18 Japanese children with ASD. Random assignment was used to allocate ten 
children to the experimental group, where they were prescribed the SSRI fluvoxamine, and nine 
children were placed in the placebo group; these groups were then reversed to form a two-way 
crossover study design. They utilised the Behavioural Assessment Scale (BAS) to rate ASD-
related deficits. Genotyping found that one child had the L/L genotype, 7 children had the L/S 
genotype, and 10 had the S/S genotype. Due to the low incidence of the L/L genotype, 
participants were grouped according to the presence of a long allele (i.e. L/L genotype and L/S 
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genotype were grouped), rather than according to the presence of a short allele as was done in the 
previously described genotype-phenotype studies. Sugie et al. (2005) found that the long allele 
group showed greater global improvement than the S/S genotype group. When specific 
symptoms were assessed, they found that the long allele group improved in emotion expression 
while the S/S genotype group showed improved eye movement.  
The number of studies investigating the exact role of 5-HTTLPR in ASD presentations is 
limited, and results are inconsistent or unclear due to different methodologies. Genetic studies 
tend to support a higher incidence of the short allele for 5-HTTLPR in ASD, indicating a 
mechanism that would undermine serotonergic transmission in this group. Phenotype studies 
have found links between this short allele and social impairment in ASD, but further research is 
needed to elucidate the role of this polymorphism.  
Conclusion 
The ToM Theory for ASD proposed that individuals with ASD have ToM deficits, and 
these deficits explain the impairment in social functioning. ToM deficits are often noted in ASD, 
although the degree of these deficits varies. Some research supports an association between these 
deficits and social competence, particularly in neurotypical samples, and this could extend to 
ASD samples. The mechanisms underlying ToM deficits are not understood, but serotonin is 
implicated in ToM and in social functioning, with 5-HTTLPR being a polymorphism of specific 
interest in ASD. To my knowledge, research assessing ToM abilities and possible associations 
with 5-HTTLPR genotypes in the context of ASD has not been conducted, but phenotypic 
studies have found associations between these genotypes and social functioning in ASD. More 
research is needed on the link between specific aspects of ASD symptom profiles and 5-
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HTTLPR genotypes, and it would be of interest to include ToM in the assessment of ASD-
related deficits as it may be a core aspect of this disorder.  
Rationale 
ASD remains a prevalent but complex disorder with an incompletely understood 
aetiology and high variability in clinical presentations. Further research into underlying 
mechanisms and into the development of deficits is required to allow for the development of 
more targeted management strategies. ToM has been proposed as a core area of deficit in ASD, 
but the degree of deficit compared to neurotypical peers, and the relationship between ToM 
deficits and other ASD-related deficits, remain inadequately explored. The exact role of ToM 
skills in overall ASD social competence must be established, and this must be done in a 
developmentally-sensitive manner that not only accounts for the role of age across childhood, but 
which also considers the hierarchical development of ToM, rather than simply focusing on a 
single aspect of ToM, such as false belief reasoning. 
Further, our understanding of the causes of ToM deficits in ASD and other disorders is 
also incomplete. As ToM deficits are so common in ASD, it is possible that ASD and ToM 
deficits (in ASD and other disorders) share, to some extent, a neurobiological underpinning. 
Numerous neuroanatomical areas and neurochemical pathways are implicated in ToM, and 
hundreds of genes have been implicated in ASD, but the serotonin system is implicated in both 
ASD and ToM processes, and 5-HTTLPR genotypes are specifically implicated. It is therefore 
important to explore the role of ToM deficits in the ASD-phenotype, and to explore what role 
specific aspects of the serotonin system, including 5-HTTLPR genotypes, may play in ToM and 
ASD-related deficits. As medications already exist to target 5-HTTLPR, a better understanding 
of its phenotypic role may have direct implications for management plans. 
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Aims and Hypotheses 
This study therefore aimed to explore the role of ToM in ASD, and whether 5-HTTLPR 
genotypes were associated with ASD deficits and/or ToM deficits. Due to the verbal nature of the 
ToM battery, this study only included the verbal ASD group in the analyses for ToM, although all 
ASD participants who provided DNA were included when assessing for relationships between 
ASD symptoms and 5-HTTLPR. I predicted that the ASD group would have less developed ToM 
capabilities than the neurotypical group. I also hypothesised that ASD children carrying one or 
more short allele for 5-HTTLPR would have greater ASD-related deficits, as measured by the 
ADOS2, and would perform more poorly on ToM tasks than ASD children who did not carry any 
short alleles. I therefore asked the following questions, and addressed them with the associated 
hypotheses:  
Question 1. Do children with ASD exhibit lower levels of ToM than neurotypical 
children? 
Hypothesis 1.1. Children with ASD will have lower ToM scores than neurotypical 
children.  
Question 2. Do ToM deficits relate to greater ASD-related deficits in children with ASD? 
Hypothesis 2.1. Lower ToM scores will predict higher ADOS2 scores.  
Question 3. Does 5-HTTLRP play a role in ASD-related deficits and/or ToM deficits in 
an ASD sample? 
Hypothesis 3.1. Children with ASD will show a higher rate of the 5-HTTLPR short allele, 
which indicates atypical serotonergic transmission, than is reported for neurotypical samples.  
Hypothesis 3.2. ASD children carrying the short allele for 5-HTTLPR will present with 
higher ADOS2 scores than those without a short allele. 
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Hypothesis 3.3. ASD children carrying the short allele for 5-HTTLPR will score lower in 
ToM tests than those without a short allele. 
Hypothesis 3.4. In children with ASD, the 5-HTTLPR short allele will be associated with 
poor ToM performance, and ToM performance will mediate a relationship between 5-HTTLPR 
genotypes and ADOS2 scores.  
Method 
Research Design 
 The Theory of Mind Study was the second of two studies in this protocol. This study had 
the same design as the Social Motivation Study (Chapter 3: The Social Motivation Chapter - 
Method, pg.52) as it had a cross-sectional relational design. This study assessed the degree of 
ToM deficits in ASD, the possible associations between ToM deficits and ASD-related deficits, 
and then assessed whether 5-HTTLPR genotypes were implicated in ASD-related deficits and/or 
ToM deficits.  
Participants 
Participants were drawn from the Social Motivation Study (Chapter 3: The Social 
Motivation Chapter – Method – Participants, pg.53) sample and formed the same three groups 
(i.e. non-verbal ASD, verbal ASD, neurotypical). The recruitment of these participants into this 
second study is shown in Figure 6. 
The non-verbal ASD group was included in analyses for genotype-phenotype 
associations (i.e. associations between ADOS2 scores and 5-HTTLPR genotypes; Question 3), so 
only those who provided DNA were included. In the Social Motivation Study 34 non-verbal 
ASD participants provided DNA and were successfully genotyped for 5-HTTLPR and were 
included in the current study.  
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Figure 6. Samples for the Theory of Mind Study drawn from the Social Motivation Study 
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All children from the verbal ASD group completed ToM assessment. There were 
therefore 51 children available for Question 1 (i.e. ToM performance comparison between ASD 
and neurotypical samples) and for Question 2 (i.e. possible associations between ADOS2 and 
ToM scores). Of these children, 42 provided DNA; 39 were successfully genotyped for 5-
HTTLPR. This left a sample of 39 verbal children with ASD for Question 3 (i.e. genotype-
phenotype associations between ADOS2 scores and 5-HTTLPR, and ToM scores and 5-
HTTLPR).  
 
Figure 8. Verbal ASD group data collected per measure, and sample available for each research 
question. 
 
All neurotypical children completed the ToM assessment and served as a control group 
for Question 1, resulting in a sample size of 51 participants. (For full participant information see 
Chapter Three: The Social Motivation Study – Results, pg.76).  
Given the limitations on recruitment when working with a clinical sample, and that my 
exclusion criteria further limited this pool, a prioiri power analyses were not relied on for sample 
sizes. Instead, recruitment aimed to exhaust the possible recruitment pool, and to approximate 
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sizes for both studies in this protocol were decided based on studies with a similar design to the 
Theory of Mind Study, as genotype-phenotype studies for OPRM1 in ASD were not found. The 
two genotype-phenotype studies for 5-HTTLPR in ASD research were consulted (Brune et al., 
2006; Tordjman et al., 2001). These studies conducted ADI-R parent interviews and genotyping 
on 71 children (Tordjman et al., 2001), or ADI-R parent interviews and ADOS assessment with 
genotyping on 73 children (Brune et al., 2006). My full protocol included parent interviews and 
ADOS2 assessments, much like these two studies, and therefore aimed to recruit a minimum of 
80 child-parent pairs; a total of 102 ASD child-parent pairs were recruited, and DNA was 
obtained from 76 children within this sample.  
Procedure 
The Theory of Mind Study was an extension of the Social Motivation Study, and 
therefore had the same initial procedure; that is, participants were recruited, screened, and ASD 
participants completed ADOS2 assessment as part of the first study and relevant data was 
included in both studies. Non-verbal participants did not need to complete any further data 
collection for the current study as DNA collected for the first study was sufficient for further 
genotyping for 5-HTTLPR. The verbal ASD participants and neurotypical participants completed 
IQ and ToM assessments to provide data for this protocol. Parents did not need to provide any 
further data.  
Child Sessions. Once children were allocated to their groups, child sessions were 
conducted at their schools or at their homes for children with ASD who were not currently 
placed at schools. Non-verbal children with ASD did not need to complete further sessions as 
their ADOS2 data had been collected during screening. Verbal children with ASD and 
neurotypical children were seen three to four times to complete IQ assessment and 
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comprehensive ToM assessment; each session was 30-60 minutes long and duration of the 
session was flexible, based on the child’s age and attention span to avoid fatigue.  
Measures 
The non-verbal ASD children only completed the ADOS2, and no other child-measures 
were administered. The verbal ASD and neurotypical sample completed additional assessment 
for IQ and ToM data, and the ADOS2 data for the verbal ASD group had been collected in the 
first study.  
General intellectual functioning. Participants from the verbal ASD group and 
neurotypical group completed IQ assessments and verbal IQ (VIQ) percentile scores were used 
in analyses due to the known relationship between VIQ and ToM performance (Fombonne et al., 
1994; Happe, 1995). These participants completed the Wechsler Abbreviated Scale of 
Intelligence (WASI; Weschler, 1999).  
The WASI consists of four subtests that are collectively scored for an intelligence 
quotient (IQ) estimate. Two subtests assess VIQ, namely the Similarities and the Vocabulary 
subtests, and two assess performance IQ, namely the Block Design and the Matrix Reasoning 
subtests (Weschler, 1999). The WASI is designed for use in individuals 6-89 years old. Test-retest 
reliability scores range from .92-.95, and validity has been comprehensively assessed and found 
to be appropriate (Stano, 2004; Weschler, 1999). The WASI has been translated and adapted for 
some non-English populations (Abu-Hilal et al., 2011; Trentini et al., 2014), and Afrikaans 
translations have been used in local research (Ferrett et al., 2010). For this study I administered 
the WASI in English, as per the ADOS2 assessment.  
Theory of Mind Assessment. Participants from the verbal ASD group and the 
neurotypical group completed the UCT ToM Battery (Hoogenhout & Malcolm-Smith, 2014). 
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This battery has four modules of increasing difficulty and allows comprehensive assessment of 
ToM with a developmental approach (Appendix M). This battery consists of recognised ToM 
tasks from the literature (Baron-Cohen et al., 1999; Peterson et al., 2012; Steele et al., 2003) that 
have been adapted for use in the South African population.  
The first module is termed the Early Module and assesses the most rudimentary ToM 
skills. This module consists of the Desire task (understanding intentions), the Pretend Play task, 
the Perception-Knowledge task, the Diverse Desires task, and the Diverse Beliefs task. The Basic 
Module consists of the Location-Change False Belief task, the Unexpected-Contents False Belief 
task, the Belief-Emotion tasks, and the Real-Apparent Emotion task. The Intermediate Module 
consists of the Second-Order False Belief task and the Strange Stories task. The Advanced 
Module of this ToM battery consists of the Lies and Jokes task and the Children’s Version of the 
Faux Pas task. This battery is appropriate for children as young as 2 years as pretend play 
develops in neurotypical children between 14 and 24 months (Frith & Frith, 2003), and assesses 
ToM development up until age 11 years, which is when neurotypical children generally develop 
the ability to recognise social faux pas (Baron-Cohen et al., 1999). 
All tasks except the Pretend Play task include control and test questions, and if children 
fail the control questions their ToM scores are voided as they may not have understood the task. 
Other than the Faux Pas task, all tasks either used dolls or pictures to minimize linguistic and 
memory demands. Each module was worth 25% of the total possible score for the battery, and 
within each module tasks were weighted equally. Children were therefore able to achieve a total 
overall score which indicated their level of ToM development. Children started the battery at 
either the Basic or Intermediate Module, based on their age. If they achieved below 50% for this 
module they reversed to earlier modules, but if they achieved 50% or more for the first module 
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they were credited 100% for earlier modules and moved to the next module, continuing until 
either completing the battery or failing a module.  
This raw scoring did not take age into account. Children were therefore divided into three 
age bands: 6-7 years, 8-10 years, and 11+ years. The neurotypical group’s age bands were 
considered as controls, and means and standard deviations from these age bands were used in the 
neurotypical and ASD samples to calculate z-scores for each participant. These scores were then 
converted into percentiles to allow for direct comparisons to be made between all participants, 
and for consistency in analyses as VIQ percentiles were always considered alongside ToM 
scores. The use of percentile ToM scores allowed us to report scores that were developmentally 
relevant, and to directly compare the scores between the two groups. 
 DNA Collection and Genotyping. DNA extracted for Study One was also genotyped for 
5-HTTLPR. For DNA extraction details and Direct (Sanger) sequencing details see Chapter 3: 
The Social Motivation Study – Methods – DNA Collection and Genotyping, pg. 70. 
5-HTTLPR Genotyping. All reagents and kits were used according to the manufacturer’s 
instructions. 5-HTTLPR was amplified with primer sequences from Klauck et al. (1997) and 
GoTaq G2 Taq polymerase (Promega, Madison, WI, USA). Amplicons were separated on a 
2.5% agarose gel and fragments sizes were estimated by comparison to a DNA ladder 
(GeneRuler 100bp Plus; Thermo Fisher Scientific, Johannesburg, South Africa). Genotypes were 
classified as long (L) or short (S) alleles, with the latter amplicon 43 bp shorter than the reference 
allele. Selected genotypes were confirmed with DNA cycle sequencing. DNA was amplified as 
before and products were purified with 1U each of ExoI and FastAP (both from Thermo Fisher 
Scientific) according the manufacturer’s protocols. DNA sequencing was performed with a 
BigyDye™ Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific) according to the 
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manufacturer’s instructions. Capillary electrophoresis was performed on a 3130xl Genetic 
Analyzer (Applied Biosystems) using standard run conditions. DNA sequencing data was 
analysed with Sequencing Analysis v5.4 software. Direct (Sanger) Sequencing used to confirm 
subset of genotypes for 5-HTTLPR with primer sequences from Klauck et al. (1997). 
Analyses 
All statistical analyses were run using IBM SPSS Statistics, Version 25 (IBM, 2017). All 
verbal ASD and neurotypical participants from the Social Motivation Study were included in the 
current study. Of the 51 non-verbal participants in that study, 34 were successfully genotyped for 
5-HTTLPR and were included in Question 3 with the verbal ASD group. The verbal ASD and 
neurotypical groups had already been assessed for group differences in demographic variables, 
and were aggregate matched for age and SES (Chapter 3: The Social Motivation Study - Results 
Participant Characteristics, pg. 76). As the non-verbal group for the current study was a sub-
sample from the previous study, this group was compared to the verbal ASD group for 
differences in age and SES. It was expected that the non-verbal ASD group would be younger on 
average, which is to be expected due to the nature of language delays in ASD, so where 
necessary age was included the analyses.  
The Theory of Mind Study asked three main questions, with a set of hypotheses for each 
question. For this study ADOS2 scores were again used to indicate level of ASD-related deficits. 
ToM scores were calculated across a developmental battery and compared to neurotypical scores 
to establish age-adjusted percentile scores. These ToM percentiles were continuous with higher 
scores indicating better ToM ability. Finally, 5-HTTLPR genotypes were processed for a subset 
of the ASD participants, and the presence of at least one short allele was indicative of reduced 
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serotonergic transmission. All assumptions for each statistical test were assessed and the analyses 
only continued if assumptions were upheld, or if the test would be robust against such violations.  
The first question for this study assessed whether male children with ASD had lower 
ToM scores than age, and SES matched male neurotypical children. This question utilised data 
from the verbal ASD group and the neurotypical group. First, the percentiles for ToM scores 
were calculated (see Chapter 4: The Theory of Mind Study – Method – Measures – Theory of 
Mind Assessment, pg. 151 for procedure). I then conducted an ANCOVA for ToM percentiles 
across groups with VIQ percentile as the covariate to assess for group differences in ToM 
performance. Further analyses to explore the nature of the relationship between VIQ and ToM 
were also conducted with an MRA for each group with age, SES, and VIQ percentile as 
predictors of ToM percentile score.  
The second question for this study assessed for associations between ToM deficits and 
ASD-related deficits. These analyses were limited to the verbal ASD group. Using partial 
correlations that controlled for age, correlations between ToM and ADOS2 scores were assessed.  
The third question looked at the possible role of 5-HTTLPR in ASD-related deficits and 
ToM deficits in ASD. A subsample of ASD participants provided data for genotyping, and the 
genotype and allelic distribution for this subsample was reported for the non-verbal ASD and 
verbal ASD groups for comparison to the literature, with an expectation of a higher incidence of 
the short allele. Data was reported for each ASD group and across ethnic groups. To assess for 
relationships between 5-HTTLPR and ASD-related deficits MRA was conducted for each ASD 
group with dummy variables for the 5-HTTLPR genotypes. In these MRAs age, SES, and 
genotype dummy variables were predictors of ADOS2 scores. To assess for a relationship 
between 5-HTTLPR and ToM, analyses were limited to the verbal ASD participants who 
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provided DNA samples. Here MRA was conducted with age, SES, VIQ percentile, and genotype 
as predictors of ToM scores. Finally, if above analyses found significant associations, MRA 
models would assess whether ADOS2 scores could be predicted by age, SES, genotype, VIQ and 
ToM, such that ToM could mediate the relationship between genotypes and ADOS2 outcomes.  
This study is one of a very small body of genotype-phenotype studies for 5-HTTLPR, 
and the first to my knowledge to include ToM in the phenotypical assessment with an ASD 
sample, so the analyses are exploratory in nature. Although the high number of analyses do 
increase the possibility of Type 1 error, this was necessary due to the exploratory nature of this 
study. To allow possible associations to emerge, I set alpha to 0.05, as is the convention. I also 
included effect size and power analyses where appropriate as an additional estimation of the 
associations seen. All such findings would ideally be further explored by later confirmatory 
studies  
Ethical considerations 
This study was part of a two-study protocol, and all ethical considerations are detailed in 
Chapter Three: The Social Motivation Study (Ethical Considerations, pg. 72). The only 
additional consideration in the current protocol was that children from the verbal ASD group and 
the neurotypical group completed ToM and IQ assessment and could therefore have experienced 
fatigue. Children were given breaks or sessions were shortened whenever necessary to prevent 
fatigue, and children were able to end a session and/or withdraw from the study at all times. 
Non-verbal children with ASD received research reports detailing their ADOS2 performance as 
part of the Social Motivation Study (Chapter Three: The Social Motivation Study – Method – 
Ethical Considerations, pg. 72). Verbal children also received an ADOS2 research report, but this 
was supplemented with details from their WASI performance from the current study. 
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The participants for this study were drawn from the Social Motivation Study. The 51 
male children in the verbal ASD group and the 51 male children in the neurotypical group were 
aggregate matched on age and SES (for detailed demographics see Chapter 3: The Social 
Motivation Study – Results – Participant Characteristics, pg. 76).  
The non-verbal ASD group was a sub-sample from the sample in the Social Motivation 
Study as only those who were genotyped for 5-HTTLPR were included in the current study. As 
they would be included in the genotype-phenotype analyses with the verbal ASD participants 
who were genotyped, the two ASD groups were assessed for differences in age and SES. As in 
the previous study, and as expected, the non-verbal ASD group was younger (M = 8.57, SD = 
3.66) than the verbal ASD group (M = 10.06, SD = 2.63). An independent t-test showed this 
difference was significant, t(71) = -2.02. p = .047. with a medium effect size, Cohen’s d = .468. 
The groups were no longer matched on SES either, as the non-verbal ASD group had a higher 
average SES (M = 29385.79, SD = 13566.27) than the verbal ASD group (M = 22334.92, SD = 
14889.48). Age and SES were therefore considered in Question 3 when the non-verbal ASD and 
verbal ASD group were both included in analyses.  
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Table 35.  






































Notes. ASD = Autism Spectrum Disorder. SES = Socio-economic status (total annual household income in 
Rands per year).  = Mean. SD = Standard deviation. 
 
Question 1: Do Children with ASD Exhibit Lower Levels of ToM Than Neurotypical 
Children?  
The Theory of Mind Study started by exploring whether the verbal ASD group had ToM 
deficits compared to a neurotypical sample, as is often reported in the literature. All 51 verbal 
ASD participants and the 51 neurotypical participants were included in this analysis. 
Hypothesis 1.1 Children with ASD Will Have Lower ToM Scores Than Neurotypical 
Children. In order to test this hypothesis, I compared the overall scores for ToM between the 
two groups for three age bands. I then assessed whether the verbal ASD group and neurotypical 
group differed significantly on VIQ percentile scores. As they did, I then looked for group 
differences in ToM when VIQ was considered.  
ToM Scoring. The participants for this study completed the University of Cape Town 
Theory of Mind Battery (Appendix M). Initially participants scored an overall percentage for the 
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battery, and these scores were assessed and compared between the groups (Table 36). The mean 
score for the neurotypical group in the age band 6-7 years (M = 72.05, SD = 15.45) showed that 
they were able to understand first-order false belief tasks (Basic Module) but had not consistently 
mastered second-order false belief tasks (Intermediate Module). The neurotypical group in the 
age band 8-10 years (M = 80.85, SD = 8.01) had mastered second-order false beliefs 
(Intermediate Module) but struggled with social faux pas and with distinguishing between lies 
and jokes (Advanced Module). The final age band, 11 years and older (M = 86.02, SD = 4.85), 
showed improved performance in social faux pas and differentiating lies and jokes (Module 4) in 
comparison to the previous age band, although they did not have complete mastery of these skills 












6 – 7 9 72.05 (15.46) 11 42.06 (17.22) 
8 – 10 24 80.85 (8.01) 22 61.26 (24.09) 
11 + 18 86.02 (4.85) 18 63.56 (21.33) 
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Figure 9. Mean Theory of Mind percentile per group with 95% confidence interval. 
 
By comparison, the ASD sample showed considerably poorer performance on ToM tasks, 
and greater variability in scores within each age band. The ASD age band 6-7 years (M = 42.06, 
SD = 17.22) were able to pass basic tasks such as Pretend Play (Early Module) but struggled 
with first-order false belief tasks (Basic Module), placing them an entire module behind the age-
matched neurotypical group. The ASD groups for ages 8-10 years (M = 61.26, SD = 24.09) and 
ages 11 years and older (M = 63.56, SD = 21.33) were able to complete first-order false belief 
tasks (Basic Module) but struggled with second-order false belief tasks (Intermediate Module), 
again placing them a module behind the comparable neurotypical groups.  
Although the above analyses divided participants into age bands, the battery does not 
account for age in the overall scoring percentage, and norms have not yet been developed. To 
overcome this limitation, standardised z-scores were calculated for each age band (see Chapter 4: 
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The Theory of Mind Study – Method – Measures – Theory of Mind Assessment, pg. 151 for 
details). Using the means and standard deviations from the neurotypical group, whose scores did 
not deviate from the reported norms in the literature for neurotypical samples (Robberts, 2011), I 
was able to get a better comparison of the differences between the groups. To allow for easier 
interpretations, these z-scores were then converted into percentiles, and these percentiles were 
used in all later analyses. On average, the ASD group had lower ToM percentile scores (M = 
22.59; SD = 22.86) than the neurotypical group (M = 75.31; SD = 22.8). An independent sample 
t-test showed that this difference was significant, t(100) = -11.65, p < .001, with a large effect, r 
= .76. 
Table 37. 











t p r 
 (SD) 75.31 (22.85) 22.59 (22.86) -11.65 <.001 .73 
Notes. ASD=Autism Spectrum Disorder. ToM = Theory of Mind.  = Mean. SD 
= Standard Deviation.  
Verbal IQ Scores. VIQ is implicated in the ability to complete ToM tasks and was 
assessed in my sample so that any differences between groups in ToM would be seen over and 
above the impact of VIQ abilities. An independent t-test found that on average neurotypical 
participants had higher VIQ scores (M = 113.33, SD = 12.73) than the verbal ASD group (M = 
84.55, SD = 14.17). This difference was significant, t(100) = -10.79, p<.001, with a large effect r 
= .73 (Table 38). Due to the groups having differences in both VIQ percentile scores and in ToM 
scores, the groups were assessed independently to see what role VIQ played in ToM 
performance, and whether it differed across the groups. For consistency, as ToM scores were 
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VIQ Scores Across Groups 
 





t p r 
 (SD) 113.33 (12.73) 84.55 (14.17) -10.79 <.001 .73 
Notes. ASD=Autism Spectrum Disorder. VIQ = WASI Verbal Intelligence Quotient.  = Mean. 
SD=Standard Deviation.  
 
ToM Across Groups. To explore ToM differences across groups, I used an ANCOVA to 
assess whether any between-group difference in ToM was present over and above the group 
difference in VIQ performance. The correlation between VIQ percentile scores and ToM 
percentile scores for all participants was high, r = .66, p < .001. VIQ percentile score was a 
significant covariate, F(1,99) = 29.06, p <.001. However, group no longer had a significant 
association with ToM when the covariate was considered, F(1,99) = .235, p = .629, 2 = -.004. 
As the literature consistently reports ToM deficits over and above VIQ deficits in ASD, I 
ran separate MRAs for the neurotypical group and the verbal ASD group to establish whether the 
role of VIQ was consistent across the two groups. The models placed age and SES first, followed 
by VIQ percentile, with ToM percentile as the outcome variable. 
For the neurotypical group, ToM percentile was significantly correlated with the 
predictor, VIQ percentile, as predicted, r = .41, p <.001 (Table 39). No issues with 
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multicollinearity were noted, as the only other correlations were weak and all tolerance scores 
and VIF scores were acceptable, confirming no multicollinearity (Field, 2013).  
 
Table 39. 
Zero-Order Correlation Matrix for Neurotypical Participants: ToM 
 1 2 3 4 
1. Age (Months) -    
2. SES -.18 -   
3. VIQ percentile -.16 .40** -  
4. ToM percentile .01 .19 .41** - 
Notes. SES=Socio-Economic Status (total annual household income).  
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
The final model was significant, F (3,47) = 3.41, p = .025. This model had a medium 
effect size, f2 = .22, and an observed power of .78. The adjusted R2 value showed that this model 
explained 12.6% of the variance in ToM percentile scores, and the R2 change value of .140 
showed that this was accounted for by the VIQ percentile scores (Table 40). Table 41 shows that 
VIQ percentile was the only significant predicator.  
Table 40. 



















1 .197 .039 -.001 28.04 .039 0.97 2 48 .386 
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2 .423 .179 .126 26.20 .140 7.99 1 47 .007 
Notes. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, Total Annual Family Income (SES), Age 
Model 2: Constant, Total Annual Family Income (SES), Age, VIQ Percentile 
 
Table 41. 









Model Predictors B 
Std. 
Error 
β t p Tolerance VIF 
2 (Constant) -1.94 26.20  -0.07 .941   
 Age 0.11 0.17 .09 0.64 .528 0.96 1.05 
 SES <0.01 0.00 .04 0.30 .766 0.83 1.21 
 
VIQ 
percentile 0.50 0.18 .41 2.83 .007 0.83 1.20 
Notes. SES = Socio-Economic Status (total annual household income) 
 
For the verbal ASD group, the outcome variable, ToM percentile, was significantly 
correlated with the predictor, VIQ percentile, as predicted, r = .54, p <.001 (Table 42). No issues 
with multicollinearity were noted, as the only other correlations were weak and all tolerance 
scores and VIF scores were acceptable, confirming no multicollinearity (Field, 2013). 
 
Table 42. 
Zero-Order Correlation Matrix for ASD Participants: ToM 
 1 2 3 4 
1. Age (Months) -    
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 170 
2. SES -.18 -   
3. VIQ percentile -.29* .12 -  
4. ToM percentile -.06 .08 .54** - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status 
(total annual household income).  
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
The overall model was significant, F(3,47) = 3.95, p = .001, with a large effect size, f2 = 
.44, and an observed power of .98. This model explained 26.3% of the variance in ToM 
percentile scores, and the R2 change value of .30 showed that this was accounted for by the VIQ 
percentile (Table 43). Table 44 showed that VIQ percentile was the only significant predicator.  
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Table 43. 



















1 .086 .007 -.034 27.18 .007 0.18 2 48 .837 
2 .554 .307 .263 22.94 .300 20.34 1 47 <.001 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). 
Model 1: Constant, Total Annual Family Income (SES), Age 
Model 2: Constant, Total Annual Family Income (SES), Age, VIQ Percentile 
 
Table 44. 









Model Predictors B 
Std. 
Error 
β t p Tolerance VIF 
2 (Constant) -11.15 16.64  -0.67 .506   
 Age 0.10 0.11 .12 0.92 .364 0.89 1.12 
 SES <0.01 0.00 .03 0.20 .840 0.96 1.04 
 
VIQ 
Percentile 0.67 0.15 .57 4.51 
<.00
1 0.91 1.10 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). 
 
As per my hypothesis, the verbal ASD group had significantly worse performances for 
ToM tasks than the neurotypical sample. Comparing the two regression models, we see that VIQ 
percentile and ToM percentile had a stronger association for the verbal ASD group than that seen 
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in the neurotypical group. I also note that VIQ percentile appeared to explain a greater amount of 
variance in ToM performance for the verbal ASD group than the neurotypical group. The role of 
VIQ in ToM therefore seems different in ASD compared to the neurotypical sample, and VIQ 
was considered in all further analyses.  
Question 2: Are ToM Deficits Associated with ASD-Related Deficits?  
ToM deficits are common in ASD, but the relationships between these deficits and ASD 
symptoms is unclear. I therefore investigated whether ToM deficits were associated with specific 
aspects of ASD. The above analyses also showed that VIQ can be a protective factor when 
considering ToM deficits in ASD, so VIQ further complicates the relationship between ToM 
deficits and ASD deficits.  
Hypothesis 2.1 Lower ToM Scores Will Be Associated with Higher ADOS2 Scores. 
This analysis was limited to the 51 verbal ASD participants, and I expected higher ToM 
percentile scores to correlate with lower ADOS2 scores. To assess for these relationships, I 
initially looked at partial correlations between ToM scores and ADOS2 Scores while controlling 
for VIQ percentile scores. An MRA assessing the association between ToM percentile and 
ADOS2 scores over and above the roles of age, SES, and VIQ percentile was considered, but 
was rejected due to the multicollinearity issues that would arise from the correlation between 
VIQ percentile and ToM. Partial correlation analysis between ToM and ADOS2 scores when 
controlling for VIQ percentile was therefore conducted.  
Where VIQ percentile was controlled for with partial correlations, ToM was inversely 
correlated with greater severity scores for ADOS2 Comparison score (r = -.40, p = .002) and 
ADOS2 Social Affect score (r = -.28, p = .024), but not with ADOS2 RRB Score (r = -.20, p = 
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.083). These correlations indicated a specific relationship between ToM and the ASD deficits 
associated with the social communication and interaction symptom domain.  
Table 45. 
Partial Correlation Matrix for ASD Participants: ToM when controlling for VIQ percentile 
 1 2 3 4 
1. ToM -    
2. ADOS2 Comparison  -.40** -   
3. ADOS2 SA -.28* .85** -  
4. ADOS2 RRB -.20 .31* -.08 - 
Notes. ASD = Autism Spectrum Disorder. RRB = Restricted and Repetitive Behaviours and 
Interests Symptom Domain. 
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
Question 3: Could 5-HTTLPR Play A Role In ASD-Related Deficits and/or ToM Deficits?  
As serotonin is implicated in a multitude of social functions and in ASD, I aimed to 
clarify whether 5-HTTLPR linked to specific ASD characteristics assessed by the ADOS2, 
and/or linked to ToM. I initially assessed the allelic distribution of 5-HTTLPR in the sample for 
the full 73 ASD participants who provided DNA (34 non-verbal; 39 verbal) and then assessed 
whether ADOS2 scores related to 5-HTTLPR genotypes for this sample. I then looked at the 39 
verbal ASD children who provided DNA to assess for relationships between 5-HTTLPR and 
ToM performance.  
Hypothesis 3.1 Children with ASD Will Show A Higher Rate of the 5-HTTLPR 
Short Allele Than Reported in Neurotypical Samples. For this aspect of the study, 73 children 
with ASD were genotyped for 5-HTTLPR. For the current sample, the distribution was 38.4% 
L/L genotype, 47.9% L/S genotype, and 13.7% S/S genotype (Table 46). It was noted that the 
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verbal ASD group tended to have higher prevalence of the short allele than the non-verbal ASD 
group, and particularly to have higher rates of the S/S genotype. Overall, the current sample 
showed a higher prevalence of the short allele, and specifically the S/S genotype, than reported in 
a neurotypical South African sample, where the S/S genotype only occurred in 5% of their 
sample (Esau et al., 2008). 
Table 46. 
5-HTTLPR Genotypes and Allelic Distribution in ASD 
 Genotypes Allelic Distribution 
 L/L L/S S/S L S 
Total (n=73) 28 (38.36%) 35 (47.95%) 10 (13.70%) .62 .38 
Non-Verbal ASD (n=34) 15 (44.12%) 17 (50.00%) 2 (5.88%) .69 .31 
Verbal ASD (n=39) 13 (33.33%) 18 (46.15%) 8 (20.51%) .56 .44 
Notes. ASD = Autism Spectrum Disorder.  
The distribution of 5-HTTLPR genotypes and alleles across ethnic groups in the ASD 
samples is shown below (Tables 47-49). As ethnicity was not a factor in recruitment, there were 
not equal sample sizes for each ethnic group. The current study had a similar ethnic distribution 
to the local ASD sample report by Arieff et al. (2010), with similar allelic frequency prevalence 
as in their findings. The current sample, however, had lower rates of the S/S genotype for each 
ethnic group compared to their study. When I compared the three local studies, I noted that the 
Caucasian ASD samples in my study and the Arieff et al. (2010) study did not show the 
predicted disparity in allelic frequency between these ASD samples and neurotypical sample in 
the Esau et al. (2008) study.   
 
  
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 175 
Table 47. 
5-HTTLPR Genotypes and Allelic Distribution in ASD Across Ethnic Groups 
 Genotypes Allelic Distribution 
 L/L L/S S/S L S 
Caucasian (n=25) 8 (32.00%) 13 (52.00%) 4 (16.00%) .58 .42 
African (n=6) 3 (50.00%) 3 (50.00%) 0 (0.00%) .75 .25 
Mixed race (n=38) 16 (42.11%) 17 (44.74%) 5 (13.12%) .64 .36 
Asian (n=2) 1 (50.00%) 1 (50.00%) 0 (0.00%) .75 .25 
Other (n=2) 0 (0.00%) 1 (50.00%) 1 (50.00%) .25 .75 
Notes. ASD = Autism Spectrum Disorder. 
 
Table 48. 
5-HTTLPR Genotypes and Allelic Distribution in Non-Verbal ASD across Ethnic Groups 
 Genotypes Allelic Distribution 
 L/L L/S S/S L S 
Caucasian (n=12) 4 (33.33%) 6 (50.00%) 2 (16.67%) .58 .42 
Mixed race (n=16) 9 (56.25%) 7 (43.75%) 0 (0.00%) .78 .22 
African (n=4) 1 (25.00%) 3 (75.00%) 0 (0.00%) .63 .38 
Asian (n=1) 1 (100.00%) 0 (0.00%) 0 (0.00%) 1.00 .00 
Other (n=1) 0 (0.00%) 1 (100.00%) 0 (0.00%) .50 .50 
Notes. ASD = Autism Spectrum Disorder. 
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Table 49. 
5-HTTLPR Genotypes and Allelic Distribution in Verbal ASD across Ethnic Groups 
 Genotypes Allelic Distribution 
 L/L L/S S/S L S 
Caucasian (n=13) 4 (30.77%) 7 (53.85%) 2 (15.38%) .58 .42 
Mixed race (n=22) 7 (31.82%) 10 (45.45%) 5 (22.73%) .55 .45 
African (n=2) 2 (100%) 0 (0.00%) 0 (0.00%) 1.00 .00 
Asian (n=1) 0 (0.00%) 1 (100%) 0 (0.00%) .50 .50 
Other (n=1) 0 (0.00%) 0 (0.00%) 1 (100%) .00 1.00 
Notes. ASD = Autism Spectrum Disorder. 
Hypothesis 3.2 Children with ASD Carrying the 5-HTTLPR Short Allele Will Have 
Higher ADOS2 Scores Than Those Without This Allele. As ASD is likely to arise from 
multiple genetic contributions, I aimed to see whether 5-HTTLPR linked to particular aspects of 
ASD. I therefore assessed ADOS2 scores across the genotypes for the ASD participants who had 
provided DNA samples and I had predicted that the short allele would relate to higher deficits. 
As the Social Motivation Study (Chapter 3: The Social Motivation Study – Results – Question 2, 
Hyp. 2.2, pg. 83) found significant group differences for ADOS2 scores between the non-verbal 
ASD group and the verbal ASD group, I conducted separate analyses for these two groups.  
ADOS2 Comparison Scores Across 5-HTTLPR Genotypes. I conducted a hierarchical 
regression model to assess for a relationship between 5-HTTLPR and ADOS2 Comparison 
scores. I entered age and SES, followed by the dummy variables for 5-HTTLPR, with ADOS2 
Comparison score as the outcome variable. The dummy variables for 5-HTTLR were coded as 
follows: Dummy1 assigned a value of zero to all genotypes with a short allele (i.e. S/S and L/S 
genotypes); Dummy2 assigned a zero to all genotypes without a long allele (i.e. S/S genotype 
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only). This analysis was conducted for the non-verbal ASD group and for the verbal ASD group 
separately.  
  For the non-verbal ASD group, 34 participants had the required data. Assessing ADOS2 
Comparison scores across genotypes showed that the L/L genotype had the lowest deficit score 
(M = 5.87, SD = 1.73), followed by the L/S genotype (M = 6.29, SD = 0.85), and the S/S 
genotype (M = 8.50, SD = 0.71) had the highest deficit score. Although this followed the 
hypothesised pattern of scoring, as the S/S genotype only had 2 participants, the relevance of the 
mean scores is limited.  
 No issues for multicollinearity were noted in the correlation matrix or when assessing 
tolerance and VIF scores (Field, 2013). Table 50 shows the zero-order correlations for this 
model, and I noted only one significant correlation to the outcome variable, namely the second 5-
HTTLPR dummy variable to ADOS2 Comparison score, r = -.41, p = .009. This dummy 
variable compared the S/S genotype to the genotypes that carried at least one long allele and the 
correlation indicated that children carrying a long allele tended to show lower deficits scores than 
those only carrying short alleles, as hypothesised.  
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Table 50. 
Zero-Order Correlation Matrix for Non-Verbal ASD Participants: ADOS2 Comparison Score 
 1 2 3 4 5 
1. Age (Months) -     
2. SES .03 -    
3. S-carriers v L/L a .07 -.10 -   
4. SS v L-carriers a .19 -.15 .22 -  
5. ADOS2 Comparison score .14 -.12 -.24 -.41** - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). a 5-HTTLPR dummy variables  
*. Correlation is significant at the .05 level (1-tailed).  
**. Correlation is significant at the .01 level (1-tailed). 
 
The first model included SES and age, and was not significant, F (2,31) = 0.56, p = .576. 
The second model included the 5-HTTLPR dummy variables and was significant, F (4,29) = 
2.75, p = .042, with a large effect size, f2 =.39, and an observed power of .78. The adjusted R2 
valued showed that this second model explained 18.3% of the variance in ADOS2 Comparison 
score, and the R2 change value of .247 showed that this was accounted for by the 5-HTTLPR 
dummy variables (Table 51). Table 52 shows that the second 5-HTTLPR dummy variable was 
the only significant predicator, indicating that the S/S genotype had higher deficits than those 
carrying a long allele. Although this supported my hypothesis, it contradicted the reported 
dominant effect for the short allele.  
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Table 51. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .187 .035 -.027 1.44 .035 0.56 2 31 .576 
2 .531 .282 .183 1.28 .247 4.99 2 29 .014 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 
Model 2: Constant, SES, Age, 5-HTTLPR Dummy1, 5-HTTLPR Dummy2 
 
Table 52. 









Model Predictors B Std. Error β t p Tolerance VIF 
2 (Constant) 8.81 1.15  7.70 <.001   
 Age (months) 0.01 0.01 .241 1.50 .145 0.96 1.04 








-2.65 0.98 -.447 -2.69 .012 0.90 1.11 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
* 5-HTTLPR genotype dummy variables 
 
 For the verbal ASD group, 39 participants had the required data. Assessing ADOS2 
Comparison scores across genotypes showed that the L/S genotype (M = 6.06, SD = 1.96) had the 
highest deficit score, followed by the S/S genotype (M = 5.38, SD = 2.00), with the L/L genotype 
having the lowest deficit score (M = 5.08, SD = 2.15). Although this supported my hypothesis 
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that short allele carriers would have higher ASD-related deficits, for the L/S genotype to have the 
highest deficit score I would need the short allele for 5-HTTLPR to have a dominant effect, yet 
this scoring pattern does not clearly indicate that the L/S genotype and S/S genotype have similar 
scores.  
 No issues for multicollinearity were noted in the correlation matrix or when assessing 
tolerance and VIF scores (Field, 2013). Table 53 shows the zero-order correlations for this 
model, and I noted only one significant correlation to the outcome variable, namely age to 
ADOS2 Comparison score, r = .31, p = .028. Neither of the 5-HTTLPR dummy variables 
correlated to the outcome variable.  
Table 53. 
Zero-Order Correlation Matrix for verbal ASD Participants: ADOS2 Comparison Score 
 1 2 3 4 5 
1. Age (Months) -     
2. SES -.28* -    
3. S-carriers v L/L a -.01 .06 -   
4. SS v L-carriers a .16 .26 .36* -  
5. ADOS2 Comparison score .31* -.20 -.18 .05 - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). a 5-HTTLPR dummy variables  
*. Correlation is significant at the .05 level (1-tailed).  
**. Correlation is significant at the .01 level (1-tailed). **. Correlation is significant at the .01 level (1-
tailed). 
 
 The first model included SES and age, and was not significant, F (2,36) = 2.24, p = .121. 
The second model included the 5-HTTLPR dummy variables and was also not significant, F 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 181 
(4,34) = 2.75, p = .215, f2 =.18. This analysis therefore did not support the hypothesis that short 
allele carriers would have higher ADOS2 Comparison scores compared to non-carriers.  
Table 54. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .333 .111 .061 1.99 .111 2.24 2 36 .121 
2 .391 .153 .053 1.99 .042 0.84 2 34 .440 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 
Model 2: Constant, SES, Age, 5-HTTLPR Dummy1, 5-HTTLPR Dummy2 
 
Table 55. 






  Collinearity Statistics 
Model Predictors B Std. Error β t p Tolerance VIF 
2 (Constant) 3.98 1.57  2.54 .016   
 Age (months) 0.02 0.01 .242 1.12 .165 0.86 1.17 








0.66 0.91 .132 0.73 .472 0.76 1.32 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
* 5-HTTLPR genotype dummy variables 
 
ADOS2 Social Affect Scores Across 5-HTTLPR Genotypes. I conducted similar 
hierarchical regression models to assess for a relationship between 5-HTTLPR and ADOS2 
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Social Affect scores for each ASD group. I entered age and SES, followed by the dummy 
variables for 5-HTTLPR, with ADOS2 Social Affect score as the outcome variable.  
 For the non-verbal ASD group, 34 participants had the required data. Assessing ADOS2 
Social Affect scores across genotypes showed that the S/S genotype (M = 15.50, SD = 2.12) had 
the highest deficit score, followed by the L/S genotype (M = 13.12, SD = 3.95), with the L/L 
genotype having the lowest deficit score (M = 12.80, SD = 4.09). Although this followed the 
hypothesised pattern of scoring, as the S/S genotype only had 2 participants, the relevance of the 
mean scores is limited, and the pattern does not clearly indicate a dominant effect for the short 
allele as predicted.  
 No issues for multicollinearity were noted in the correlation matrix or when assessing 
tolerance and VIF scores (Field, 2013). Table 56 shows the zero-order correlations for this 
model, and none of the predictor variables correlated with the outcome variable.  
Table 56. 
Zero-Order Correlation Matrix for Non-Verbal ASD Participants: ADOS2 Social Affect Score 
 1 2 3 4 5 
1. Age (Months) -     
2. SES .03 -    
3. S-carriers v L/L a .07 -.10 -   
4. SS v L-carriers a .19 -.15 .22 -  
5. ADOS2 Social Affect 
score 
.18 -.09 -.07 -.16 - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). a 5-HTTLPR dummy variables  
*. Correlation is significant at the .05 level (1-tailed).  
**. Correlation is significant at the .01 level (1-tailed). 
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The first model included SES and age, and was not significant, F(2,31) = 0.64, p = .534. 
The second model included the 5-HTTLPR dummy variables and was also not significant, F 
(4,29) = 0.69, p = .605, f2 =.10. The hypothesised role for 5-HTTLPR in ADOS2 Social Affect 
scores was therefore not supported for the non-verbal ASD group.  
Table 57. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .199 .040 -.022 3.94 .040 0.64 2 31 .534 
2 .295 .087 -.039 3.97 .047 0.75 2 29 .482 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 
Model 2: Constant, SES, Age, 5-HTTLPR Dummy1, 5-HTTLPR Dummy2 
  
Table 58. 









Model Predictors B Std. Error β t p Tolerance VIF 
2 (Constant) 15.52 3.56  4.36 <.001   
 Age (months) 0.02 0.02 .224 1.24 .226 0.96 1.04 








-3.36 3.05 -0.21 -1.10 .281 0.90 1.11 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). * 
5-HTTLPR genotype dummy variables 
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For the verbal ASD group, 39 participants had the required data. Assessing ADOS2 
Social Affect scores across genotypes showed that the L/S genotype (M = 8.11, SD = 3.20) had 
the highest deficit score, followed by the L/L genotype (M = 6.92, SD = 4.13), with the S/S 
genotype (M = 6.75, SD = 2.55) showing the lowest deficit score. This was contrary to my 
hypothesised expectation that the short allele would be linked to greater ASD-related deficits, 
and once again did not support a dominant role for the short allele.  
No issues for multicollinearity were noted in the correlation matrix or when assessing 
tolerance and VIF scores (Field, 2013). Table 59 shows the zero-order correlations for this 
model, and I noted the only one significant correlation to the outcome variable was age, r= .36, p 
=.013. Neither of the 5-HTTLPR dummy variables correlated to the outcome variable. 
 
Table 59. 
Zero-Order Correlation Matrix for Verbal ASD Participants: ADOS2 Social Affect Score 
 1 2 3 4 5 
1. Age (Months) -     
2. SES -.28* -    
3. S-carriers v L/L a -.01 .06 -   
4. SS v L-carriers a .16 .26 .36* -  
5. ADOS2 Social Affect 
score 
.36* -.15 -.11 .10 - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). a 5-HTTLPR dummy variables  
*. Correlation is significant at the .05 level (1-tailed).  
**. Correlation is significant at the .01 level (1-tailed). 
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The first model included SES and age and was not significant, F (2,36) = 2.69, p = .082. 
The second model included the 5-HTTLPR dummy variables and was also not significant, F 
(4,34) = 1.54, p = .214, f2 =.18. This analysis therefore did not support the hypothesis that short 
allele carriers would have higher ADOS2 Social Affect scores compared to non-carriers. 
 
Table 60. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .360 .130 .082 3.26 .130 2.69 2 36 .082 
2 .391 .153 .053 3.31 .023 0.46 2 34 .633 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 
Model 2: Constant, SES, Age, 5-HTTLPR Dummy1, 5-HTTLPR Dummy2 
 
Table 61. 









Model Predictors B Std. Error β t p Tolerance VIF 
2 (Constant) 3.43 2.61  1.32 .197   
 Age (months) 0.03 0.02 .307 1.80 .081 0.86 1.17 








1.08 1.51 .130 0.72 .478 0.76 1.32 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
* 5-HTTLPR genotype dummy variables 
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ADOS2 RRB Scores Across 5-HTTLPR Genotypes. I conducted hierarchical regression 
models to assess for a relationship between 5-HTTLPR and ADOS2 RRB scores for each ASD 
group. I entered age and SES, followed by the dummy variables for 5-HTTLPR, with ADOS2 
RRB score as the outcome variable.  
 The non-verbal ASD group had 34 participants with the required data. Assessing ADOS2 
RRB scores across genotypes showed that the S/S genotype (M = 6.00, SD = 1.41) had the 
highest deficit score, followed by the L/S genotype (M = 3.47, SD = 2.15), with the L/L genotype 
having the lowest deficit score (M = 3.00, SD = 1.96). Although this followed the hypothesised 
pattern of scoring, the S/S genotype only had 2 participants so the relevance of the mean scores is 
limited. Further, the scoring pattern did not support a dominant role for the short allele.  
No issues for multicollinearity were noted in the correlation matrix or when assessing 
tolerance and VIF scores (Field, 2013). Table 62 shows the zero-order correlations for this 
model, and I noted only one significant correlation to the outcome variable, namely 5-HTTLPR 
Dummy2 to ADOS2 RRB score, r = -.31, p =.036. This dummy variable compared the S/S 
genotype to the genotypes that carried at least one long allele and the correlation indicated that 
children carrying a long allele tended to show lower deficits scores than those only carrying short 
alleles, as hypothesised. However, this supports a dominant role for the long allele and not the 
short allele. 
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Table 62. 
Zero-Order Correlation Matrix for Non-verbal ASD Participants: ADOS2 RRB Score 
 1 2 3 4 5 
1. Age (Months) -     
2. SES .03 -    
3. S-carriers v L/L a .07 -.10 -   
4. SS v L-carriers a .19 -.15 .22 -  
5. ADOS2 RRB score .17 -.28 -.18 -.31* - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). a 5-HTTLPR dummy variables  
*. Correlation is significant at the .05 level (1-tailed).  
**. Correlation is significant at the .01 level (1-tailed 
 
The first model included SES and age and was not significant, F (2,31) = 1.88, p = .169. 
The second model included the 5-HTTLPR dummy variables and was significant, F (4,29) = 
2.96, p = .036, with a large effect size, f2 =.41, and an observed power of .79. The adjusted R2 
value showed that the second model explained 19.2% of the variance in ADOS2 RRB score and 
the R2 change value of .182 showed that this was accounted for by the 5-HTTLPR dummy 
variables (Table 63). Table 64 showed that SES was a significant predictor. The second 5-
HTTLPR dummy variable was also a significant predicator, indicating that the S/S genotype had 
higher deficits than those carrying a long allele. Although this supported the hypothesis, it again 
contradicted the expected dominant role for the short allele.  
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Table 63. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .329 .108 .051 2.05 .108 1.88 2 31 .169 
2 .538 .290 .192 1.89 .182 3.71 2 29 .037 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, SES, Age 
Model 2: Constant, SES, Age, 5-HTTLPR Dummy1, 5-HTTLPR Dummy2 
 
Table 64. 









Model Predictors B Std. Error β t p Tolerance VIF 
2 (Constant) 7.20 1.69  4.25 <.001   
 Age (months) 0.01 0.01 .266 1.66 .107 0.96 1.04 








-3.40 1.45 -.385 -2.34 .027 0.90 1.11 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
* 5-HTTLPR genotype dummy variables 
 
 For the verbal ASD group, 39 participants had the required data. Assessing ADOS2 RRB 
scores across genotypes showed that the S/S genotype (M = 2.38, SD = 1.41) had the highest 
deficit score, followed by the L/L genotype (M = 1.92, SD = 1.66), and the L/S genotype (M = 
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1.83, SD = 1.69) with the lowest deficit score. This scoring pattern indicated that there was not a 
relationship between 5-HTTLPR genotypes and ADOS2 RRB scores.  
 There were no indications of multicollinearity in the correlation matrix or when assessing 
tolerance and VIF scores (Field, 2013). Table 65 shows the zero-order correlations for this 
model, and there were no significant correlations between the predictors and the outcome 
variable. It was therefore unsurprising that the regression models were not significant, F(4,34) = 
0.25, p = .907, f2 =.03. Analysis therefore did not support the hypothesised relationship between 
5-HTTLPR and ADOS2 RRB scores.  
 
Table 65. 
Zero-Order Correlation Matrix for Verbal ASD Participants: ADOS2 RRB Score 
 1 2 3 4 5 
1. Age (Months) -     
2. SES -.28* -    
3. S-carriers v L/L a -.01 .06 -   
4. SS v L-carriers a .16 .26 .36* -  
5. ADOS2 RRB score -.03 -.13 -.02 -.13 - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). a 5-HTTLPR dummy variables  
*. Correlation is significant at the .05 level (1-tailed).  
**. Correlation is significant at the .01 level (1-tailed). 
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Table 66. 






Std. Error of 
the Estimate 





df 1 df 2 
Sig. F 
Change 
1 .146 .021 -.033 1.62 .021 0.39 2 36 .680 
2 .170 .029 -.086 1.66 .008 0.13 2 34 .877 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income).  
Model 1: Constant, SES, Age 
Model 2: Constant, SES, Age, 5-HTTLPR Dummy1, 5-HTTLPR Dummy2 
 
Table 67. 






  Collinearity Statistics 
Model Predictors B Std. Error β t p Tolerance VIF 
2 (Constant) 2.83 1.31  2.16 .038   
 Age (months) <-0.01 0.01 -.045 -0.25 .805 0.86 1.17 








-.384 .759 -.098 -0.51 .616 0.76 1.32 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
* 5-HTTLPR genotype dummy variables 
 
Summary of Findings for Hypothesis 3.2. I had hypothesised that children with ASD 
who carried a short allele for 5-HTTLPR would present with greater ASD-related deficits than 
those who only carried the long allele. I found two significant relationships for the non-verbal 
ASD group, and these indicated that carriers of the S/S genotype scored higher for ADOS2 
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Comparison scores, indicating ASD severity, and ADOS2 RRB scores than did carriers of a long 
allele. This supported the hypothesis but did not support the reported dominant effect for the 5-
HTTLPR short allele. There were no significant findings for the verbal ASD group, indicating 
that 5-HTTLPR did not play a role in ASD-related deficits in this group.  
Hypothesis 3.3 Children with ASD Carrying the 5-HTTLPR Short Allele Will Have 
Lower ToM Scores Than Those Without This Allele. I hypothesised that short allele carriers 
for 5-HTTLPR would have lower ToM scores than those who did not carry short alleles. To 
assess the relationship between 5-HTTLPR and ToM I conducted hierarchical regression with 
the 39 verbal ASD participants who provided DNA. I placed age and SES first, followed by VIQ 
percentile, followed by genotype dummy variables, with ToM percentile score as the outcome 
variable.  
Assessing ToM scores across genotypes showed that the L/L genotype (M = 30.04, SD = 
32.02) tended to score higher than the other two genotypes, followed by the S/S genotype (M = 
22.90 SD = 31.28), with the L/S genotype scoring the lowest (M = 12.30, SD = 24.49). This 
suggested that having one or more short alleles would undermine ToM performance, as 
predicted, indicating a dominant effect for the short allele for 5-HTTLPR, as found in the 
literature (Arieff et al., 2010; Tordjman et al., 2001). Due to the strong relationship between VIQ 
and ToM, VIQ percentile scores were also noted for the genotypes. Here no clear pattern 
emerged: the S/S genotype had the least deficits (M = 33.50, SD = 35.73), followed by very 
similar scores for the L/L genotype (M = 20.42, SD = 16.83) and L/S genotype (M = 20.85, SD = 
22.33). This suggested a dominant effect for the long allele on VIQ percentile scores, which 
contrasted with the pattern for ToM. However, for both ToM percentile and VIQ percentile 
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scores the variability for each genotype represented in standard deviation scores indicated that 
genotypes did not represent homogenous groups for either of these abilities.  
No issues for multicollinearity were noted in the correlation matrix (Table 68) or when 
assessing tolerance and VIF scores (Field, 2013). ToM correlated with VIQ, r =.54, p <.001, but 
not with either of the 5-HTTLPR genotype dummy variables.  
 
Table 68. 
Zero-Order Correlation Matrix for ToM 
 1 2 3 4 5 6 
1. Age (Months) -      
2. SES -.28* -     
3. VIQ -.31* .20 -    
4. Genotype: SS v L-carriers -.01 .06 -.07 -   
5. Genotype: LL v S-carriers .16 .26 -.23 .36* .  
6. ToM -.04 .16 .54** -.24 -.05 - 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income).  
*. Correlation is significant at the .05 level (1-tailed). 
**. Correlation is significant at the .01 level (1-tailed). 
 
The first regression model had only age and SES as predictors and was not significant, 
F(2,36) = 0.49, p =.615. The second model added VIQ percentile and was significant, F (3,35)= 
5.59, p = .003, and the adjusted R2 value showed that the model explained 26.6% of the variance 
in ToM, and the R2 change value of .297 showed that this was accounted for by VIQ percentile 
(Table 69). When 5-HTTLPR genotype was added to the model, the overall model remained 
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significant, F(5,33) = 4.52, p = .003, with a large effect size, f2 =.68, and an observed power of 
.97. The adjusted R2 value for the third model explained 31.6% of the variance in ToM, although 
the R2 change value was only .082 and the F change was not significant, indicating that the 5-




Predictors of ToM Percentile: Model Summary 
Model R R Square 
Adjusted 
R Square 
Std. Error of 
the Estimate 
  Change Statistics 
R Square 
Change 
F Change df 1 df 2 
Sig. F 
Change 
1 .163 .027 -.027 29.32 .027 0.49 2 36 .615 
2 .569 .324 .266 24.78 .297 15.38 1 35 <.001 
3 .637 .406 .316 23.91 .082 2.29 2 33 .117 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household income). 
Model 1: Constant, Total Annual Family Income (SES), Age 
Model 2: Constant, Total Annual Family Income (SES), Age, VIQ percentile 
Model 3: Constant, Total Annual Family Income (SES), Age, VIQ percentile, 5-HTTLPR (Dummy 
Variables) 
 
Table 70 shows that VIQ percentile was the only significant predicator in Model 2. For 
Model 3 VIQ percentile and the first dummy variable for 5-HTTLPR were significant predictors 
of ToM percentile. The dummy variable that was significant was the coding for a change from 
carrying a short allele to being long-allele homogenous (i.e. it indicates the difference between 
S/S and L/S as one group compared to the L/L genotype group). This positive relationship 
supports a dominant role for the short allele, and indicates, as was suggested by the descriptive 
statistics, that having one or more short alleles for 5-HTTLPR was associated with poor ToM 
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performance when compared to long allele carriers, as predicted. However, the F-change statistic 
was not significant when the genotypes were added to the model, and it is noted that genotypes 
did not show consistent scoring in either ToM or VIQ.  
 
Table 70.  






  Collinearity Statistics 
Model Predictors B Std. Error β t p Tolerance VIF 
3 (Constant) -24.26 20.61  -1.18 .248   
 Age 0.18 0.14 .194 1.31 .201 0.82 1.23 












-5.66 11.18 -.080 -0.51 .616 0.72 1.39 
Notes. ASD = Autism Spectrum Disorder. SES = Socio-Economic Status (total annual household 
income). *5-HTTLPR genotype dummy variables 
 
Hypothesis 3.4 In children with ASD, the 5-HTTLPR Short Allele Will Be 
Associated with Poor ToM Performance, and ToM Performance Will Mediate A 
Relationship Between 5-HTTLPR Genotypes and ADOS2 Scores. I had predicted that the 5-
HTTLPR genotype would be associated with both ToM performance and ADOS2 scores. 
However, hypothesis 3.2 found no association between 5-HTTLPR genotypes and ADOS2 
scores for the verbal ASD group. Analyses to assess for ToM having a mediation effect between 
genotypes and ADOS2 scores was therefore not conducted.  
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Summary of Findings 
The Theory of Mind Study found that the verbal ASD group performed significantly 
worse on ToM tasks and had lower VIQ percentile scores than the neurotypical sample. I found a 
stronger association between VIQ percentile and ToM performance for the ASD group than for 
the neurotypical group. When I assessed the role of ToM in ASD while controlling for VIQ 
percentile I found that ToM deficits linked to greater deficits in ADOS2 Comparison scores and 
ADOS2 Social Affect scores. 
I then considered the role of 5-HTTLPR and had anticipated that carriers of the short 
allele for this gene would have greater deficits in ToM and for ASD-related deficits measured by 
the ADOS2. I found a higher incidence of the S/S genotype in the current sample compared to 
the literature for neurotypical South Africans (Esau et al., 2008). For the non-verbal ASD group I 
found that children with the S/S genotype tended to have higher scores for ADOS2 Comparison 
scores and ADOS2 RRB scores compared to carriers of the long allele. This supported the 
hypothesis but did not support the dominant role for the short allele as reported in the literature. 
There were no significant relationships between 5-HTTLPR and ADOS2 scores for the verbal 
ASD group. However, there was a possible relationship between 5-HTTLPR and ToM 
performance for the verbal group, with carriers of the short allele performing more poorly on 
ToM tasks than carriers of the L/L genotype as predicted, although the high variability in ToM 
and VIQ performance when the sample was divided by genotype indicates that this is unlikely. 
Discussion 
The Theory of Mind Study aimed to further our knowledge regarding the role of ToM 
deficits in ASD, and to explore the possible role of 5-HTTLPR genotypes in ToM deficits and in 
the ASD phenotype. Although these deficits have been widely recognised and theories for the 
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role of ToM deficits have been developed, the mechanisms underlying these deficits are not fully 
understood. My results were consistent with the literature showing that children with ASD have 
ToM deficits, and that these deficits correlated with overall ASD severity and with greater 
impairment in the social communication and interaction symptom domain. VIQ played a 
significant role in ToM performance for neurotypical children and children with ASD but 
appeared to play a larger role in performance for the children with ASD, suggesting a different 
relationship between ToM and VIQ for children with ASD. My study was able to establish the 
ASD participants’ developmental stage for ToM, a novel finding, and showed that their ToM 
skills were consistently behind those of neurotypical children over the early and middle school 
years. 
Finally, 5-HTTLPR did have an atypical allelic distribution in my ASD sample when 
compared to reported distributions for neurotypical samples, supporting a role for this 
polymorphism and the serotonergic system in ASD. Although my sample sizes were small, I 
found that 5-HTTLPR was associated with overall ASD severity and the restricted and repetitive 
behaviours and interests symptom domain for the non-verbal ASD group, but no associations 
between 5-HTTLPR and ASD-related deficits were found for the verbal ASD group. The verbal 
ASD group also failed to show the predicted relationships between the 5-HTTLPR short allele 
and poor ToM performance. The 5-HTTLPR genotypes added some value to the models 
predicting ToM performance in this group, but the contribution was not significant and the 
relationship between ToM, VIQ and 5-HTTLPR was unclear. This study supported a core role for 
ToM in ASD presentations and showed that 5-HTTLPR and the serotonergic system is 
implicated in specific ASD-related impairment in non-verbal ASD. The possible role of 5-
HTTLPR in verbal children with ASD did not clearly emerge in this study. As with the previous 
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study in this protocol, this suggests that verbal abilities play a significant role in ASD 
presentations.  
This study was limited by a small sample size but benefited from the comprehensive ToM 
assessment that went beyond typical false belief testing. This is also one of very few studies 
internationally to assess for genotype-phenotype relationships for 5-HTTLPR in ASD, and, to my 
knowledge, the first to do so in a South African sample. My findings are discussed in greater 
detail below.  
Theory of Mind Assessment. One of the strengths of my study was the use of a 
comprehensive ToM battery that went beyond false-belief testing and assessed ToM along its 
developmental trajectory. The assessment included pretend play tasks, which assess behaviours 
considered as pre-cursors for later ToM development, and then increased in complexity until the 
final module assessed the child’s ability to understand social faux pas and to differentiate lies 
from jokes using sarcasm. Using this developmental approach, I was able to directly compare 
children with ASD’s performance to neurotypical children’s performance on the same tasks. In 
this way I was able to overcome the limitations of binary pass-fail ToM assessments of false 
belief tasks (Liddle & Nettle, 2006; Peterson et al., 2012), and to establish a ToM developmental 
stage for participants. 
This study also strove to overcome some important confounding variables such as 
culture, cognitive and language difficulties, and age. The comparison to a matched group of 
neurotypical children reduced the effects of cultural factors possibly confounding the assessment 
(Shahaeian et al., 2014). The tasks were also presented in such a way that typical concerns 
regarding cognitive and language functions were minimized: earlier tasks included props or 
comic-like stories so that children could point to answers if they did not wish to speak, and the 
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instructions and story details were simplistic so that language difficulties did not undermine 
understanding; story tasks included pictures that were left in view to limit the load on working 
memory; and tasks were short and again the use of visual stimuli prevented memory difficulties 
from confounding the results. I also screened all verbal children prior to ToM testing to ensure 
they could follow at least two-stage instructions and ensured the instructions did not exceed this. 
Further, VIQ was assessed and included in all analyses for ToM performance. Finally, age was 
included in the calculation of ToM percentile scores and included in analyses.  
In terms of ecological validity, my tests were conducted in a one-on-one assessment 
format, and although the tasks were game or story-based, they did still face the limitations of 
being more simplistic than real-world scenarios relying on ToM skills (Hutchins et al., 2012; 
Scheeren et al., 2013; Senju, 2012). When this concern is raised in the literature, however, the 
concern is that ToM tasks overestimate children with ASD’s true capabilities. If this is the case, 
then it only serves to reinforce my finding that children with ASD had significant ToM deficits 
compared to matched neurotypical children who completed the same tasks. 
Theory of Mind deficits in ASD. My study found that children with ASD tended to 
struggle with ToM tasks a module behind the matched neurotypical children, indicating a 
significant delay in ToM development. My results support the known correlation between VIQ 
and ToM in both ASD and neurotypical samples but found that this association may differ 
between the groups as VIQ appeared to play a larger role in ToM performance in the current 
ASD sample (see Chapter 4: The Theory of Mind Study - Results – Question1, Hyp. 1.1, 
pg.158). 
I compared the performance of my ASD sample with a matched neurotypical sample on 
the same ToM battery and found that the children with ASD were at least one module behind 
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neurotypical children of the same age. While the ages at which children progressively develop 
ToM can differ across countries (Liu et al. 2008), the children in my study had similar 
demographics so their differences in performance are more likely associated with the presence 
(or absence) of ASD. 
For example, the neurotypical children in the 6-7 year age band in my study could 
complete the Basic Module (tasks generally achieved at 3-5 years old) and were developing the 
ability to complete the Intermediate Module (tasks generally achieved at 5-7 years old). This 
indicated that the neurotypical children’s ToM was in keeping with the generally reported 
developmental stage for their age in the literature. By contrast, the children with ASD in this age 
band could only complete tasks of ToM precursors (Early Module), but they struggled with tasks 
in the Basic Module. This suggests that these children with ASD had only developed the ToM 
skills neurotypical children generally master by age 5 years. 
A similar pattern was seen for the older samples (i.e. the 8-10 year age band and 11+ year 
age band). The neurotypical samples for these two age bands performed as the literature 
predicted and were able to complete the Intermediate Module (tasks generally achieved 5-7 years 
old) and were developing the ability to complete the Advanced Module (tasks generally achieved 
9-11 years old). The ASD samples in these age bands were able to complete the Basic Module 
but struggled with the Intermediate Module. These two ASD age bands showed very similar 
performance, indicating little developmental difference.  
It was also noted that there was less variance in performance for the neurotypical sample 
as they got older, whereas the ASD group showed greater variance in scoring in the older age 
bands. This could suggest that while neurotypical children are developing their skills and 
ultimately “catch up” with each other, the delays seen in ASD are variable and as children age 
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and the expectations regarding their abilities are raised, their deficits become more apparent. This 
finding of variable degrees of delay is in keeping with Hoogenhout and Malcolm-Smith (2014) 
finding of both plateaued and delayed ToM development in a local ASD sample. However, they 
found that the difference was associated with IQ, as plateaued development was seen in the 
children classified as having low functioning ASD vs. delayed development in those with high 
functioning ASD. Other studies are mixed, as some also noted ToM development as delayed 
rather than having plateaued in higher functioning ASD samples (Paynter & Peterson, 2010) 
while others found their performance was comparable to neurotypical peers (Scheeren et al., 
2013). As I did not classify level of functioning in the current sample, I cannot directly compare 
my results with this literature. However, given the variability in ToM performance in the later 
age bands, I think that the older children with a more severe deficit in ToM performance could 
perhaps indicate plateaued development, while the others may represent delayed development. I 
have established the developmental degree to which participants with ASD were delayed 
compared to their neurotypical peers in regard to ToM development. If future research utilised 
the same approach and conducted further developmental tracking, we could see points where, 
and to what degree, ToM development would stop, accelerate, or “catch up” for these children.  
ToM performance in ASD is variable, as some children have greater deficits than others, 
so age norms are not available (Hoogenhout & Malcolm-Smith, 2014). It has been reported that 
children with ASD require a verbal mental age of 11 years and older in order to pass first-order 
false belief tasks (Happe, 1995). The majority of the current ASD sample showed VIQ deficits, 
indicating lower verbal mental age than chronological age, but some of these children were able 
to complete first-order false belief tasks, which is not in keeping with Happe’s (1995) findings. 
The verbal ASD sample showed reduced VIQ compared to the neurotypical group, but their 
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mean score was 85. This score is not considered a great deficit in the South African context as 
tests were normed and developed for Western cultures and tend to under-estimate true IQ in local 
children (Lynn & Meisenberg, 2010; Wicherts et al., 2010). 
The role of VIQ in ToM performance was particularly important in this study. VIQ was a 
stronger predictor of ToM performance than either age or SES for both samples. The 
neurotypical sample had a mean VIQ in the high average range, and the ASD sample had a mean 
VIQ in the low average range. It is noted that I only included children who were able to pass 
two-stage commands and were verbally fluent, so children with more severe language deficits 
were excluded from this aspect of the study. VIQ did not fully account for the ToM deficits seen 
in the current ASD sample, however, as the level of deficits in ToM appeared more severe than 
their slightly reduced VIQ abilities.  
Although VIQ did not fully explain the ToM deficits in the current ASD sample, it did 
play a significant role in ToM performance. The ASD group showed a different correlation 
pattern between VIQ and ToM than the neurotypical sample, perhaps suggesting a greater role 
for VIQ in ToM performance in the ASD group compared to the neurotypical group. The ASD 
sample also had a larger standardised beta value for VIQ in a regression model predicting ToM 
performance, and the model had a larger effect size for the ASD group, confirming VIQ had a 
greater association with ToM for this group. Happe (1995) argued that children with ASD may be 
more reliant on language skills during ToM testing as they use language structure and knowledge 
to help solve ToM problems in the absence of fully developed ToM abilities. In the current 
sample, the association between VIQ and ToM in the ASD groups supports the notion of VIQ as 
a protective factor in ToM development.  
Theory of Mind deficits and ASD-Related Deficits 
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I found significant relationships between ToM deficits and overall ASD severity, as well 
as ToM deficits and deficits in social functioning as assessed by the ADOS2 Social Affect 
scoring domain which focuses on symptoms in the social communication and interaction 
domain. This is in keeping with the literature that supports a role for ToM in ASD deficits, and 
specifically in social deficits in this disorder. The association between ToM and ADOS2 
Comparison scores was stronger than the association between ToM and ADOS2 Social Affect 
score, and was not significant for ADOS2 RRB scores (i.e. symptoms in the restricted and 
repetitive behaviours and interests domain); this pattern indicates that ToM is directly linked to 
social deficits in ASD rather than those in the restricted and repetitive behaviours and interests 
symptom domain, but that the relationship to overall ASD severity went beyond this link to 
social deficits (see Chapter 4: The Theory of Mind Study – Results – Question 2, pg. 166).  
I found an association between ToM ability and reduced overall ASD severity as 
indicated by the ADOS2 Comparison score when VIQ was controlled for. I used the ADOS2 to 
rate ASD-related deficits, which is a gold-standard for ASD diagnostics, and adds support to the 
existing literature using other measures. Lerner et al. (2011) found associations between ToM 
deficits and overall scores of ASD-related deficits measured by the Social Communication 
Questionnaire, Social Skills Rating System – Parent, and Social Responsiveness Scale (SRS). 
The relationship between ASD-severity and ToM ability has therefore been found across several 
measures. 
The association in the current sample between ToM ability and lower scores on the 
ADOS2 Social Affect domain, and the absence of a relationship between ToM and ADOS2 RRB 
scores, indicates that ToM specifically has a greater role in social deficits in ASD than in 
restricted and repetitive behaviours and interests. This specific association has been found 
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previously in the literature. Fombonne et al. (1994) found an association between better ToM 
skills and reduced maladaptive behaviours as assessed by the VABS. Frith et al. (1994) expanded 
the VABS to differentiate between social behaviours that required ToM abilities and those that 
did not and found that children who could pass false belief tasks had better communicative 
abilities; they also found that only the children who passed these tasks displayed the ability to 
have insightful interactions.  
While the current study supports the literature above, it does not support the findings of 
Joseph and Tager-Flusberg (2004), who found that ToM ability did not explain the variance of 
ASD-related deficits in either the social domain or the symptom domain of restricted and 
repetitive behaviours and interests. Our studies had considerable similarities: we both used the 
ADOS/ADOS2 to rate ASD-related deficits; my ToM battery included all three of the false belief 
tasks they used, although my battery was more comprehensive; and both study samples had 
VIQs in the low average range. Both study samples were also predominantly male children: my 
study sample constituted 51 children who were all male, and their sample had 31 participants, 
only four of which were female. Our studies were therefore highly comparable, and yet I found 
contrasting results. In their study they initially found a correlation between ToM and ADOS 
scores, but this was not significant when language ability was controlled for. The similar VIQs 
across the studies indicate that language capability does not explain the different results. One 
possible factor that might explain the differences in our findings then is that my study had a 
slightly older sample, with a mean age of 10 years 3 months while theirs was 8 years 9 months. I 
did however control for age in my analyses, which would limit the effect of this difference. It is 
therefore more likely that the association between ToM and ASD-related deficits emerged in my 
study because my ToM battery encompassed a wider set of tasks, I controlled for age in the ToM 
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scoring, and because my sample’s wider age range allowed a better overview of ToM 
development in childhood.  
This study therefore suggests that ToM capability in ASD is related to better outcomes in 
both overall severity as well as in the social domain specifically. ToM deficits are consistently 
noted in ASD samples. Targeting ToM deficits in ASD for intervention could therefore lead to 
improvements in social deficits in ASD, as well as other areas resulting in a decreased overall 
ASD severity.  
A Possible Role for 5-HTTLPR in ASD-Related Deficits and ToM Deficits  
My ASD sample showed a higher incidence of the short allele for 5-HTTLR than 
reported in the literature, supporting the hypothesis that this polymorphism may be, at least in 
part, responsible for atypical serotonergic transmission in ASD. This polymorphism is implicated 
in overall ASD severity and level of deficit in the ADOS2 RRB symptom domain for the current 
non-verbal ASD sample, although not for the verbal ASD sample. The 5-HTTLPR genotypes 
were also not clearly associated with ToM performance in the verbal ASD sample. This 
difference between ASD groups was not anticipated and was limited by the small sample sizes. 
A future study might examine whether these group differences could be replicated, ideally with 
equal group sizes and a more comprehensive assessment of language ability beyond my 
categorical grouping. This novel finding has considerable implications for our current application 
of research findings to non-verbal children with ASD, who are generally under-represented in the 
literature, as our findings for verbal children with ASD may not generalise to this group. 
Allelic Distribution of 5-HTTLPR in ASD. My study found a similar 5-HTTLPR allelic 
distribution for this cohort of male children with ASD to what was noted in a previous local 
study with a different ASD sample (Arieff et al., 2010), and a higher rate of the short allele than 
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the reported rate for neurotypical South Africans (Esau et al., 2008). In my sample of 73 male 
children with ASD I found an incidence of .38 of the short allele, with 13.70% of the total ASD 
sample carrying the S/S genotype. When I divided the sample according to verbal ability, the 
non-verbal ASD group had an incidence rate of .31 for the short allele and 5.88% of this sample 
carried the S/S genotype, while the verbal ASD group had an incidence rate of .44 for the short 
allele and 20.51% of this sample carried the S/S genotype.  
Previous research showed local ASD samples had an incidence rate for the short allele 
of .39 (Arieff et al., 2010) and .46 (Hamilton, 2014), and in these samples the S/S genotype was 
present in 25-30% of cases. The current full ASD sample therefore showed a similar incidence 
rate for the short allele for 5-HTTLPR, but a lower incidence of the S/S genotype. The non-
verbal ASD group showed the lowest incidence rate of the short allele, while the verbal ASD 
group had an incidence of the short allele and the S/S genotype similar to those previously 
reported for ASD samples locally.  
The ethnic breakdown of my study can be compared to that of the Arieff et al. (2010) 
local study with an ASD sample. Our studies had similar rates of Caucasian participants and 
these subsamples showed similar prevalence of the short allele for 5-HTTLPR: my study was 
34% Caucasian with an allelic rate of 0.42 for the short allele compared to their sample at 37% 
Caucasian with an allelic rate of 0.49. I also had similar rates for the mixed race participants: my 
study constituted 52% mixed race participants with an allelic rate of 0.36 for the short allele 
compared to their sample at 44% mixed race participants with an allelic rate 0.33. Our samples 
differed in terms of African participants, however, as my sample only had 8% African 
participants compared to their 19%. This could explain, at least in part, our lower prevalence for 
the short allele, as my African participants had an allelic frequency of 0.25 for the short allele 
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compared to the Arieff et al. (2010) prevalence of 0.36, suggesting differences may have partly 
been driven by my sample underrepresenting participants of African descent. However, my 
sample was male, while theirs was mixed sex.  
These values can therefore be seen as a baseline for the local male ASD population. 
When compared to a study with a neurotypical South African sample (Esau et al., 2008), I note 
that my ASD sample had a far higher prevalence of the short allele for the African (0.25) and 
mixed race / “mixed” (0.36) samples compared to the rates in their study (0.16 and 0.14 
respectively). The Caucasian samples, however, showed a far slighter disparity: neurotypical rate 
of 0.39 (Esau et al., 2008), compared to my ASD sample at 0.42 and the previous rate of 0.49 
samples (Arieff et al., 2010). Previous international studies with Caucasian samples have found 
similarly high rates of the short allele (for a review see Esau et al. (2008)). It therefore appears 
that the allelic rate of the short allele may not differ between neurotypical and ASD Caucasian 
samples.  
The picture is more mixed when we look at the S/S genotype specifically, showing no 
clear pattern across ethnicities in local samples. For African samples, I had no incidence of this 
genotype, another local ASD sample found this genotype in 33% of their African participants 
(Arieff et al., 2010), and a local neurotypical sample had no incidence of this genotype (Esau et 
al., 2008). For the mixed race samples, I had a prevalence of 13.16% for this genotype, the other 
local ASD sample found this genotype in 20.83% of their mixed race participants (Arieff et al., 
2010), and the local neurotypical sample had an incidence of 2.81% for this genotype (Esau et 
al., 2008). The rates for the Caucasian subsamples were similarly mixed, at 16% for my sample, 
40% for the other ASD sample (Arieff et al., 2010), and 11% for the neurotypical sample (Esau 
et al., 2008). 
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It therefore appears that the allelic rate for the short allele for 5-HTTLPR is higher in 
ASD samples for African and mixed race participants compared to neurotypical samples, but not 
for Caucasian samples. This indicates that if 5-HTTLPR is implicated in male children with 
ASD, this may be limited to ethnicities other than Caucasians. The incidence of the S/S genotype 
does not appear to show a pattern across ethnicities and between ASD and neurotypical samples. 
However, as ethnicity was not considered in recruitment, I did not have adequate or balanced 
representation for each ethnic group, so these results must be interpreted with caution. Ideally 
later studies would consider better representation of ethnic groups, especially when looking for 
genotype-phenotype relationships. 
The Role of 5-HTTLPR in ASD-Related Deficits. When I assessed ASD-related 
deficits as rated by the ADOS2 assessment across 5-HTTLPR genotypes, I only found 
relationships for the non-verbal sample. For the non-verbal ASD group I found that the S/S 
genotype was associated with greater deficits in ADOS2 Comparison scores, indicating overall 
ASD severity, and with greater deficits in ADOS2 RRB scores, indicating impairment in the 
restricted and repetitive behaviours domain. Genotype-phenotype studies for 5-HTTLPR and 
ASD are very limited, and to my knowledge only two studies have been published. These 
studies, however, disagreed on the role of the short allele in the ASD phenotype: Brune et al. 
(2006) were unable to replicate Tordjman et al. (2001) and Brune et al. (2006) studies Tordjman 
et al. (2001) finding of an association between the short allele and ASD severity. My study found 
strong evidence for this association, and also suggests a different role for 5-HTTLPR in non-
verbal ASD vs. verbal ASD, at least for male children, which was also suggested by Brune et al. 
(2006). 
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Associations Between 5-HTTLPR and ASD-Related Deficits. My study found that 5-
HTTLPR was only related to deficits in the non-verbal participants, and these associations were 
between the S/S genotype and ADOS2 Comparison scores and between the S/S genotype and 
ADOS2 RRB scores. This indicates that while 5-HTTLPR is linked to language in some way (as 
associations were not noted in the verbal ASD group), the actual role of this polymorphism 
appears to be implicated in overall ASD severity and in the restricted and repetitive behaviours 
and interest domain rather than the social interaction and communication domain in this study. 
These associations also indicate a dominant effect for the long allele, as it was the S/S genotype 
that was associated with deficits rather than the short allele specifically.  
One of the strengths of my study design was the use of MRA to assess the role of the 5-
HTTLPR genotypes. The Tordjman et al. (2001) and Brune et al. (2006) studies both merged the 
two genotypes with short alleles (i.e. S/S genotype and L/S genotype) into a reduced transmission 
group for comparison to the L/L genotype group, which would only reveal group differences if 
the short allele had a dominant effect. I used dummy coding for the genotypes in the MRA 
models so I could assess for a dominant effect for either allele. I found that the S/S genotype, 
rather than the short allele, was associated with deficits in the non-verbal ASD group. This 
suggests that it could be possible that the merging of groups used in the Tordjman et al. (2001) 
and Brune et al. (2006) studies may have masked genotype-phenotype relationships, although 
their data did justify this grouping as it suggested a dominant effect for the short allele. My study 
suggests that non-verbal children who are homogenous for the short allele are likely to have 
greater deficits than those who carry even a single long allele.  
Association Between 5-HTTLPR and Non-Verbal Aspects of ASD. Another strength of 
my study was the division of the ASD sample according to verbal ability, as this revealed that 
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ASD-related deficits were only associated with 5-HTTLPR in the non-verbal ASD group. 
Although it is not clearly stated, it appears that both the previous studies recruited children with 
ASD regardless of language ability, and therefore were likely to have included a mix of non-
verbal and verbal children. The proportion of non-verbal children included in their studies, as 
well as the genotype-phenotype analyses per group, was not reported, making direct comparisons 
less useful.  
It is of interest, however, that although the Brune et al. (2006) group did not find an 
association between 5-HTTLPR and overall ASD severity, they did find a specific association 
between the short allele and non-verbal aspects of social interaction, specifically for impairment 
in the “failure to use non-verbal communication to regulate social interaction” domain of the 
ADI-R. In this analysis, a comparison between their study and mine is again limited as they 
merged the L/S genotype and S/S genotype groups, while I found specific associations only for 
the S/S genotype group, and only for the non-verbal ASD sample. However, both studies do 
support a role for the short allele in non-verbal aspects of ASD. While the Brune et al. (2006) 
study suggested a role in general for non-verbal aspects of ASD, my study clarifies and expands 
on this notion by suggesting a role for the short allele for individuals with ASD who are non-
verbal, and that this association is for the restricted and repetitive behaviours and interests 
domain. 
I did not find any associations between the L/L genotypes and ASD-related deficits. In 
contrast, the Brune et al. (2006) study found associations for the L/L genotype and “stereotyped 
and repetitive motor mannerism” on the ADI-R, and for the ADOS scores for “failure to direct 
facial expressions” and unusual sensory interests. This is in contrast to my study, as these scores 
would fall under the ADOS2 RRB score, which was associated with the S/S genotype in my 
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sample. I did not assess specific ADOS2 questions across genotypes, but rather looked at the 
overall scores (to limit type one error), so I cannot say which specific ADOS2 scores would be 
associated with 5-HTTLPR. However, based on the associations I found to the S/S genotype, and 
the absence of specific relationships to the L/L genotype, I do not believe I would have replicated 
their findings if I did assess specific ADOS2 questions rather than overall scores.  
My study therefore adds to the existing body of genotype-phenotype studies for ASD and 
5-HTTLPR. It indicates a potential role for this genotype in non-verbal ASD, and that this role is 
seen in an association between the S/S genotype and overall ASD severity as well as in the 
restricted and repetitive behaviours and interests domain. Previous studies assumed a dominant 
role for the short allele and grouped all short allele carriers into one group (i.e. S/S and L/S 
genotypes were merged), whereas my study allowed for either allele to be dominant, and the 
importance of the S/S genotype, rather than the short allele, emerged. It is noted, however, that 
the S/S genotype did not appear to be more prevalent in the ASD group compared to reported 
rates for neurotypical samples. My results therefore suggest that although the S/S genotype may 
not be more prevalent in ASD samples, when it is present it has implications for the ASD 
phenotype that emerges.  
A further study should be conducted that does not assume a dominant role for either allele 
and that assesses for a qualitative difference in ASD based on language ability in order to clarify 
this. If my findings are replicated, it indicates that the serotonergic system should be targeted 
when a patient is non-verbal, and when they present with deficits in the restricted and repetitive 
behaviours and interests domain.  
The Role of 5-HTTLPR in ToM. In my study, male verbal children with ASD who 
carried at least one short allele presented with lower ToM scores compared to those without short 
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alleles, as expected. However, each genotype showed high variability in ToM scores so the exact 
nature of this association needs to be further explored to consider other mediating variables. In 
regression analyses, the 5-HTTLPR genotypes were not significant predictors over and above 
VIQ despite increasing the strength of the model. It would appear then that 5-HTTLPR is not 
directly related to ToM ability in ASD, and if there is a relationship, there are further variables 
involved in this association that I did not identify. As the previous analyses showed no 
relationship between ADOS2 scores and 5-HTTLPR for the verbal ASD group, this further 
supports the hypothesis that in boys, if 5-HTTLPR plays a role for verbal children with ASD, it 
is a different role compared to that in non-verbal children with ASD.  
VIQ was strongly associated with ToM in my sample and was the only significant 
predictor in my MRA model for ToM which included age, SES, and 5-HTTLPR genotypes as 
predictors. Including the genotypes in the model strengthened it, although the exact role of these 
genotypes was not clearly evident. Neither ToM nor VIQ correlated with 5-HTTLPR genotypes, 
and they showed different patterns across the genotypes: VIQ was highest for the S/S genotype 
group while the L/S genotype and L/L genotype showed similar scores; ToM scores were highest 
for the L/L genotype group, with the S/S genotype group scoring approximately midway between 
the L/L genotype group and L/S genotype. Therefore, although the children carrying short alleles 
performed poorly on ToM tasks, those with only one short allele performed worse than those 
with two short alleles, and there was no clear dominant effect for either allele for ToM scores in 
this study.  
Previous studies found associations between poor serotonin binding and ToM skills in 
ASD samples (Murphy et al., 2006; Nakamura et al., 2010). My results did not support the 
hypothesis that 5-HTTLPR plays a role in the relationship between serotonin and ToM 
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performance, but perhaps other aspects of the system do – such as the 5-HT2A receptor 
researched by Murphy et al. (2006). It is also worth noting that while my study recruited children 
with ASD, these two previous studies recruited adult males, and one must be cautious when 
comparing a developing brain to that of an adult. Further, Murphy et al. (2006) had a small 
sample of only 8 men, and they assessed ToM indirectly by analysing ADI-R scores for 
reciprocal social interactions and stating that these skills were reliant on ToM abilities; the actual 
association to ToM is therefore less clear. The association between serotonin and ToM in the 
Nakamura et al. (2010) study was to performance on faux pas tasks. My sample was younger and 
were developmentally further behind in their ToM development than their neurotypical peers, so 
they were unable to complete social faux pas tasks. It is perhaps possible then that serotonin’s 
relationship to ToM changes between childhood and adulthood, and is then evident on more 
advanced ToM tasks. A longitudinal study or cohort which included children and adults with 
ASD is required to clarify if 5-HTTLPR’s possible role in ToM changes across development, or 
whether 5-HTTLPR is not included in the aspects of the serotonergic system that are implicated 
in ToM processing.  
Summary of the Theory of Mind Study 
The Theory of Mind Study showed that ToM was associated with ASD-related deficits in 
a male verbal ASD sample, and that the relationship between VIQ and ToM in ASD is different 
to that in neurotypical samples, potentially indicating that VIQ provides alternate means to 
complete ToM tasks for children with ASD. I found that the short allele for 5-HTTLPR had a 
higher prevalence in my ASD sample compared to reported rates for neurotypical samples. There 
was not an obviously higher rate of the S/S genotype specifically, but the S/S genotype did still 
appear to influence ASD phenotypes. The S/S genotype had an association with overall ASD 
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severity and with deficits in the restricted and repetitive behaviours and interest domain for non-
verbal children with ASD, but not for verbal children with ASD. The role of 5-HTTLPR in 
verbal children with ASD was not elucidated in this study, and although an association between 
5-HTTLPR, VIQ, and ToM did not emerge in my sample, the contribution 5-HTTLPR made to 
the MRA model predicting ToM performance suggests it may have a role that did not emerge 
due to unconsidered variables. ToM and serotonin are therefore both important aspects of ASD 
that should be considered during diagnostics and treatments. Targeting ToM deficits for 
intervention could result in decreasing other ASD-related deficits, and regulating serotonergic 
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Chapter 5: General Discussion 
The aim of this protocol was to assess for genotype-phenotype relationships in ASD, and 
to illustrate an approach that merged existing knowledge from psychological and medical / 
genetic research. Genome wide association studies are becoming the widely preferred approach 
in ASD genetic research and are revealing interesting findings regarding the genetic 
underpinning of ASD. These types of studies allow for comprehensive assessment of the human 
genome that reveal novel targets not yet identified by other investigations, and can identify 
linkages and interactions between genes that candidate genes cannot. However, I believe that 
these kinds of studies can be coupled with hypothesis-driven candidate gene approaches such as 
mine, as this may allow existing psychological knowledge regarding ASD to be paired with our 
expanding genetic understanding of this disorder. I propose that the historical contribution from 
psychological research, and how this has aided our understanding of how ASD unfolds across 
development, can continue to provide valuable insight into the underlying genetic mechanisms 
for ASD if we also pair strong psychological theories with selected ASD candidate genes in 
research. Using this approach, I focused on the role of reduced social motivation and ToM 
deficits in the overall ASD phenotype, and explored whether two ASD candidate genes, OPRM1 
and 5-HTTLPR, were implicated in the ASD phenotype and in impairment in these two areas 
respectively.  
From the time ASD was first recognised as a unique disorder, we have relied on 
psychological theories to deepen our understanding of this complex disorder. Recently there has 
been a surge in genetic studies in ASD, where researchers hope to identify key genes that underly 
the core phenotypic traits in ASD in an endeavour to elucidate the neurobiological mechanisms 
contributing to this disorder. Although there are studies which aim to expose the genetic basis for 
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specific ASD phenotypes and clinical variance, these studies have tended to do so without 
including psychological theory in their approaches. Similarly, psychological theories for ASD 
often implicate genetic contributors, but either do not empirically assess the genetic aspects of 
their claims or limit their research to animal studies. This separation of fields has resulted in a 
somewhat fragmented understanding of the causes and development of ASD. This greatly limits 
our understanding of the neurobiological basis of this disorder, which may hamper the efficacy 
of medical and psychological interventions. Drawing on the contributions from psychological 
and genetic research, and furthering research by combining these fields, we may be better 
positioned to identify contributing factors to ASD, and their role in the development of different 
phenotypes. Understanding the neurobiological basis of the core deficits within the context of 
psychological theory may provide the opportunity to design targeted biological and 
psychological interventions within developmentally appropriate windows.  
The findings of each study have been presented in detail in the empirical chapters, but are 
briefly discussed below, with a focus on their overall implications. This is followed by a 
discussion of methodological considerations in this protocol and for future research.  
The Social Motivation Study  
The Social Motivation Study is unique in how it examined the three main tenet’s of 
Panksepp’s (1979) Social Motivation Theory for its role in ASD directly in a sample of male 
children with ASD. I found significantly decreased levels of social motivation in the ASD sample 
compared to the neurotypical sample and found associations between reduced social motivation 
and deficits in the social communication and interaction domain for the non-verbal ASD group. 
The absence of this relationship in the verbal ASD group suggests a further relationship between 
language acquisition or development and social motivation. Panksepp (1979) proposed that the 
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relationship between reduced social motivation and social impairment in ASD could extend to 
atypical language development, but this hypothesis remained relatively unexplored. The Social 
Motivation Study presented here supported this theory and led me to propose that Panksepp’s 
(1979) theory could possibly be expanded to include a threshold effect for the impact of reduced 
social motivation on social development in male children with ASD. I propose that male children 
with more severely reduced social motivation experience, more severe deficits in social 
competence and that this may prevent or undermine language development, while those with less 
impairment to their social motivation are able to develop language more easily. Further, I 
propose that once language had developed, these children have a relative advantage, as other 
social and cognitive domains are then better able to develop - this then reduces the long term 
impact of their early deficits in social motivation.  
Language is developed socially, with social interest and social interaction being strongly 
tied to language development (Kuhl, 2010). A literature review on non-verbal children with ASD 
by Tager-Flusberg and Kasari (2013) noted that these children tended to have severely reduced 
social motivation. Kintwall et al. (2014) found that reduced social motivation was associated 
with greater language deficits. This literature suggests that the difference in social motivation 
scores between the two ASD samples in the current study are, at least in part, related to their 
language abilities as suspected. As expressive language is one of the strongest predictors of ASD 
outcome (Szatmari et al., 2003), this relationship between reduced social motivation and poor 
language abilities remains important when considering ASD interventions. And, as there are 
associations between verbal communication skills and cognitive abilities (Kjellmer et al., 2012), 
this could further support the hypothesis that if social motivation is reduced but not sufficiently 
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so to meet a proposed threshold (i.e. the child has less severely reduced social motivation that 
does not prevent language development), then other cognitive domains are better able to develop.  
This study also supported a role for altered mu-opioid processes in ASD and reported that 
children with ASD in this study had an unprecedentedly high prevalence of the OPRM1 G allele. 
This meant that statistical exploration of the possible link between this allele and reduced social 
motivation was not possible. However, I note that all of the non-verbal ASD participants carried 
at least one of the G alleles, and the two non-carriers in the verbal ASD group lacked significant 
reductions in social motivation (Chapter 3: The Social Motivation Study - Results – Question 3, 
Hyp. 3.3, pg. 102).   
The suggested threshold effect for the role of reduced social motivation in ASD has 
important implications for the management of ASD. If early targeting of reduced social 
motivation could prevent this low social interest from meeting the proposed threshold, this could 
have a lasting impact on a child’s development. If lowered social motivation can be targeted and 
levels increased, perhaps language may be better able to develop and remaining social 
motivation difficulties have less of an impact on a child’s psychosocial development. Elevated 
mu-opioids levels are easily treated with medications such as naltrexone, and research already 
exists that shows that naltrexone administration has a possible ameliorating effect on ASD 
symptoms (Bouvard et al., 1995; Herman et al., 1987). Interventions also exist that specifically 
target social interest in ASD, such as the Early Start Denver Model (ESDM) which teaches 
parents to use the child’s non-social interests as a way to engage socially (Dawson et al., 2010; 
Estes et al., 2015). Perhaps then, toddlers with suspected ASD could be assessed for mu-opioid 
levels or OPRM1 genotypes, and psychological interventions to increase their social motivation 
could be coupled with appropriate medications. The hope would be that this combined approach 
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could diminish the long-term effects of reduced social motivation and decrease the severity of 
symptoms in the social communication and interaction domain. This, however, is speculative at 
this point, but it is an area of research that may be promising and replication studies regarding 
the proposed threshold effect are required.  
Limitations and Future Directions 
The Social Motivation Study was exploratory in nature, and the findings here should be 
confirmed in replication studies that also address the limitations this study faced. Limitations 
specific to this study are discussed here, while overarching limitations for the entire protocol are 
discussed toward the end of this chapter. 
I assessed social motivation indirectly through parent interviews. I used attachment 
behaviours as a proxy for level of social motivation and used a measure that looked at a child’s 
response to feelings about social interactions and separations. Measuring attachment beyond 
infancy can be controversial as social behaviours become far more complex in childhood and 
adolescence when compared to those of early infancy (Dwyer, 2005). However, as I was not 
assessing true attachment, but rather indicators of social interest and pleasure, this debate is of 
lesser concern in the context of this particular study. The attachment measure in this study 
assessed whether children sought out social interaction, as well as how they responded to others 
initiating this contact. The responses that indicated secure attachment were those that showed a 
child sought interaction, enjoyed this engagement, and responded well when others initiated it. 
These are suggested indicators of positive social motivation, just as low scores would indicate 
poor social motivation. Further, as these responses were based on the general pattern of the 
child’s behaviour over time, I believe they can give a robust indication of the child’s general 
level of social motivation.  
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The use of the ASCQ as the attachment measure also had the advantage of being 
developmentally appropriate across the lifespan. This measure relied on parent report, which is 
always open to some bias, but avoided the limitations of a strange situation test (i.e. this test is 
not appropriate for older children and novel situations can be anxiety provoking for children with 
ASD). Ideally a measure of social motivation should be developed that can be administered in 
human samples that assesses the level of social interest behaviourally, emotionally, and 
cognitively. To my knowledge, two such measures have recently been developed with ASD 
samples (Elias & White, 2019; Schapp, 2016). These were only published after the current study 
had already been conceptualised and data collection had commenced, but their release indicates a 
growing interest in assessing social motivation in ASD samples. However, considerations will 
still need to be made to ensure that non-verbal children are not unfairly graded on such measures, 
and a measure that can be utilised without reliance on self-report is needed. 
I included children with a range of symptom severities, including those with little to no 
language. The inclusion of these children showed the importance of language ability when 
considering phenotypic research, as associations between genotypes and variables of interest 
differed between the non-verbal ASD and the verbal ASD groups. However, in the context of the 
Social Motivation Theory Study, the evidence for a relationship between language acquisition 
and social motivation was limited by my binary categorisation of language ability into verbal 
(i.e. fluent expressive speech) and non-verbal. 
Due to methodological considerations of the second study, which required fluent 
language for ToM assessment, I grouped children based on whether they were fluent or not. 
Although a standard definition of “non-verbal” does not exist in the literature (Tager-Flusberg & 
Kasari, 2013), research tends to include fully verbal children at the cost of “the rest”. This results 
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in a pragmatic approach in research where participants are either fully verbal and able to 
complete most research measures, or are not fluent and fall into the non-verbal categorisation. I 
followed the same categorisation to ensure non-verbal children were included where possible. 
However, due to the low inclusion rates of non-verbal ASD children in existing research, I had 
no reason to anticipate different genotype-phenotype relationships between the groups, and 
therefore did not include a better, more nuanced, assessment of language ability. This binary 
characterisation of language ability as either “non-verbal” or “verbal” in the current study limits 
our understanding of the extent of the relationship between language and social motivation, and 
later studies should consider more comprehensive language assessments. Where possible a 
continuous measure of language ability alongside a continuous measure of social motivation 
should be utilised. Such a study would reveal what level, if any, of social motivation is critical 
for language development, and the degree to which the two are related.  
While a large focus of this study was the genetic role of the OPRM1 genotypes in the 
ASD phenotype, unanticipated findings did not allow me to conduct the statistical analyses 
originally proposed. The exceptionally low rate of the A allele meant that statistical analyses to 
investigate possible associations between the OPRM1 G allele and phenotypic traits could not be 
conducted on the current sample. I had anticipated a higher rate of the G allele in my ASD 
samples compared to those reported for neurotypical samples, but as the highest previously 
reported prevalence of this allele for neurotypical samples was .35 (A. C. Chen et al., 2013; Way 
et al., 2009; Wei et al., 2017), I could not have foreseen that only two of my participants would 
not carry the G allele. The high rate of the G allele was a novel finding that needs to be replicated 
in other ASD samples.  
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 221 
The unprecedentedly high rate of the OPRM1 G allele requires that future studies have 
larger and more diverse samples sizes to get a higher representation of non-carriers of this allele. 
However, studies should include non-ASD samples to avoid this underrepresentation of the A 
allele. For these studies, I would suggest merging children with ASD and without ASD into a 
single group and measuring ASD-related traits / tendencies and social motivation on a 
continuous scale. As Panksepp (1979) proposed these relationships exist in all humans, and that 
children with ASD represented the extreme in regard to social motivation difficulties, such a 
study could allow for an overall picture of how social motivation deficits may be in part 
underpinned by alteration in OPRM1 alleles and genotypes. The inclusion of mixed samples will 
also allow a direct comparison of OPRM1 rates between ASD samples and neurotypical samples 
with similar genetic heritage.  
The Theory of Mind Study  
The Theory of Mind Study explored the phenotypical role of ToM deficits in male 
children with ASD, and the possible role of the 5-HTTLPR genotypes in ToM deficits and the 
ASD phenotype. I found that male children with ASD were typically at least one developmental 
stage behind neurotypical children in their ToM development, and that VIQ may play a larger 
role in ToM performance for the children with ASD. As expected, ToM ability was associated 
with symptoms in the social communication and interaction domain over and above the influence 
of VIQ, age, and SES. The role of 5-HTTLPR in ASD was not what I hypothesised: I found an 
association between the 5-HTTLPR short allele and symptoms associated with the restricted and 
repetitive behaviours and interests symptom domain rather than the social communication and 
interaction domain, and only found this association for the non-verbal ASD group. No 
associations between 5-HTTLPR and ToM emerged, nor between 5-HTTLPR and ASD 
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symptoms in the verbal ASD group. This genotype is therefore unlikely to play a major role in 
the ToM Theory for ASD, although it may be implicated in other aspects of this disorder.  
The link between ToM and social competence suggests that targeting ToM deficits for 
intervention could have long lasting positive effects on social deficits in ASD. The role of VIQ 
must also be kept in mind and interventions should consider this domain as well, as 
strengthening VIQ skills may further assist in acquiring ToM capabilities. As mentioned 
previously, my study was limited to male children, and language and social development may be 
different in female children (Kuhl, 2010). 
By contrast, 5-HTTLPR may play in a role in the second symptom domain, namely 
symptoms under the restricted and repetitive behaviours and interest domain. Previous studies 
have had mixed findings for the use of SSRIs for treatment of symptoms in this domain: some 
found improvements in this symptom domain (Hollander et al., 2005; Namerow et al., 2003), 
while others did not (King et al., 2009). An alternative approach to treatments might include a 
targeted strategy based on genotyping as well as phenotyping, and an association between 5-
HTTLPR genotypes and treatment responses could emerge. Given the diverse presentations 
associated with ASD, being able to identify which children would most benefit from each 
possible treatment could be beneficial.  
Limitations and Future Directions 
The Theory of Mind Study used a comprehensive ToM assessment, but this meant the 
exclusion of the non-verbal participants from the ToM assessment. Although it would have been 
possible to conduct non-verbal ToM tasks, many of these tests are considered simplistic and do 
not assess higher order levels of ToM, which would create a ceiling effect in testing. Ideally more 
comprehensive non-verbal ToM tasks should be developed, and the phenotypic role of ToM 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 223 
deficits should be explored in non-verbal children with ASD as well. As this protocol frequently 
found differences between the non-verbal ASD group and the verbal ASD group, it would be 
useful to explore whether ToM deficits played the same role in both groups as this will impact 
intervention outcomes. However, given the intertwined nature of language and other cognitive 
domains in development (Mody et al., 2013), and the relationship between language and ToM 
(Happe, 1995), it is likely that the relationship between ToM and biological processes may be 
different in non-verbal ASD samples compared to verbal ASD samples. 
I therefore opted to limit this aspect of the study to verbal participants and conduct 
comprehensive ToM testing. I utilised a ToM battery that expanded the typical analyses of first- 
or second-order false belief assessment, and included assessment of ToM capabilities from basic 
pretend play through to more complex ToM tasks such as understanding social faux pas. This 
decision prevented a ceiling effect on ToM testing for the neurotypical group. It also allowed us 
to provide an assessment of ToM capabilities in the verbal ASD group that indicated their ToM 
developmental stage by having them complete tasks of increasing complexity and then directly 
comparing their performance to the matched neurotypical group’s performance. However, as 
discussed above, I considered children to be verbal if they were able to follow two-stage 
commands. While this was sufficient for following the instructions of the ToM tasks, it is 
possible that for the higher order ToM tasks in the Advanced module, the performance of some of 
these children may have been impacted on by language-related difficulties. I do not think this 
was a large risk to the study, however, for two reasons: first, the majority of the ASD participants 
did not reach the Advanced level of the battery as they struggled with more basic ToM tasks; and, 
second, all tasks included control questions to assess comprehension of the material. 
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Nonetheless, a greater focus on assessing language more comprehensively in future studies 
would allow us to appreciate the influence of language skills on ToM in a more nuanced fashion.  
A further limitation of this study was that I assessed only one aspect of the serotonin 
system. While there is support for the role of serotonin in ASD and in ToM development, I did 
not find strong support for 5-HTTLPR specifically in my sample. While negative findings do 
help research, it would be more productive if one was able to assess the serotonergic system 
more comprehensively. A previous study found that the 5-HT1A receptor was implicated in ToM 
performance in schizophrenic patient (Bosia et al., 2011), and perhaps future studies could assess 
5-HT1A’s role in ToM in ASD as well.  
Overall Considerations From This Study 
 I aimed to integrate existing knowledge from psychological theories and genetic 
research, as I hypothesised that this approach could generate more comprehensive and nuanced 
knowledge regarding the neurobiological bases of core deficits in ASD within the context of our 
psychological understanding of this disorder. Ultimately, this knowledge may facilitate the 
development of better interventions for children with ASD. The Social Motivation Theory for 
ASD and the ToM Theory for ASD were selected as both have considerable support from 
psychological research and deficits in these areas are already the focus of some ASD 
interventions. Similarly, OPRM1 and 5-HTTLPR were selected because they are implicated in 
ASD and because medications already exist that can target the effects of these genes – that is, 
medications exist to reduce mu-opioids binding, or that target 5-HTTLPR directly if serotonergic 
transmission is atypical. The diverse nature of ASD presentations can make it a challenging 
disorder to research and there is an overwhelming amount of research from various fields. This 
research lacks integration and needs to be better synthesised for meaningful explanations about 
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the causes and development of this disorder so that treatments and interventions can be properly 
informed.  
Several further considerations could be made in future genotype-phenotype studies. 
Perhaps most importantly, the current research was conducted directly with an ASD sample with 
a matched neurotypical group for comparison. Psychological theories about ASD that include 
biological aspects should ensure an element of assessment with human ASD samples. For both 
psychological theories here, a great deal has been learnt from animal models (e.g. Cinque et al., 
2012; Moles et al., 2004), as well as from inferences from other disorders with shared traits or 
deficits (e.g. McDonald et al., 2013). To ensure the theories are valid, however, they do need to 
be assessed within human ASD samples. The complexities of human nature and the interplay 
between demographic, cognitive, and societal influences can only be considered when working 
with a human sample, and the variability of possible ASD presentations requires that these 
studies include participants with ASD.  
Human studies are complex, however, as there is not a single ASD phenotype. I used the 
ADOS2 to assess ASD-related deficits, focusing on the severity of the overall disorder, as well 
as severity of symptoms in the two main ASD symptom domains (i.e. social communication and 
interaction, and restricted and repetitive behaviours and interests). My studies were exploratory 
and among the first to explore these genotype-phenotype relationships in ASD. As the ADOS2 is 
used in diagnostics, it allows an examination of the symptoms and behaviours that clinicians tend 
to focus on. Although this gave the research clinical validity, it only allowed for a broad 
examination of the ASD phenotype. As an exploratory study this can set the foundation for later 
studies to conduct more targeted investigations. For example, where the ADOS2 SA scores 
showed associations, future studies can identify more specific symptoms in their phenotyping. In 
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this way, we may learn more about the biological underpinnings of specific aspects ASD. 
Ultimately, this may help us understand the various presentations seen in ASD.  
This protocol consistently found that non-verbal children with ASD showed different 
associations between variables of interest compared to the verbal children with ASD. Language 
is therefore a critical aspect of the ASD phenotype and needs to be considered in future research. 
My study only looked at whether language had been acquired or not, but it would have been 
useful to understand the role language plays in the ASD phenotype in more detail; future studies 
could consider the role of language delay and could aim to characterise language deficits in a 
more detailed manner. This protocol showed that children who acquired language had a 
significant advantage in their social competence compared to those who did not, and that 
understanding the mechanisms that prevent language acquisition as well as the influence of 
language deficits on the development of the ASD phenotype is needed.  
Another limitation with regard to language, is how generalisable my findings may be for 
South African children with ASD. I limited participants to children who were fluent in English, 
or non-verbal children who were from English speaking homes or schools. South Africa is a very 
diverse country, with English being only one of our 11 national languages, and it is not the home 
language of the majority of residents. This limitation was due to the use of the ADOS2, but 
efforts are being made locally to translate and validate the ADOS2, and other measures, that will 
hopefully improve the potential for more representative research from South Africa.  
The exclusion of females from my study allowed for clearer phenotyping but at a cost to 
generalisability. ASD is predominantly diagnosed in males, with a ratio of 4:1 to females 
(American Psychiatric Association, 2013). Further, there is some evidence that the female ASD 
phenotype may differ from males with the same diagnosis (River & Matson, 2011). This is 
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particularly relevant when studying social deficits, as female children with ASD may have a 
social advantage over male children with ASD. In general, female children tend to have an 
advantage in language development (Adani & Cepanec, 2019). Sedgewick et al. (2016) also 
found that female children with ASD display social motivation levels and qualities of friendships 
similar to those of female neurotypical children, and with considerably less deficits and 
difficulties in this area than male children with ASD. Female children with ASD also appear to 
have a better understanding of what is required in social relationships, and derive pleasure from 
social relationships (Cook et al., 2017; Vine Foggo & Webster, 2017). As female children with 
ASD may therefore show higher levels of social motivation than male children with ASD, as 
well as better social abilities, I did not include them in either of my studies. I did not think it 
would be possible to statistically control for sex in my studies, as I was unlikely to recruit 
sufficient females with ASD due to there being a much higher male prevalence of the disorder. 
Future studies with larger samples should aim to include females but must remain mindful of the 
possible phenotypic differences across sex in ASD.  
When considering the role of different genes in the ASD presentations, I relied on 
reported rates of the alleles as I could not afford DNA analyses for the neurotypical sample. I am 
confident that the findings are valid: for OPRM1, this high rate of the G allele has not been 
reported in any samples that I am aware of, in and outside of ASD research; and for 5-HTTLPR 
our allelic distribution was very similar to that of another local ASD sample (Arieff et al., 2010) 
which had been compared to a neurotypical sample (Esau et al., 2008) from the same 
researchers. However, it would still be best if researchers included DNA analyses for matched 
controls as this allows more direct comparison for allelic distributions differences between 
samples. Further, it will be useful to understand whether implicated genes play a unique role in 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 228 
ASD, or whether the associations between the genes and ASD-related symptoms are generally 
present in neurotypical populations as well albeit to a non-clinical degree.  
Concluding Remarks 
Combining the knowledge obtained through psychological and genetic research may 
enable progress in our understanding of underlying biological mechanisms for ASD, as well as 
their roles in ASD phenotypes across development. ASD is a prevalent and complex disorder and 
has therefore attracted the attention of researchers in various fields. Numerous psychological 
theories regarding the aetiology and development of ASD have been developed and some are 
well supported, while genetic studies have implicated hundreds of possible candidate genes. In 
the current study, I argue that there is value in combining both these fields and have done so with 
two psychological theories and two candidate genes.  
I chose to focus on deficits that are noted early in ASD as their presence early in 
development suggests they would have a critical role in later social development, and I therefore 
explored the Social Motivation Theory for ASD and the ToM Theory for ASD. Both theories 
were supported in my study, and this suggests that reduced social motivation and ToM deficits 
are areas that should be targeted early in development. While psychological intervention may not 
prevent the development of ASD, it has the potential to limit the severity of symptoms and their 
effects across the lifespan.  
I chose to focus on genes that, if found to be implicated, could be targeted with existing 
medications. Ideally children with ASD would be diagnosed early in life and based on the level 
of reduced social motivation or ToM deficits, they could be treated with medication as well as 
psychological intervention. The hope would be that this would give these children the best 
possible chance of reaching their full potential.  
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While my protocol included two genotype-phenotype studies, it was exploratory in nature 
and I faced marked limitations in time and funding. The study ideas I have suggested for future 
research will require multidisciplinary teams to ensure more in-depth genetic assessment, 
comprehensive psychological phenotyping, and clinical input regarding the role of medications. 
These studies are likely to be expensive and those looking at interventions or medical use will 
need to be longitudinal to some extent. I hope that my study has laid the foundation for such 
studies, as they will greatly improve our current understanding of ASD.  
Understanding ASD, revealing the neurobiological factors that contribute to its 
emergence, and being able to predict how the disorder will present across development will help 
with improving diagnostics and treatments, and ultimately could help thousands of children and 
their families. The current protocol has contributed by demonstrating a methodology for unifying 
existing research in a meaningful way, by furthering our knowledge of two key areas of deficits 
in ASD that are not included in the diagnostic criteria, and by identifying some important future 
avenues of research in this field.   
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Appendix A 
DSM5 ASD Diagnostic Criteria for Autism Spectrum Disorder 
Diagnostic Criteria299.00 (F84.0) 
A. Persistent deficits in social communication and social interaction across multiple 
contexts, as manifested by the following, currently or by history (examples are 
illustrative, not exhaustive; see text): 
1. Deficits in social-emotional reciprocity, ranging, for example, from abnormal 
social approach and failure of normal back-and-forth conversation; to reduced 
sharing of interests, emotions, or affect; to failure to initiate or respond to social 
interactions. 
2. Deficits in nonverbal communicative behaviors used for social interaction, 
ranging, for example, from poorly integrated verbal and nonverbal 
communication; to abnormalities in eye contact and body language or deficits in 
understanding and use of gestures; to a total lack of facial expressions and 
nonverbal communication. 
3. Deficits in developing, maintaining, and understanding relationships, ranging, for 
example, from difficulties adjusting behavior to suit various social contexts; to 
difficulties in sharing imaginative play or in making friends; to absence of interest 
in peers. 
Specify current severity: 
 Severity is based on social communication impairments and 
restricted, repetitive patterns of behavior. 
B. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least 
two of the following, currently or by history (examples are illustrative, not exhaustive; 
see text): 
1. Stereotyped or repetitive motor movements, use of objects, or speech (e.g., simple 
motor stereotypies, lining up toys or flipping objects, echolalia, idiosyncratic 
phrases). 
2. Insistence on sameness, inflexible adherence to routines, or ritualized patterns of 
verbal or nonverbal behavior (e.g., extreme distress at small changes, difficulties 
with transitions, rigid thinking patterns, greeting rituals, need to take same route 
or eat same food every day). 
3. Highly restricted, fixated interests that are abnormal in intensity or focus (e.g., 
strong attachment to or preoccupation with unusual objects, excessively 
circumscribed or perseverative interests). 
4. Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of 
the environment (e.g., apparent indifference to pain/temperature, adverse response 
to specific sounds or textures, excessive smelling or touching of objects, visual 
fascination with lights or movement). 
Specify current severity: 
 Severity is based on social communication impairments and 
restricted, repetitive patterns of behavior. 
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C. Symptoms must be present in the early developmental period (but may not become fully 
manifest until social demands exceed limited capacities, or may be masked by learned 
strategies in later life). 
D. Symptoms cause clinically significant impairment in social, occupational, or other 
important areas of current functioning. 
E. These disturbances are not better explained by intellectual disability (intellectual 
developmental disorder) or global developmental delay. Intellectual disability and autism 
spectrum disorder frequently co-occur; to make comorbid diagnoses of autism spectrum 
disorder and intellectual disability, social communication should be below that expected 
for general developmental level. 
Note: Individuals with a well-established DSM-IV diagnosis of autistic disorder, Asperger’s 
disorder, or pervasive developmental disorder not otherwise specified should be given the 
diagnosis of autism spectrum disorder. Individuals who have marked deficits in social 
communication, but whose symptoms do not otherwise meet criteria for autism spectrum 
disorder, should be evaluated for social (pragmatic) communication disorder. 
Specify if: 
• With or without accompanying intellectual impairment 
• With or without accompanying language impairment 
• Associated with a known medical or genetic condition or environmental factor 
(Coding note: Use additional code to identify the associated medical or genetic 
condition.) 
• Associated with another neurodevelopmental, mental, or behavioral disorder 
(Coding note: Use additional code[s] to identify the associated neurodevelopmental, 
mental, or behavioral disorder[s].) 
• With catatonia (refer to the criteria for catatonia associated with another mental 
disorder, pp. 119–120, for definition) (Coding note: Use additional code 293.89 [F06.1] 
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Appendix B 
Study Information Sheets: ASD Participants  
 
 
Brief Overview of Psychology Doctoral Study 
The Biological Bases of Social Deficits: The possible roles of two candidate genes in social 
motivation and social ability in Autism Spectrum Disorder 
Dear Parents  
 
You and your child are invited to participate in my study! I am a PhD Psychology student with a 
history in in Neuropsychology (MA Clinical Neuropsychology), and am a member of the 
University of Cape Town Autism Research Group (uctautism.com). I am investigating the social 
difficulties in Autism Spectrum Disorders (ASD). I am interested in general social ability, and 
specifically in social motivation and Theory of Mind. Theory of Mind refers to the ability to 
understand other people’s thoughts, beliefs, and emotions, and to understand that these are 
different from one’s own. For example, the ability to understand jokes and the ability to 
understand that when you know something, everyone else doesn’t automatically know it too, 
are forms of Theory of Mind. I am interested in two candidate genes as one may be involved in 
whether children look for social interaction (the mu-opioid receptor, OPRM1), and the other 
may be involved in how well children understand social interaction and other people’s 
behaviours (the serotonin transporter promoter length polymorphism, 5-HTTLPR).  
 
Who can participate? 
In order to participate, your son must be between 4-16 years old and must understand English. 
Children with limited language ability can participate, and even non-verbal children can 
participate, as long as their home language or the language their teachers use with them is 
English. Children can participate either if they have or are suspected to have Autism Spectrum 
Disorder. You as the parent must also be fluent in either English or Afrikaans as I will need to 
interview you about your son.  
 
Must my child and I participate?  
No, not at all – this study is completely optional. There are no negative consequences if you 
choose not to participate. Also, if you decide to participate and then change your mind, you can 
just let me know that you are withdrawing and you don’t even need to provide a reason. If this 
happens, you and your son will not be penalised in any way.  
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What will happen if we take part? 
If you decide to participate in the study, I will ask you to sign a consent form and complete a 
demographics form. The demographic forms asks about your son’s medical history and your 
family income and education. I understand that this is personal information, so as soon as I 
receive it I will remove your name and record the information under a confidential participation 
number. This information will not be shared with anyone else. We need this personal 
information for two reasons: first, we need the medical information to establish whether 
anything else could explain the relationships we are exploring, in which case we may not be 
able to include your son in the study (for example, if your child experienced a severe head 
injury, we cannot conclude that his social difficulties are due to ASD and the genes we are 
exploring); and second, we need the financial information to make sure that this research 
recruits children from all backgrounds and is therefore representative of the South African 
population.  
 
Myself or someone in my team will then call you to arrange a time to interview you. The 
interview will consist of two parts, each 30 minutes, and can be done telephonically or we can 
meet and conduct the interview in person.  
 
I will then meet with your son at his school. At the start of every session I will ask your son if he 
is willing to play the games with me that day, and if he isn’t then we won’t have a session. I will 
meet each child for 1-4 sessions, where we will complete several tasks all designed to measure 
different aspects of social and cognitive ability. All the tasks are designed to appear as games 
for the children, so they are all toy or story based.  
 
Included in these sessions is the ADOS2 assessment. The ADOS2 (Autism Diagnostic 
Observation Schedule, Second Edition) is the international gold-standard ASD diagnostic tool. 
The information from an ADOS2 assessment is very valuable to your school and any doctors or 
psychologists involved in your child’s treatment. Unfortunately there are usually long waiting 
lists to get an ADOS2 assessment and having it done privately can be quite expensive. However, 
if your child completes this assessment as part of this study I can share this information with 
the appropriate professionals.  
 
Later in my PhD I will contact some families again to arrange to use a non-invasive cheek swab 
to collect a DNA sample from your child, but only if you are comfortable with this. This is done 
to see which expression of the candidate genes I’m researching your son has. I will do this by 
gently rubbing a cotton swab on the inside of his cheek. This swab is similar to an earbud and 
will not hurt your son or pose any risk to him. To make sure your son is comfortable, I will first 
let him play with a cotton bud and get used to putting it in his mouth. He can then imitate me 
showing him how to rub the inside of the cheek. I will only collect the sample once your son is 
comfortable.  
 
What will happen to the information I give you and the information from seeing my son? 
All information is recorded under a confidential participant number, and your privacy will be 
maintained at all times. I will not share this information with others, and if any data is shared it 
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will be the kind of information that does not reveal who you are (for example, when I send the 
lab samples I may give them the age and sex of you son, but not his name, school, or anything 
else). Therefore, your name, income information, son’s medical information, and all other 
information will not be shared with anyone. All information will be securely stored so that no 
one else can access it, and the data is coded so that your name and your son’s name are 
removed. Any DNA that is unused will be destroyed.  
 
What will happen with the results of this study? 
At the end of this study I will provide you with a personalised report explaining what I learnt 
about your son. You can keep this report, and you can choose to share it with schools or any 
clinical professional involved in your son’s care (for example, psychologists, GPs, speech 
therapists, etc). I am also always available to discuss anything about the research and to answer 
any questions.  
 
If I publish my findings from this study, you and your son will never be identified personally. I 
will be delighted to share the results with you as soon as they are available.  
 
Who has approved this study?  
This study has received ethical approval from the Western Cape Education Department, the 
UCT Psychology Department Ethics Board, and the UCT Faculty of Science Ethics Board.  
 
Who is responsible for this study?  
I am the Doctoral Candidate who is conducting the study, and can be contacted at any time 
with any questions. My supervisor, Dr Susan Malcolm-Smith, is a senior lecturer and 
Neuropsychologist at UCT can also be contacted if you have any queries or complaints that you 
would rather address to her. Or, alternatively you can address these issues to Rosaline Adams, 
the administrative assistant for the Psychology Department Ethics board. All contact details are 
included at the end of this letter. 
 
How to participate? 
Thank you for considering participating in my study! In order to join the study, please sign the 
attached consent form, complete the demographic form and return these forms to your school. 
Please feel free to call me with any questions or for help submitting these forms.  
 
I look forward to hearing from you! 
 
Katie Hamilton 
PhD Psychology Candidate 
Department of Psychology, 
UCT 
082 463 8335 
kate@hamilton.co.za  
Dr Susan Malcolm-Smith 
Senior Lecturer  






Admin. Assistant: Ethics Committee 








Your name: ____________________________ Date: _____________________________ 
Child’s Name: __________________________    School: _____________________________ 
Age: __________________________________    Date of Birth: ________________________ 
Please note that you may skip any questions that you are not comfortable answering. 
1. Sex (circle one): Male  Female 
2. Ethnicity:   White   Black  Indian  Coloured 
Asian  Other                 If other please specify: _______ 
3. Home Language: _______________________ 
4. Handedness (circle one): Left  Right  Ambidextrous 
5. Number of siblings: ________________ 
6. Number of older siblings: ___________ 
7. Who is the child’s primary caregiver? ___________________________________________ 
8. What is your relationship to the child (e.g. mother, father, etc)? ______________________ 
9. Has your child ever been diagnosed with Autism Spectrum Disorder (ASD)?    YES NO 
Please indicate any other diagnoses or information related to your child’s ASD:  
 
10. Has your child ever been diagnosed with a disruptive, impulse-control, or conduct disorder, such 
as conduct disorder or oppositional defiant disorder (ODD)? YES  NO 
If yes, please specify: 
 
11. Has your child ever had a communication disorder? (For example: Having problems with 
understanding or producing speech, slow vocabulary development, difficulties recalling words or 
problems with producing sentences appropriate for his/her age.) YES  NO 
If yes, please specify: 
 
12. Has your child ever experienced learning difficulties such as dyslexia or attention-deficit / 
hyperactivity disorder (ADD/ ADHD)?     YES  NO 
If yes, please specify:  
 
13. Has your child ever experienced a head injury? (e.g., being hit on the head and losing 
consciousness as a result)      YES   NO 
If yes, please give details:  
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14. Has your child ever experienced any of the following medical conditions: 
a. Neurological problems (e.g., epilepsy, meningitis, cerebral palsy, encephalitis, Tourette’s 
syndrome, brain tumour, other) YES   NO 




b. Depression    YES   NO 




c. Memory problems   YES   NO 




d. Problems with their vision:  YES   NO 




e. Problems with their hearing (e.g. difficulty hearing, hearing aids, grommets): YES 
 NO 





f. Is he/she currently taking any prescription medication? YES  NO 
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Parent / Guardian Information 
Please indicate here if child is adopted): _____________________________ 
Please note that information on the primary caregiver is required. If the primary caregiver is not 
the biological or adoptive mother or father, please place their information under “Guardian”.  
 
What is the total monthly income of your household? (Tick the appropriate block):  
[NOTE: This should be total household income, not personal income.] 
0 – R2999  R3000 – R6299  R6300 – R 10 499  R10 500 – R 14599  
R14 600 – R18 799  R18 800 – R22 999  R23 000 – R26 999   R27 000 – R31 299  
R31 300 – R35 499  R35 500 - R39 499  R39 500 – R43 750  more than R43 750:  
What is the estimated value of your total monthly household income: R  
 
Highest level of education completed for … (please circle 
number): 
Mother Father Guardian 
1) 0 years (Never went to school) 1  1  1  
2) Grade 1  2  2  2  
3) Grade 2  3  3  3  
4) Grade 3 / Standard 1 4  4  4  
5) Grade 4 / Standard 2 5  5  5  
6) Grade 5 / Standard 3 6  6  6  
7) Grade 6 / Standard 4 7  7  7  
8) Grade 7 / Standard 5 [Completed primary school] 8  8  8  
9) Grade 8 / Standard 6 9  9  9  
10) Grade 9 / Standard 7  10  10  10  
11) Grade 10 / Standard 8 11  11  11  
12) Grade 11 / Standard 9 12  12  12  
13) Grade 12 / Standard 10 [Matric; Completed high school]  13  13  13  
14) Tertiary education: Higher education certificate 14  14  14  
15) Tertiary education: Diploma received 15  15  15  
16) Tertiary education: Bachelor’s degree received 16  16  16  
17) Tertiary education: Post graduate degree received  17  17  17  
18) Don’t know 18  18  18  
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Parental employment: (Please circle appropriate number) Mother Father Guardian 
1. Higher executives, owners of large businesses, major professionals 
(e.g. doctors, lawyers) 
2. Business managers of medium sized businesses, professions like 
nurses, opticians, pharmacists, social workers, teachers, 
accountants 
3. Administrative personnel, managers, owners / sole proprietors of 
small businesses (decorator, actor, reporter, travel agent) 
4. Clerical and sales, technicians, 
(e.g. bank teller, bookkeeper, clerk, draftsperson, timekeeper, 
secretary) 
5. Skilled manual – usually having had training  
 (e.g. baker, barber, chef, electrician, fireman, machinist, mechanic, 
welder, police, plumber, electrician) 
6. Semi-skilled (e.g. hospital aide, painter, bartender, bus driver, cook, 
garage guard, checker, waiter, machine operator) 
7. Unskilled (e.g. attendant, janitor, construction helper, unspecified 
labour, porter) 
8. Homemaker 


















































Which of the following items, in working order, does your household 
have? Yes No 
1. A refrigerator or freezer 
2. A vacuum cleaner or polisher 
3. A television 
4. A hi-fi or music center (radio excluded) 
5. A microwave oven 
6. A washing machine 
















Which of the following do you have in your home? Yes No 
1. Running water 
2. A domestic servant 
3. At least one car 
4. A flush toilet 
5. A built-in kitchen sink 
6. An electric stove or hotplate 
















Do you personally do any of the following?   
1. Shop at supermarkets 
2. Use financial services such as a bank account, ATM card or credit card 







Thank you for your participation! 
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Appendix D 
Consent Form: ASD Participants 
 
 
The study has been explained to me, and my questions have been answered. I understand that 
participation in this study is voluntary, and that I may withdraw my child at any point. I understand that 
my child will not be identified except by an initial, and that this anonymity will be maintained throughout 
the study and when the research is published.  
 
I consent to participate and to allow my child to participate in this study.  
Child’s name:  




(Optional)I hereby give consent for DNA samples to be collected from my child using cheek swabs. I 
understand that this DNA will only be used for research purposes, and will be destroyed after analysis for 
this project.  




I hereby give consent for ADOS2 administration to be video recorded. I understand that this video will 
only be used for research purposes. I give consent for this video to be stored at the Department 
Psychology, UCT, and to be used in later research.  
Signature of parent /guardian:  
Date:  
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Please indicate below if you would like to be notified of future research conducted by our research group:  
Yes, I ______________ (initial) would like to be added to your research participation pool and be notified 
of research projects in which I or my child might participate in the future.  
Phone number:  
Cell phone number:  




(Parent/guardian) ______________ has been informed of the purpose, procedures, and any possible risks 
or this study. He / she has been given time to ask any questions, and these questions have been answered 
to the best of my ability. He / she understands that participation is voluntary.  
Researcher:  
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Appendix E 
Study Information Sheets: Neurotypical Participants  
 
Brief Overview of Psychology Doctoral Study 
The Biological Bases of Social Deficits: Exploring social functioning in Autism Spectrum Disorder and 
Neurotypical Children 
Dear Parents  
 
You and your child are invited to participate in my study! I am a PhD Psychology student with a history in 
in Neuropsychology (MA Clinical Neuropsychology, 2014), and am a member of the University of Cape 
Town Autism Research Group (uctautism.com). I am investigating the social difficulties in Autism 
Spectrum Disorders (ASD) and I am inviting children with ASD and without ASD to participate. I am 
interested in general social ability, and specifically in social motivation and Theory of Mind. Theory of 
Mind refers to the ability to understand other people’s thoughts, beliefs, and emotions, and to 
understand that these are different from one’s own. For example, the ability to understand jokes and 
the ability to understand that when you know something, everyone else doesn’t automatically know it 
too, are forms of Theory of Mind. I am interested in the functioning of two candidate genes in the ASD 
group. In order to conduct my study, I have recruited children with ASD and I am now inviting children 
who do not have ASD to participate. This will enable me to make comparisons and improve our 
understanding of how children with ASD may differ from other children. 
 
Who can participate? 
In order to participate, your son must be between 4-16 years old and must understand English. Children 
can participate as long as they do not have a diagnosed Autism Spectrum Disorder and their home 
language or the language their teachers use with them is English. You as the parent must also be fluent 
in either English or Afrikaans as I will need to interview you about your son.  
 
Must my child and I participate?  
No, not at all – this study is completely optional. There are no negative consequences if you choose not 
to participate. Also, if you decide to participate and then change your mind, you can just let me know 
that you are withdrawing and you don’t even need to provide a reason. If this happens, you and your 
son will not be penalised in any way.  
 
What will happen if we take part? 
If you decide to participate in the study, I will ask you to sign a consent form and complete a 
demographics form. The demographic forms asks about your son’s medical history and your family 
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income and education. I understand that this is personal information, so as soon as I receive it I will 
remove your name and record the information under a confidential participation number. This 
information will not be shared with anyone else. We need this personal information for two reasons: 
first, we need the medical information to establish whether anything else could explain the relationships 
we are exploring, in which case we may not be able to include your son in the study, and second, we 
need the financial information to make sure that this research recruits children from all backgrounds 
and is therefore representative of the South African population.  
 
Myself or someone in my team will then call you to arrange a time to interview you. The interview will 
consist of two parts, each 30-60 minutes, and can be done telephonically or we can meet and conduct 
the interview in person.  
 
I will then meet with your son at his school. At the start of every session I will ask your son if he is willing 
to play the games with me that day, and if he isn’t then we won’t have a session. I will meet each child 
for 2 sessions of approximately 40 minutes, where we will complete several tasks all designed to 
measure different aspects of social and cognitive ability. All the tasks are designed to appear as games 
for the children, so they are all toy or story based.  
 
What will happen to the information I give you and the information from seeing my son? 
All information is recorded under a confidential participant number, and your privacy will be maintained 
at all times. I will not share this information with others, and if any data is shared it will be the kind of 
information that does not reveal who you are. Therefore, your name, income information, son’s medical 
information, and all other information will not be shared with anyone. All information will be securely 
stored so that no one else can access it, and the data is coded so that your name and your son’s name 
are removed.  
 
What will happen with the results of this study? 
At the end of this study I will provide you with a personalised report explaining what I learnt about your 
son. You can keep this report, and you can choose to share it with schools or any clinical professional 
involved in your son’s care (for example, psychologists, GPs, speech therapists, etc). I am also always 
available to discuss anything about the research and to answer any questions.  
 
If I publish my findings from this study, you and your son will never be identified personally. I will be 
delighted to share the results with you as soon as they are available.  
 
Who has approved this study?  
This study has received ethical approval from the Western Cape Education Department, the UCT 
Psychology Department Ethics Board, and the UCT Faculty of Science Ethics Board.  
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Who is responsible for this study?  
I am the Doctoral Candidate who is conducting the study, and can be contacted at any time with any 
questions. My supervisor, Dr Susan Malcolm-Smith, is a senior lecturer and Neuropsychologist at UCT 
can also be contacted if you have any queries or complaints that you would rather address to her. Or, 
alternatively you can address these issues to Rosalind Adams, the administrative assistant for the 
Psychology Department Ethics board. All contact details are included at the end of this letter.  
 
How to participate? 
Thank you for considering participating in my study! In order to join the study, please sign the attached 
consent form, complete the demographic form and return these forms to your school. Please feel free 
to call me with any questions or for help submitting these forms.  
 
I look forward to hearing from you! 
 
Katie Hamilton 
PhD Psychology Candidate 
Department of Psychology, 
UCT 
082 463 8335 
kate@hamilton.co.za  
Dr Susan Malcolm-Smith 
Senior Lecturer  






Admin. Assistant: Ethics Committee 
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Appendix F 




The study has been explained to me, and my questions have been answered. I understand that 
participation in this study is voluntary, and that I may withdraw my child at any point. I understand that 
my child will not be identified except by an initial, and that this anonymity will be maintained throughout 
the study and when the research is published.  
 
I consent to participate and to allow my child to participate in this study.  
Child’s name:  
Signature of parent /guardian:  
Date:  
 
Please indicate below if you would like to be notified of future research conducted by our research group:  
Yes, I _____________ (initial) would like to be added to your research participation pool and be notified 
of research projects in which I or my child might participate in the future.  
Phone number:  
Cell phone number:  
E-mail address:  
 
(Parent/guardian) ______________ has been informed of the purpose, procedures, and any possible risks 
or this study. He / she has been given time to ask any questions, and these questions have been answered 
to the best of my ability. He / she understands that participation is voluntary.  
Researcher:  
Signature & Date:  
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Appendix G 
ADOS2 Research Reliability Certification 
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Appendix H 
Attachment Style Classification Questionnaire  
For the following questions, I would like you to think about how your son is around 
friends, or around other children. For each question, I would like to know whether the 
statement is true or not for your son. If you are not sure, that is also fine.  
 Not true Unsure True 
1. My son makes friends with other children easily. True or not true?* 0 1 2 
2. My son doesn’t feel comfortable trying to make friends. 0 1 2 
3. It is easy for my son to depend on others, if they’re good friends of 
his. * 
0 1 2 
4. Sometimes others get too friendly and too close to my son. 0 1 2 
5. Sometimes my son is afraid that other kids won’t want to be with him. 0 1 2 
6. My son would like to be really close to some children and always be with 
them. 
0 1 2 
7. It’s all right with my son if good friends trust and depend on him.* 0 1 2 
8. It’s hard for my son to trust others completely. 0 1 2 
9. My son sometimes feels that others don’t want to be good friends with 
him as much as he does with them. 
0 1 2 
10. My son usually believes that others who are close to him will not 
leave him.* 
0 1 2 
11. My son is sometimes afraid that no one really loves him. 0 1 2 
12. My son finds it uncomfortable and gets annoyed when someone tries to 
get too close to him. 
0 1 2 
13. It’s hard for my child to really trust others, even if they’re good friends of 
his/hers. 
0 1 2 
14. Children sometimes avoid my child when he wants to get too close and 
be a good friend of theirs. 
0 1 2 
15. Usually when anyone tries to get too close to my child, it does not 
bother him.* 
0 1 2 
* Items indicating Secure Attachment 
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Appendix I 
UCT Psychology Department Ethics Board Clearance  
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Appendix J 
UCT Faculty of Science Research Ethics Committee Clearance 
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Appendix K 
UCT Faculty of Health Sciences Human Research Ethics Committee Clearance 
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Appendix L 
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Appendix M 
University of Cape Town Theory of Mind Battery: Task Descriptions 
 
EARLY MODULE 
TASK ASSESSES EXAMPLE 
Desire Ability to predict behaviour based 
on a character’s stated desire in a 
simple comic 
Comic explaining Sam wants to find his cellular phone. He 
thinks it is either in the cupboard under the bed. He looks in 
the cupboard but finds a different item. Check child knows 
what Sam was looking for. Ask child, “What will Sam do now – 
will be go to school or will be look under the bed?”  
Pretend Play Ability to use a doll appropriately 
(i.e. as the agent of action) in a 
structured pretend situation 
Use doll and props. “It is time to water the plants. Watch 
what Sam does. Look, Sam is getting the watering can.” 
Examiner makes doll take watering can. “Show me what Sam 




Ability to understand that a 
character obtains knowledge 
from visual access to a box the 
child cannot see inside of 
Using two dolls and props; act out while dictating. “Tina looks 
in the box. Sam pushes the box. Does Tina know what is in the 
box? Does Sam know what is in the box?” 
Diverse Desires Ability to understand that a 
character has desires different to 
one’s own, and that this will 
guide their choices.  
Use dolls and images of food items. “It is snack time, and Sam 
wants a snack to eat. There are carrots and chips. Which 
would you like best?” Allow child to respond. “That’s a good 
choice, but Sam really likes [alternate food to child’s choice]. 
Which snack will Sam choose, carrots or chips?” 
Diverse Beliefs
  
Ability to understand a character 
can have different thoughts to 
their own, and that this will guide 
their actions.  
Use doll and images of locations. “Tina wants to find her cat. 
Her cat might be hiding in the bushes or it might be hiding in 
the garage. Where do you think the cat is?” Allow child to 
respond. “That’s a good idea, but Tina thinks her cat is in 
[alternate location to child’s choice]. So where will Tina look, 
the garage or the bushes?” 
 
BASIC MODULE 




First-order false belief; Ability to 
understand that a character’s 
false belief about an item’s 
location would guide their 
behaviour when looking for the 
item 
Illustrated picture story shows Emma eating chocolate in the 
kitchen, then playing it in a drawer before leaving. While 
away, her mother moves it to the fridge. Emma comes back 
into the kitchen later. Ask child where Emma would look first 




First-order false belief; Ability to 
understand that a character’s 
false belief about a box’s content 
would guide the expectation of 
its contents 
Place crayons inside a Smarties (chocolate) box without the 
child seeing. Ask the child what they think is inside the box. 
Show them the items and ask, then close the box again. Ask 
child what is in the box [reality]. Ask child what they had 
thought was in the box [representational change]. Ask if their 
mother would know what was in the box if she entered the 
room now and saw the closed box [ignorance]. Ask child what 
their mother would think is in the box [false belief].  
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Belief-Emotion First-order false beliefs; Ability to 
understand how a character’s 
false beliefs will guide their 
expectations and emotions, and 
then how their emotions will 
change when these expectations 
are not met by reality.  
Use dolls and props. Show child a closed cookie box containing 
a spoon, without letting them touch the box. Ask child what 
they think is in the box. State the doll’s favourite snack is 
cookies. Remove dolls so it does not have visual access and 
show the child the real contents of the box. Bring doll back 
and give doll the box. Ask the child how the doll would feel on 
receiving the box. Open the box, and ask child how doll would 
feel now.  
Real-Apparent 
Emotion 
Ability to differentiate how a 
character’s true feelings may 
differ from their expressed 
emotion state 
Story task with pictures. Tell a story about a child who is 
joking around with his friends. A friend tells a mean joke 
about the main character, Matt. Tell child that Matt did not 
find the joke funny, but did not want the other children to 
know how he felt so he tried to hide how he felt. Ask child 
control questions, ask child how Matt really felt when the joke 
was told [emoticon faces of happy, sad, okay provided]. Ask 
child how he tried to look on his face when the joke was told.  
 
INTERMEDIATE MODULE 
TASK ASSESSES EXAMPLE 
Second Order 
False Belief 
Second order false beliefs; 
Knowledge of a character’s 
beliefs about another character’s 
beliefs.  
Story with pictures. Ted wants to surprise his mother with 
breakfast in bed for Mother’s Day. He starts to cook the meal, 
then goes to his mother’s room. She is in bed and states she 
wants breakfast in bed. Ted wants it to be a surprise, so states 
that he actually made her a card. Ted returns to kitchen and 
does not notice his mother observe him doing so. Later, his 
father enters the kitchen and asks Ted: “Does Mom know 
what you’re making her for Mother’s Day? [child answers] 
What does mom think you are making her?” [child answers]. 
Strange Stories Ability to identify situations 
where language was used in lies, 
white lies, jokes, pretend/play, 
double-bluff, persuasion, figures 
of speech, appearance vs reality, 
irony, or contrary emotions, or to 
indicate situations where 
characters had forgotten or 
misunderstood.  
Story task. Philip and Ian see Mrs Thompson coming out of the 
hairdresser’s one day. She looks a bit funny because they cut 
her hair much too short. Phlilip says to Ian, “She must have 
been in a fight with a lawnmower!”. ASD child if what Phillip 
says is true. Ask child why Phillip said it.  
 
ADVANCED MODULE 
TASK ASSESSES EXAMPLE 
Lie-Joke Ability to identify whether 
something that was untrue was a 
lie or a joke based on a 
character’s knowledge (e.g. 
Patricia) of another character’s 
knowledge (e.g. Mom).  
Story task. Patricia’s mom based muffin and told Patricia not 
to eat any. Mom then leaves, and a friend comes over to play, 
Tina. When Tina leaves the room, Patricia eats a muffin, but 
Mom has returned and sees her through the window. Patricia 
sees her mom looking angrily at her as she eats the muffin, 
but continues to do so. Tina returns and asks if Mom knows 
Patricia is eating the muffin [child responds]. Mom enters the 
kitchen and asks Patricia if she ate a muffin and Patricia 
denies it. Ask child, “When Patricia said that, did she think her 
BIOLOGICAL BASIS OF SOCIAL DEFICITS IN ASD 280 
mom would believe her? [child responds] Was she lying to 
avoid getting caught or joking to cover her 
embarrassment?”[child responds] 
Faux Pas Ability to identity if a character 
makes a social faux pas - that is, 
how socially adept the child is at 
identify when an action / 
statement offends someone  
Story task. Kim helped mom bake an apple pie for her uncle 
and presents it to him. He responds, “That looks lovely. I love 
pies, except for apple, of course”. Ask child what kind of pie it 
was. Ask child if the uncle knew what kind of pie it was. Ask 
child if anyone said something they shouldn’t have.  
 
 
 
 
